{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:01:54Z","timestamp":1789621314080,"version":"build-2803163510"},"reference-count":548,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Research Grants Council-General Research Fund","award":["14110625"],"award-info":[{"award-number":["14110625"]}]},{"name":"CUHK Knowledge Transfer Committee-IdeaBooster Fund","award":["IDBF25MED10"],"award-info":[{"award-number":["IDBF25MED10"]}]},{"name":"United College Endowment Fund Research Grant","award":["8509804"],"award-info":[{"award-number":["8509804"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chromatin remodeling comprises a set of molecular mechanisms that regulate gene transcription, DNA replication, and DNA repair by altering nucleosome structure. Previous studies have found that chromatin remodelers are heavily mutated in cancer patients, and targeting aberrant chromatin remodeling activities holds great potential for clinical benefit. Despite these promising findings, several significant hurdles remain before this strategy can be successfully transitioned from bench to bedside. The classic concept of chromatin remodeling focuses on the linear 2D chromatin structural level. While the emergence of sophisticated sequencing modalities has underscored the significance of 3D chromatin architecture, the mechanistic underpinnings and broader implications for cancer biology continue to be largely elusive. This review provides a comprehensive synthesis of the mechanisms and functional roles of classical chromatin remodelers within both physiological and neoplastic contexts. Furthermore, we integrate emerging insights regarding the cohesin complex as a primary mediator of three-dimensional (3D) genomic organization. By proposing a hierarchical framework that distinguishes between 'first-level' (classical) and 'higher-order' chromatin remodeling, we aim to provide a more holistic understanding of the integrated regulatory networks governing chromatin architecture. Furthermore, we have systematically cataloged the landscape of therapeutic strategies targeting chromatin remodelers in oncology. By evaluating the divergence between clinically approved therapies and those currently in developmental pipelines, we delineate the primary challenges confronting the field and propose strategic directions for future research. Collectively, we have delineated the multifaceted contributions of chromatin remodeling to cancer progression. The strategic modulation of these remodeling processes represents a vital frontier in the development of novel therapeutic interventions and is likely to emerge as a primary focus for future cancer management strategies.<\/jats:p>","DOI":"10.1186\/s12943-026-02763-x","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T03:13:28Z","timestamp":1786072408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The roles of chromatin remodeling and 3D genome organization in cancers: from mechanistic insights to emerging treatment options"],"prefix":"10.1186","volume":"25","author":[{"given":"Chuqiao","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninglin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin Yee","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U Sin","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Y.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Man","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok Wai","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mumin","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh K.","family":"Alahari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary M.","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"issue":"5365","key":"2763_CR1","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/238444a0","volume":"238","author":"J Paul","year":"1972","unstructured":"Paul J. General theory of chromosome structure and gene activation in eukaryotes. Nature. 1972;238(5365):444\u20136.","journal-title":"Nature"},{"key":"2763_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1146\/annurev.bi.63.070194.001405","volume":"63","author":"SM Paranjape","year":"1994","unstructured":"Paranjape SM, Kamakaka RT, Kadonaga JT. Role of chromatin structure in the regulation of transcription by RNA polymerase II. Annu Rev Biochem. 1994;63:265\u201397.","journal-title":"Annu Rev Biochem"},{"issue":"4","key":"2763_CR3","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/0022-2836(84)90315-2","volume":"178","author":"M Stern","year":"1984","unstructured":"Stern M, Jensen R, Herskowitz I. Five SWI genes are required for expression of the HO gene in yeast. J Mol Biol. 1984;178(4):853\u201368.","journal-title":"J Mol Biol"},{"issue":"5","key":"2763_CR4","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.cell.2018.09.032","volume":"175","author":"N Mashtalir","year":"2018","unstructured":"Mashtalir N, D\u2019Avino AR, Michel BC, Luo J, Pan J, Otto JE, et al. Modular Organization and Assembly of SWI\/SNF Family Chromatin Remodeling Complexes. Cell. 2018;175(5):1272-88.e20.","journal-title":"Cell"},{"issue":"7","key":"2763_CR5","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1091\/mbc.6.7.777","volume":"6","author":"AK Dingwall","year":"1995","unstructured":"Dingwall AK, Beek SJ, McCallum CM, Tamkun JW, Kalpana GV, Goff SP, et al. The Drosophila snr1 and brm proteins are related to yeast SWI\/SNF proteins and are components of a large protein complex. Mol Biol Cell. 1995;6(7):777\u201391.","journal-title":"Mol Biol Cell"},{"issue":"3","key":"2763_CR6","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/0092-8674(92)90191-E","volume":"68","author":"JW Tamkun","year":"1992","unstructured":"Tamkun JW, Deuring R, Scott MP, Kissinger M, Pattatucci AM, Kaufman TC, et al. brahma: a regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2\/SWI2. Cell. 1992;68(3):561\u201372.","journal-title":"Cell"},{"issue":"17","key":"2763_CR7","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.1093\/nar\/20.17.4649","volume":"20","author":"I Okabe","year":"1992","unstructured":"Okabe I, Bailey LC, Attree O, Srinivasan S, Perkel JM, Laurent BC, et al. Cloning of human and bovine homologs of SNF2\/SWI2: a global activator of transcription in yeast S. cerevisiae. Nucleic Acids Res. 1992;20(17):4649\u201355.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2763_CR8","first-page":"2225","volume":"14","author":"LK Elfring","year":"1994","unstructured":"Elfring LK, Deuring R, McCallum CM, Peterson CL, Tamkun JW. Identification and characterization of Drosophila relatives of the yeast transcriptional activator SNF2\/SWI2. Mol Cell Biol. 1994;14(4):2225\u201334.","journal-title":"Mol Cell Biol"},{"issue":"3\u20134","key":"2763_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1159\/000015027","volume":"81","author":"T Aihara","year":"1998","unstructured":"Aihara T, Miyoshi Y, Koyama K, Suzuki M, Takahashi E, Monden M, et al. Cloning and mapping of SMARCA5 encoding hSNF2H, a novel human homologue of Drosophila ISWI. Cytogenet Cell Genet. 1998;81(3\u20134):191\u20133.","journal-title":"Cytogenet Cell Genet"},{"issue":"4","key":"2763_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0968-0004(00)88990-2","volume":"20","author":"CL Peterson","year":"1995","unstructured":"Peterson CL, Tamkun JW. The SWI-SNF complex: a chromatin remodeling machine? Trends Biochem Sci. 1995;20(4):143\u20136.","journal-title":"Trends Biochem Sci"},{"issue":"5713","key":"2763_CR11","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/279494a0","volume":"279","author":"R DiLauro","year":"1979","unstructured":"DiLauro R, Taniguchi T, Musso R, de Crombrugghe B. Unusual location and function of the operator in the Escherichia coli galactose operon. Nature. 1979;279(5713):494\u2013500.","journal-title":"Nature"},{"issue":"3","key":"2763_CR12","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1073\/pnas.77.3.1432","volume":"77","author":"R Grosschedl","year":"1980","unstructured":"Grosschedl R, Birnstiel ML. Identification of regulatory sequences in the prelude sequences of an H2A histone gene by the study of specific deletion mutants in vivo. Proc Natl Acad Sci U S A. 1980;77(3):1432\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"2763_CR13","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.1073\/pnas.81.16.5017","volume":"81","author":"TM Dunn","year":"1984","unstructured":"Dunn TM, Hahn S, Ogden S, Schleif RF. An operator at -280 base pairs that is required for repression of araBAD operon promoter: addition of DNA helical turns between the operator and promoter cyclically hinders repression. Proc Natl Acad Sci U S A. 1984;81(16):5017\u201320.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"2763_CR14","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.1093\/nar\/12.14.5589","volume":"12","author":"B Wasylyk","year":"1984","unstructured":"Wasylyk B, Wasylyk C, Chambon P. Short and long range activation by the SV40 enhancer. Nucleic Acids Res. 1984;12(14):5589\u2013608.","journal-title":"Nucleic Acids Res"},{"issue":"5558","key":"2763_CR15","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1126\/science.1067799","volume":"295","author":"J Dekker","year":"2002","unstructured":"Dekker J, Rippe K, Dekker M, Kleckner N. Capturing chromosome conformation. Science. 2002;295(5558):1306\u201311.","journal-title":"Science"},{"issue":"11","key":"2763_CR16","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/ng1891","volume":"38","author":"Z Zhao","year":"2006","unstructured":"Zhao Z, Tavoosidana G, Sj\u00f6linder M, G\u00f6nd\u00f6r A, Mariano P, Wang S, et al. Circular chromosome conformation capture (4C) uncovers extensive networks of epigenetically regulated intra- and interchromosomal interactions. Nat Genet. 2006;38(11):1341\u20137.","journal-title":"Nat Genet"},{"issue":"10","key":"2763_CR17","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1101\/gr.5571506","volume":"16","author":"J Dostie","year":"2006","unstructured":"Dostie J, Richmond TA, Arnaout RA, Selzer RR, Lee WL, Honan TA, et al. Chromosome Conformation Capture Carbon Copy (5C): a massively parallel solution for mapping interactions between genomic elements. Genome Res. 2006;16(10):1299\u2013309.","journal-title":"Genome Res"},{"issue":"5950","key":"2763_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1126\/science.1181369","volume":"326","author":"E Lieberman-Aiden","year":"2009","unstructured":"Lieberman-Aiden E, van Berkum NL, Williams L, Imakaev M, Ragoczy T, Telling A, et al. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science. 2009;326(5950):289\u201393.","journal-title":"Science"},{"issue":"1","key":"2763_CR19","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.cell.2015.05.048","volume":"162","author":"TH Hsieh","year":"2015","unstructured":"Hsieh TH, Weiner A, Lajoie B, Dekker J, Friedman N, Rando OJ. Mapping Nucleosome Resolution Chromosome Folding in Yeast by Micro-C. Cell. 2015;162(1):108\u201319.","journal-title":"Cell"},{"issue":"2","key":"2763_CR20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/ng.2871","volume":"46","author":"JR Hughes","year":"2014","unstructured":"Hughes JR, Roberts N, McGowan S, Hay D, Giannoulatou E, Lynch M, et al. Analysis of hundreds of cis-regulatory landscapes at high resolution in a single, high-throughput experiment. Nat Genet. 2014;46(2):205\u201312.","journal-title":"Nat Genet"},{"issue":"7398","key":"2763_CR21","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature11082","volume":"485","author":"JR Dixon","year":"2012","unstructured":"Dixon JR, Selvaraj S, Yue F, Kim A, Li Y, Shen Y, et al. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature. 2012;485(7398):376\u201380.","journal-title":"Nature"},{"issue":"7398","key":"2763_CR22","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nature11049","volume":"485","author":"EP Nora","year":"2012","unstructured":"Nora EP, Lajoie BR, Schulz EG, Giorgetti L, Okamoto I, Servant N, et al. Spatial partitioning of the regulatory landscape of the X-inactivation centre. Nature. 2012;485(7398):381\u20135.","journal-title":"Nature"},{"issue":"22","key":"2763_CR23","doi-asserted-by":"publisher","first-page":"11202","DOI":"10.1093\/nar\/gks925","volume":"40","author":"E Alipour","year":"2012","unstructured":"Alipour E, Marko JF. Self-organization of domain structures by DNA-loop-extruding enzymes. Nucleic Acids Res. 2012;40(22):11202\u201312.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"2763_CR24","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.cell.2012.01.010","volume":"148","author":"T Sexton","year":"2012","unstructured":"Sexton T, Yaffe E, Kenigsberg E, Bantignies F, Leblanc B, Hoichman M, et al. Three-dimensional folding and functional organization principles of the Drosophila genome. Cell. 2012;148(3):458\u201372.","journal-title":"Cell"},{"issue":"6471","key":"2763_CR25","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1126\/science.aaz3418","volume":"366","author":"IF Davidson","year":"2019","unstructured":"Davidson IF, Bauer B, Goetz D, Tang W, Wutz G, Peters JM. DNA loop extrusion by human cohesin. Science. 2019;366(6471):1338\u201345.","journal-title":"Science"},{"key":"2763_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1146\/annurev.biochem.77.062706.153223","volume":"78","author":"CR Clapier","year":"2009","unstructured":"Clapier CR, Cairns BR. The biology of chromatin remodeling complexes. Annu Rev Biochem. 2009;78:273\u2013304.","journal-title":"Annu Rev Biochem"},{"issue":"7","key":"2763_CR27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41571-020-0357-3","volume":"17","author":"P Mittal","year":"2020","unstructured":"Mittal P, Roberts CWM. The SWI\/SNF complex in cancer - biology, biomarkers and therapy. Nat Rev Clin Oncol. 2020;17(7):435\u201348.","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"2763_CR28","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nrc3068","volume":"11","author":"BG Wilson","year":"2011","unstructured":"Wilson BG, Roberts CW. SWI\/SNF nucleosome remodellers and cancer. Nat Rev Cancer. 2011;11(7):481\u201392.","journal-title":"Nat Rev Cancer"},{"issue":"19","key":"2763_CR29","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1002\/j.1460-2075.1996.tb00921.x","volume":"15","author":"W Wang","year":"1996","unstructured":"Wang W, C\u00f4t\u00e9 J, Xue Y, Zhou S, Khavari PA, Biggar SR, et al. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. Embo j. 1996;15(19):5370\u201382.","journal-title":"Embo j"},{"issue":"6866","key":"2763_CR30","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/414924a","volume":"414","author":"B Lemon","year":"2001","unstructured":"Lemon B, Inouye C, King DS, Tjian R. Selectivity of chromatin-remodelling cofactors for ligand-activated transcription. Nature. 2001;414(6866):924\u20138.","journal-title":"Nature"},{"issue":"11","key":"2763_CR31","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1074\/jbc.RA117.001065","volume":"293","author":"A Alpsoy","year":"2018","unstructured":"Alpsoy A, Dykhuizen EC. Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI\/SNF chromatin remodeling subcomplexes. J Biol Chem. 2018;293(11):3892\u2013903.","journal-title":"J Biol Chem"},{"issue":"47","key":"2763_CR32","doi-asserted-by":"publisher","first-page":"32254","DOI":"10.1074\/jbc.M806061200","volume":"283","author":"MD Kaeser","year":"2008","unstructured":"Kaeser MD, Aslanian A, Dong MQ, Yates JR 3rd, Emerson BM. BRD7, a novel PBAF-specific SWI\/SNF subunit, is required for target gene activation and repression in embryonic stem cells. J Biol Chem. 2008;283(47):32254\u201363.","journal-title":"J Biol Chem"},{"issue":"7908","key":"2763_CR33","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41586-022-04658-5","volume":"605","author":"J Yuan","year":"2022","unstructured":"Yuan J, Chen K, Zhang W, Chen Z. Structure of human chromatin-remodelling PBAF complex bound to a nucleosome. Nature. 2022;605(7908):166\u201371.","journal-title":"Nature"},{"issue":"18","key":"2763_CR34","doi-asserted-by":"publisher","first-page":"gkaf958","DOI":"10.1093\/nar\/gkaf958","volume":"53","author":"N Moro","year":"2025","unstructured":"Moro N, Fujisawa-Tanaka Y, Watanabe S. ARID1A regulates histone octamer transfer activity of human canonical BAF complex. Nucleic Acids Res. 2025;53(18).","journal-title":"Nucleic Acids Res"},{"issue":"Pt 2","key":"2763_CR35","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1042\/BJ20040524","volume":"383","author":"X Wang","year":"2004","unstructured":"Wang X, Nagl NG, Wilsker D, Van Scoy M, Pacchione S, Yaciuk P, et al. Two related ARID family proteins are alternative subunits of human SWI\/SNF complexes. Biochem J. 2004;383(Pt 2):319\u201325.","journal-title":"Biochem J"},{"issue":"12","key":"2763_CR36","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/s41556-018-0221-1","volume":"20","author":"BC Michel","year":"2018","unstructured":"Michel BC, D\u2019Avino AR, Cassel SH, Mashtalir N, McKenzie ZM, McBride MJ, et al. A non-canonical SWI\/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation. Nat Cell Biol. 2018;20(12):1410\u201320.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"2763_CR37","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1038\/s41467-019-09891-7","volume":"10","author":"X Wang","year":"2019","unstructured":"Wang X, Wang S, Troisi EC, Howard TP, Haswell JR, Wolf BK, et al. BRD9 defines a SWI\/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors. Nat Commun. 2019;10(1):1881.","journal-title":"Nat Commun"},{"issue":"6","key":"2763_CR38","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nrm1945","volume":"7","author":"A Saha","year":"2006","unstructured":"Saha A, Wittmeyer J, Cairns BR. Chromatin remodelling: the industrial revolution of DNA around histones. Nat Rev Mol Cell Biol. 2006;7(6):437\u201347.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"2763_CR39","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1038\/ng.3958","volume":"49","author":"RT Nakayama","year":"2017","unstructured":"Nakayama RT, Pulice JL, Valencia AM, McBride MJ, McKenzie ZM, Gillespie MA, et al. SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promoters. Nat Genet. 2017;49(11):1613\u201323.","journal-title":"Nat Genet"},{"issue":"2","key":"2763_CR40","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/ng.3744","volume":"49","author":"R Mathur","year":"2017","unstructured":"Mathur R, Alver BH, San Roman AK, Wilson BG, Wang X, Agoston AT, et al. ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice. Nat Genet. 2017;49(2):296\u2013302.","journal-title":"Nat Genet"},{"issue":"2","key":"2763_CR41","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/ng.3746","volume":"49","author":"X Wang","year":"2017","unstructured":"Wang X, Lee RS, Alver BH, Haswell JR, Wang S, Mieczkowski J, et al. SMARCB1-mediated SWI\/SNF complex function is essential for enhancer regulation. Nat Genet. 2017;49(2):289\u201395.","journal-title":"Nat Genet"},{"issue":"1","key":"2763_CR42","doi-asserted-by":"publisher","first-page":"5139","DOI":"10.1038\/s41467-018-07528-9","volume":"9","author":"J Gatchalian","year":"2018","unstructured":"Gatchalian J, Malik S, Ho J, Lee DS, Kelso TWR, Shokhirev MN, et al. A non-canonical BRD9-containing BAF chromatin remodeling complex regulates naive pluripotency in mouse embryonic stem cells. Nat Commun. 2018;9(1):5139.","journal-title":"Nat Commun"},{"issue":"10","key":"2763_CR43","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.1093\/nar\/gkx221","volume":"45","author":"NE Wiest","year":"2017","unstructured":"Wiest NE, Houghtaling S, Sanchez JC, Tomkinson AE, Osley MA. The SWI\/SNF ATP-dependent nucleosome remodeler promotes resection initiation at a DNA double-strand break in yeast. Nucleic Acids Res. 2017;45(10):5887\u2013900.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"2763_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1500447","volume":"1","author":"C Kadoch","year":"2015","unstructured":"Kadoch C, Crabtree GR. Mammalian SWI\/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics. Sci Adv. 2015;1(5):e1500447.","journal-title":"Sci Adv"},{"issue":"6","key":"2763_CR45","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/ng.2628","volume":"45","author":"C Kadoch","year":"2013","unstructured":"Kadoch C, Hargreaves DC, Hodges C, Elias L, Ho L, Ranish J, et al. Proteomic and bioinformatic analysis of mammalian SWI\/SNF complexes identifies extensive roles in human malignancy. Nat Genet. 2013;45(6):592\u2013601.","journal-title":"Nat Genet"},{"issue":"1","key":"2763_CR46","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s13046-021-02151-x","volume":"40","author":"Y Li","year":"2021","unstructured":"Li Y, Gong H, Wang P, Zhu Y, Peng H, Cui Y, et al. The emerging role of ISWI chromatin remodeling complexes in cancer. J Exp Clin Cancer Res. 2021;40(1):346.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"2763_CR47","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S1097-2765(03)00273-9","volume":"12","author":"T Gr\u00fcne","year":"2003","unstructured":"Gr\u00fcne T, Brzeski J, Eberharter A, Clapier CR, Corona DF, Becker PB, et al. Crystal structure and functional analysis of a nucleosome recognition module of the remodeling factor ISWI. Mol Cell. 2003;12(2):449\u201360.","journal-title":"Mol Cell"},{"issue":"7428","key":"2763_CR48","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nature11625","volume":"492","author":"CR Clapier","year":"2012","unstructured":"Clapier CR, Cairns BR. Regulation of ISWI involves inhibitory modules antagonized by nucleosomal epitopes. Nature. 2012;492(7428):280\u20134.","journal-title":"Nature"},{"issue":"6","key":"2763_CR49","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/0092-8674(95)90217-1","volume":"83","author":"T Tsukiyama","year":"1995","unstructured":"Tsukiyama T, Daniel C, Tamkun J, Wu C. ISWI, a member of the SWI2\/SNF2 ATPase family, encodes the 140 kDa subunit of the nucleosome remodeling factor. Cell. 1995;83(6):1021\u20136.","journal-title":"Cell"},{"issue":"6","key":"2763_CR50","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/0092-8674(95)90216-3","volume":"83","author":"T Tsukiyama","year":"1995","unstructured":"Tsukiyama T, Wu C. Purification and properties of an ATP-dependent nucleosome remodeling factor. Cell. 1995;83(6):1011\u201320.","journal-title":"Cell"},{"issue":"6642","key":"2763_CR51","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/41587","volume":"388","author":"PD Varga-Weisz","year":"1997","unstructured":"Varga-Weisz PD, Wilm M, Bonte E, Dumas K, Mann M, Becker PB. Chromatin-remodelling factor CHRAC contains the ATPases ISWI and topoisomerase II. Nature. 1997;388(6642):598\u2013602.","journal-title":"Nature"},{"issue":"1","key":"2763_CR52","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0092-8674(00)80321-9","volume":"90","author":"T Ito","year":"1997","unstructured":"Ito T, Bulger M, Pazin MJ, Kobayashi R, Kadonaga JT. ACF, an ISWI-containing and ATP-utilizing chromatin assembly and remodeling factor. Cell. 1997;90(1):145\u201355.","journal-title":"Cell"},{"issue":"9","key":"2763_CR53","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/emboj\/21.9.2231","volume":"21","author":"L Bozhenok","year":"2002","unstructured":"Bozhenok L, Wade PA, Varga-Weisz P. WSTF-ISWI chromatin remodeling complex targets heterochromatic replication foci. Embo j. 2002;21(9):2231\u201341.","journal-title":"Embo j"},{"issue":"17","key":"2763_CR54","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1093\/emboj\/20.17.4892","volume":"20","author":"R Strohner","year":"2001","unstructured":"Strohner R, Nemeth A, Jansa P, Hofmann-Rohrer U, Santoro R, L\u00e4ngst G, et al. NoRC\u2013a novel member of mammalian ISWI-containing chromatin remodeling machines. Embo j. 2001;20(17):4892\u2013900.","journal-title":"Embo j"},{"issue":"24","key":"2763_CR55","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1101\/gad.1032202","volume":"16","author":"P Badenhorst","year":"2002","unstructured":"Badenhorst P, Voas M, Rebay I, Wu C. Biological functions of the ISWI chromatin remodeling complex NURF. Genes Dev. 2002;16(24):3186\u201398.","journal-title":"Genes Dev"},{"issue":"24","key":"2763_CR56","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2023114221","volume":"42","author":"A Radzisheuskaya","year":"2023","unstructured":"Radzisheuskaya A, Pe\u00f1a-R\u00f8mer I, Lorenzini E, Koche R, Zhan Y, Shliaha PV, et al. An alternative NURF complex sustains acute myeloid leukemia by regulating the accessibility of insulator regions. Embo j. 2023;42(24):e114221.","journal-title":"Embo j"},{"issue":"6","key":"2763_CR57","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1073\/pnas.90.6.2414","volume":"90","author":"V Delmas","year":"1993","unstructured":"Delmas V, Stokes DG, Perry RP. A mammalian DNA-binding protein that contains a chromodomain and an SNF2\/SWI2-like helicase domain. Proc Natl Acad Sci U S A. 1993;90(6):2414\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"2763_CR58","doi-asserted-by":"publisher","first-page":"11472","DOI":"10.1073\/pnas.94.21.11472","volume":"94","author":"T Woodage","year":"1997","unstructured":"Woodage T, Basrai MA, Baxevanis AD, Hieter P, Collins FS. Characterization of the CHD family of proteins. Proc Natl Acad Sci U S A. 1997;94(21):11472\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"2763_CR59","doi-asserted-by":"publisher","first-page":"11779","DOI":"10.1074\/jbc.M110.208207","volume":"286","author":"RE Mansfield","year":"2011","unstructured":"Mansfield RE, Musselman CA, Kwan AH, Oliver SS, Garske AL, Davrazou F, et al. Plant homeodomain (PHD) fingers of CHD4 are histone H3-binding modules with preference for unmodified H3K4 and methylated H3K9. J Biol Chem. 2011;286(13):11779\u201391.","journal-title":"J Biol Chem"},{"issue":"4","key":"2763_CR60","doi-asserted-by":"publisher","first-page":"a026450","DOI":"10.1101\/cshperspect.a026450","volume":"7","author":"AA Mills","year":"2017","unstructured":"Mills AA. The Chromodomain Helicase DNA-Binding Chromatin Remodelers: Family Traits that Protect from and Promote Cancer. Cold Spring Harb Perspect Med. 2017;7(4):a026450.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"21\u201322","key":"2763_CR61","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1101\/gad.348897.121","volume":"35","author":"A Alendar","year":"2021","unstructured":"Alendar A, Berns A. Sentinels of chromatin: chromodomain helicase DNA-binding proteins in development and disease. Genes Dev. 2021;35(21\u201322):1403\u201330.","journal-title":"Genes Dev"},{"issue":"7","key":"2763_CR62","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/sj.onc.1206211","volume":"22","author":"PM Thompson","year":"2003","unstructured":"Thompson PM, Gotoh T, Kok M, White PS, Brodeur GM. CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system. Oncogene. 2003;22(7):1002\u201311.","journal-title":"Oncogene"},{"issue":"3","key":"2763_CR63","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.cell.2006.11.052","volume":"128","author":"A Bagchi","year":"2007","unstructured":"Bagchi A, Papazoglu C, Wu Y, Capurso D, Brodt M, Francis D, et al. CHD5 is a tumor suppressor at human 1p36. Cell. 2007;128(3):459\u201375.","journal-title":"Cell"},{"key":"2763_CR64","doi-asserted-by":"publisher","first-page":"7108","DOI":"10.1038\/ncomms8108","volume":"6","author":"S Watanabe","year":"2015","unstructured":"Watanabe S, Tan D, Lakshminarasimhan M, Washburn MP, Hong EJ, Walz T, et al. Structural analyses of the chromatin remodelling enzymes INO80-C and SWR-C. Nat Commun. 2015;6:7108.","journal-title":"Nat Commun"},{"key":"2763_CR65","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.sbi.2019.09.002","volume":"61","author":"O Willhoft","year":"2020","unstructured":"Willhoft O, Wigley DB. INO80 and SWR1 complexes: the non-identical twins of chromatin remodelling. Curr Opin Struct Biol. 2020;61:50\u20138.","journal-title":"Curr Opin Struct Biol"},{"issue":"11","key":"2763_CR66","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.tcb.2014.06.004","volume":"24","author":"CB Gerhold","year":"2014","unstructured":"Gerhold CB, Gasser SM. INO80 and SWR complexes: relating structure to function in chromatin remodeling. Trends Cell Biol. 2014;24(11):619\u201331.","journal-title":"Trends Cell Biol"},{"issue":"6","key":"2763_CR67","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.cell.2013.08.018","volume":"154","author":"VQ Nguyen","year":"2013","unstructured":"Nguyen VQ, Ranjan A, Stengel F, Wei D, Aebersold R, Wu C, et al. Molecular architecture of the ATP-dependent chromatin-remodeling complex SWR1. Cell. 2013;154(6):1220\u201331.","journal-title":"Cell"},{"issue":"6","key":"2763_CR68","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cell.2013.08.016","volume":"154","author":"A Tosi","year":"2013","unstructured":"Tosi A, Haas C, Herzog F, Gilmozzi A, Berninghausen O, Ungewickell C, et al. Structure and subunit topology of the INO80 chromatin remodeler and its nucleosome complex. Cell. 2013;154(6):1207\u201319.","journal-title":"Cell"},{"issue":"17","key":"2763_CR69","doi-asserted-by":"publisher","first-page":"gkaf892","DOI":"10.1093\/nar\/gkaf892","volume":"53","author":"M Liu","year":"2025","unstructured":"Liu M, Xu Q, Wang H, Ji X. INO80\/SWR remodelers regulate Pol II transcription through BRD2 and chromatin landscape. Nucleic Acids Res. 2025;53(17):gkaf892.","journal-title":"Nucleic Acids Res"},{"issue":"5656","key":"2763_CR70","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1126\/science.1090701","volume":"303","author":"G Mizuguchi","year":"2004","unstructured":"Mizuguchi G, Shen X, Landry J, Wu WH, Sen S, Wu C. ATP-driven exchange of histone H2AZ variant catalyzed by SWR1 chromatin remodeling complex. Science. 2004;303(5656):343\u20138.","journal-title":"Science"},{"issue":"5","key":"2763_CR71","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.cell.2010.10.019","volume":"143","author":"E Luk","year":"2010","unstructured":"Luk E, Ranjan A, Fitzgerald PC, Mizuguchi G, Huang Y, Wei D, et al. Stepwise histone replacement by SWR1 requires dual activation with histone H2A.Z and canonical nucleosome. Cell. 2010;143(5):725\u201336.","journal-title":"Cell"},{"issue":"1","key":"2763_CR72","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41467-023-36465-5","volume":"14","author":"S Li","year":"2023","unstructured":"Li S, Wei T, Panchenko AR. Histone variant H2A.Z modulates nucleosome dynamics to promote DNA accessibility. Nat Commun. 2023;14(1):769.","journal-title":"Nat Commun."},{"issue":"6","key":"2763_CR73","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/S1097-2765(03)00497-0","volume":"12","author":"NJ Krogan","year":"2003","unstructured":"Krogan NJ, Keogh MC, Datta N, Sawa C, Ryan OW, Ding H, et al. A Snf2 family ATPase complex required for recruitment of the histone H2A variant Htz1. Mol Cell. 2003;12(6):1565\u201376.","journal-title":"Mol Cell"},{"issue":"1","key":"2763_CR74","doi-asserted-by":"publisher","first-page":"4534","DOI":"10.1038\/s41467-020-18306-x","volume":"11","author":"L Prendergast","year":"2020","unstructured":"Prendergast L, McClurg UL, Hristova R, Berlinguer-Palmini R, Greener S, Veitch K, et al. Resolution of R-loops by INO80 promotes DNA replication and maintains cancer cell proliferation and viability. Nat Commun. 2020;11(1):4534.","journal-title":"Nat Commun"},{"issue":"10","key":"2763_CR75","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1038\/onc.2016.311","volume":"36","author":"S Zhang","year":"2017","unstructured":"Zhang S, Zhou B, Wang L, Li P, Bennett BD, Snyder R, et al. INO80 is required for oncogenic transcription and tumor growth in non-small cell lung cancer. Oncogene. 2017;36(10):1430\u20139.","journal-title":"Oncogene"},{"issue":"12","key":"2763_CR76","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1038\/s41588-022-01232-7","volume":"54","author":"P Mach","year":"2022","unstructured":"Mach P, Kos PI, Zhan Y, Cramard J, Gaudin S, T\u00fcnnermann J, et al. Cohesin and CTCF control the dynamics of chromosome folding. Nat Genet. 2022;54(12):1907\u201318.","journal-title":"Nat Genet"},{"issue":"7958","key":"2763_CR77","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41586-023-05961-5","volume":"616","author":"IF Davidson","year":"2023","unstructured":"Davidson IF, Barth R, Zaczek M, van der Torre J, Tang W, Nagasaka K, et al. CTCF is a DNA-tension-dependent barrier to cohesin-mediated loop extrusion. Nature. 2023;616(7958):822\u20137.","journal-title":"Nature"},{"issue":"33","key":"2763_CR78","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2405177121","volume":"121","author":"X Yuan","year":"2024","unstructured":"Yuan X, Yan L, Chen Q, Zhu S, Zhou X, Zeng LH, et al. Molecular mechanism and functional significance of Wapl interaction with the Cohesin complex. Proc Natl Acad Sci U S A. 2024;121(33):e2405177121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6687","key":"2763_CR79","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1126\/science.adl4606","volume":"383","author":"F Ochs","year":"2024","unstructured":"Ochs F, Green C, Szczurek AT, Pytowski L, Kolesnikova S, Brown J, et al. Sister chromatid cohesion is mediated by individual cohesin complexes. Science. 2024;383(6687):1122\u201330.","journal-title":"Science"},{"issue":"6","key":"2763_CR80","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nrc3743","volume":"14","author":"A Losada","year":"2014","unstructured":"Losada A. Cohesin in cancer: chromosome segregation and beyond. Nat Rev Cancer. 2014;14(6):389\u201393.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"2763_CR81","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41568-020-0270-1","volume":"20","author":"T Waldman","year":"2020","unstructured":"Waldman T. Emerging themes in cohesin cancer biology. Nat Rev Cancer. 2020;20(9):504\u201315.","journal-title":"Nat Rev Cancer"},{"issue":"36","key":"2763_CR82","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2405543121","volume":"121","author":"XA Su","year":"2024","unstructured":"Su XA, Stopsack KH, Schmidt DR, Ma D, Li Z, Scheet PA, et al. RAD21 promotes oncogenesis and lethal progression of prostate cancer. Proc Natl Acad Sci U S A. 2024;121(36):e2405543121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2763_CR83","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nsmb.3259","volume":"23","author":"X Xia","year":"2016","unstructured":"Xia X, Liu X, Li T, Fang X, Chen Z. Structure of chromatin remodeler Swi2\/Snf2 in the resting state. Nat Struct Mol Biol. 2016;23(8):722\u20139.","journal-title":"Nat Struct Mol Biol"},{"issue":"7748","key":"2763_CR84","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41586-019-1029-2","volume":"567","author":"M Li","year":"2019","unstructured":"Li M, Xia X, Tian Y, Jia Q, Liu X, Lu Y, et al. Mechanism of DNA translocation underlying chromatin remodelling by Snf2. Nature. 2019;567(7748):409\u201313.","journal-title":"Nature"},{"issue":"2","key":"2763_CR85","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41594-021-00719-x","volume":"29","author":"IM Nodelman","year":"2022","unstructured":"Nodelman IM, Das S, Faustino AM, Fried SD, Bowman GD, Armache JP. Nucleosome recognition and DNA distortion by the Chd1 remodeler in a nucleotide-free state. Nat Struct Mol Biol. 2022;29(2):121\u20139.","journal-title":"Nat Struct Mol Biol"},{"issue":"7","key":"2763_CR86","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nrm.2017.26","volume":"18","author":"CR Clapier","year":"2017","unstructured":"Clapier CR, Iwasa J, Cairns BR, Peterson CL. Mechanisms of action and regulation of ATP-dependent chromatin-remodelling complexes. Nat Rev Mol Cell Biol. 2017;18(7):407\u201322.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"2763_CR87","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1093\/nar\/gky158","volume":"46","author":"GB Brandani","year":"2018","unstructured":"Brandani GB, Niina T, Tan C, Takada S. DNA sliding in nucleosomes via twist defect propagation revealed by molecular simulations. Nucleic Acids Res. 2018;46(6):2788\u2013801.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2763_CR88","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41580-023-00683-y","volume":"25","author":"S Eustermann","year":"2024","unstructured":"Eustermann S, Patel AB, Hopfner KP, He Y, Korber P. Energy-driven genome regulation by ATP-dependent chromatin remodellers. Nat Rev Mol Cell Biol. 2024;25(4):309\u201332.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"2763_CR89","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.molcel.2016.03.032","volume":"62","author":"CR Clapier","year":"2016","unstructured":"Clapier CR, Kasten MM, Parnell TJ, Viswanathan R, Szerlong H, Sirinakis G, et al. Regulation of DNA Translocation Efficiency within the Chromatin Remodeler RSC\/Sth1 Potentiates Nucleosome Sliding and Ejection. Mol Cell. 2016;62(3):453\u201361.","journal-title":"Mol Cell"},{"issue":"7669","key":"2763_CR90","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nature23671","volume":"548","author":"GP Dann","year":"2017","unstructured":"Dann GP, Liszczak GP, Bagert JD, M\u00fcller MM, Nguyen UTT, Wojcik F, et al. ISWI chromatin remodellers sense nucleosome modifications to determine substrate preference. Nature. 2017;548(7669):607\u201311.","journal-title":"Nature"},{"issue":"4","key":"2763_CR91","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41576-018-0089-8","volume":"20","author":"SL Klemm","year":"2019","unstructured":"Klemm SL, Shipony Z, Greenleaf WJ. Chromatin accessibility and the regulatory epigenome. Nat Rev Genet. 2019;20(4):207\u201320.","journal-title":"Nat Rev Genet"},{"issue":"7","key":"2763_CR92","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.cell.2014.11.021","volume":"159","author":"SS Rao","year":"2014","unstructured":"Rao SS, Huntley MH, Durand NC, Stamenova EK, Bochkov ID, Robinson JT, et al. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell. 2014;159(7):1665\u201380.","journal-title":"Cell"},{"issue":"7795","key":"2763_CR93","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41586-019-1910-z","volume":"578","author":"Y Li","year":"2020","unstructured":"Li Y, Haarhuis JHI, Sede\u00f1o Cacciatore \u00c1, Oldenkamp R, van Ruiten MS, Willems L, et al. The structural basis for cohesin-CTCF-anchored loops. Nature. 2020;578(7795):472\u20136.","journal-title":"Nature"},{"issue":"12","key":"2763_CR94","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1038\/s41588-025-02406-9","volume":"57","author":"T Sabat\u00e9","year":"2025","unstructured":"Sabat\u00e9 T, Lelandais B, Robert MC, Szalay M, Tinevez JY, Bertrand E, et al. Uniform dynamics of cohesin-mediated loop extrusion in living human cells. Nat Genet. 2025;57(12):3152\u201364.","journal-title":"Nat Genet"},{"issue":"3","key":"2763_CR95","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1073\/pnas.1317788111","volume":"111","author":"J Zuin","year":"2014","unstructured":"Zuin J, Dixon JR, van der Reijden MI, Ye Z, Kolovos P, Brouwer RW, et al. Cohesin and CTCF differentially affect chromatin architecture and gene expression in human cells. Proc Natl Acad Sci U S A. 2014;111(3):996\u20131001.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2763_CR96","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1016\/j.celrep.2016.04.085","volume":"15","author":"G Fudenberg","year":"2016","unstructured":"Fudenberg G, Imakaev M, Lu C, Goloborodko A, Abdennur N, Mirny LA. Formation of Chromosomal Domains by Loop Extrusion. Cell Rep. 2016;15(9):2038\u201349.","journal-title":"Cell Rep"},{"issue":"12","key":"2763_CR97","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41576-018-0060-8","volume":"19","author":"MJ Rowley","year":"2018","unstructured":"Rowley MJ, Corces VG. Organizational principles of 3D genome architecture. Nat Rev Genet. 2018;19(12):789\u2013800.","journal-title":"Nat Rev Genet"},{"issue":"24","key":"2763_CR98","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.15252\/embj.201798004","volume":"36","author":"G Wutz","year":"2017","unstructured":"Wutz G, Varnai C, Nagasaka K, Cisneros DA, Stocsits RR, Tang W, et al. Topologically associating domains and chromatin loops depend on cohesin and are regulated by CTCF, WAPL, and PDS5 proteins. EMBO J. 2017;36(24):3573\u201399.","journal-title":"EMBO J"},{"key":"2763_CR99","doi-asserted-by":"crossref","unstructured":"Rao SSP, Huang SC, Glenn St Hilaire B, Engreitz JM, Perez EM, Kieffer-Kwon KR, et al. Cohesin Loss Eliminates All Loop Domains. Cell. 2017;171(2):305\u201320.e24","DOI":"10.1016\/j.cell.2017.09.026"},{"issue":"11","key":"2763_CR100","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/s41419-021-04291-6","volume":"12","author":"XY Shang","year":"2021","unstructured":"Shang XY, Shi Y, He DD, Wang L, Luo Q, Deng CH, et al. ARID1A deficiency weakens BRG1-RAD21 interaction that jeopardizes chromatin compactness and drives liver cancer cell metastasis. Cell Death Dis. 2021;12(11):990.","journal-title":"Cell Death Dis"},{"issue":"6901","key":"2763_CR101","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/nature01024","volume":"418","author":"MA Hakimi","year":"2002","unstructured":"Hakimi MA, Bochar DA, Schmiesing JA, Dong Y, Barak OG, Speicher DW, et al. A chromatin remodelling complex that loads cohesin onto human chromosomes. Nature. 2002;418(6901):994\u20138.","journal-title":"Nature"},{"issue":"6","key":"2763_CR102","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/s41588-024-01767-x","volume":"56","author":"M Iurlaro","year":"2024","unstructured":"Iurlaro M, Masoni F, Flyamer IM, Wirbelauer C, Iskar M, Burger L, et al. Systematic assessment of ISWI subunits shows that NURF creates local accessibility for CTCF. Nat Genet. 2024;56(6):1203\u201312.","journal-title":"Nat Genet"},{"issue":"7","key":"2763_CR103","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/s41588-021-00878-z","volume":"53","author":"L Niu","year":"2021","unstructured":"Niu L, Shen W, Shi Z, Tan Y, He N, Wan J, et al. Three-dimensional folding dynamics of the Xenopus tropicalis genome. Nat Genet. 2021;53(7):1075\u201387.","journal-title":"Nat Genet"},{"issue":"7754","key":"2763_CR104","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41586-019-1115-5","volume":"569","author":"D Barisic","year":"2019","unstructured":"Barisic D, Stadler MB, Iurlaro M, Sch\u00fcbeler D. Mammalian ISWI and SWI\/SNF selectively mediate binding of distinct transcription factors. Nature. 2019;569(7754):136\u201340.","journal-title":"Nature"},{"issue":"1","key":"2763_CR105","doi-asserted-by":"publisher","first-page":"7698","DOI":"10.1038\/s41467-022-35444-6","volume":"13","author":"S Mu\u00f1oz","year":"2022","unstructured":"Mu\u00f1oz S, Jones A, Bouchoux C, Gilmore T, Patel H, Uhlmann F. Functional crosstalk between the cohesin loader and chromatin remodelers. Nat Commun. 2022;13(1):7698.","journal-title":"Nat Commun"},{"issue":"17","key":"2763_CR106","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1016\/j.molcel.2024.07.006","volume":"84","author":"RK Sahu","year":"2024","unstructured":"Sahu RK, Dhakshnamoorthy J, Jain S, Folco HD, Wheeler D, Grewal SIS. Nucleosome remodeler exclusion by histone deacetylation enforces heterochromatic silencing and epigenetic inheritance. Mol Cell. 2024;84(17):3175-91.e8.","journal-title":"Mol Cell"},{"issue":"1","key":"2763_CR107","doi-asserted-by":"publisher","first-page":"6315","DOI":"10.1038\/s41467-025-61482-x","volume":"16","author":"L Chen","year":"2025","unstructured":"Chen L, Maristany MJ, Farr SE, Luo J, Gibson BA, Doolittle LK, et al. Nucleosome spacing can fine-tune higher-order chromatin assembly. Nat Commun. 2025;16(1):6315.","journal-title":"Nat Commun"},{"key":"2763_CR108","doi-asserted-by":"crossref","unstructured":"Almassalha LM, Carignano M, Liwag EP, Li WS, Gong R, Acosta N, et al. Chromatin conformation, gene transcription and nucleosome remodeling as an emergent system. Sci Adv. 2025;11(2):eadq6652.","DOI":"10.1126\/sciadv.adq6652"},{"issue":"9","key":"2763_CR109","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41580-023-00609-8","volume":"24","author":"C Hoencamp","year":"2023","unstructured":"Hoencamp C, Rowland BD. Genome control by SMC complexes. Nat Rev Mol Cell Biol. 2023;24(9):633\u201350.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"2763_CR110","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41594-020-00539-5","volume":"28","author":"N Kubo","year":"2021","unstructured":"Kubo N, Ishii H, Xiong X, Bianco S, Meitinger F, Hu R, et al. Promoter-proximal CTCF binding promotes distal enhancer-dependent gene activation. Nat Struct Mol Biol. 2021;28(2):152\u201361.","journal-title":"Nat Struct Mol Biol"},{"issue":"6","key":"2763_CR111","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.molcel.2008.11.020","volume":"32","author":"G Badis","year":"2008","unstructured":"Badis G, Chan ET, van Bakel H, Pena-Castillo L, Tillo D, Tsui K, et al. A library of yeast transcription factor motifs reveals a widespread function for Rsc3 in targeting nucleosome exclusion at promoters. Mol Cell. 2008;32(6):878\u201387.","journal-title":"Mol Cell"},{"issue":"17","key":"2763_CR112","doi-asserted-by":"publisher","first-page":"3560","DOI":"10.1016\/j.molcel.2021.07.022","volume":"81","author":"VQ Nguyen","year":"2021","unstructured":"Nguyen VQ, Ranjan A, Liu S, Tang X, Ling YH, Wisniewski J, et al. Spatiotemporal coordination of transcription preinitiation complex assembly in live cells. Mol Cell. 2021;81(17):3560-75.e6.","journal-title":"Mol Cell"},{"issue":"2","key":"2763_CR113","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","volume":"153","author":"WA Whyte","year":"2013","unstructured":"Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell. 2013;153(2):307\u201319.","journal-title":"Cell"},{"issue":"2","key":"2763_CR114","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","volume":"153","author":"J Lov\u00e9n","year":"2013","unstructured":"Lov\u00e9n J, Hoke HA, Lin CY, Lau A, Orlando DA, Vakoc CR, et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell. 2013;153(2):320\u201334.","journal-title":"Cell"},{"key":"2763_CR115","doi-asserted-by":"publisher","first-page":"14648","DOI":"10.1038\/ncomms14648","volume":"8","author":"BH Alver","year":"2017","unstructured":"Alver BH, Kim KH, Lu P, Wang X, Manchester HE, Wang W, et al. The SWI\/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers. Nat Commun. 2017;8:14648.","journal-title":"Nat Commun"},{"issue":"1","key":"2763_CR116","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/s41467-018-03279-9","volume":"9","author":"J Huang","year":"2018","unstructured":"Huang J, Li K, Cai W, Liu X, Zhang Y, Orkin SH, et al. Dissecting super-enhancer hierarchy based on chromatin interactions. Nat Commun. 2018;9(1):943.","journal-title":"Nat Commun"},{"issue":"21","key":"2763_CR117","doi-asserted-by":"publisher","first-page":"12196","DOI":"10.1093\/nar\/gkab1105","volume":"49","author":"SM White","year":"2021","unstructured":"White SM, Snyder MP, Yi C. Master lineage transcription factors anchor trans mega transcriptional complexes at highly accessible enhancer sites to promote long-range chromatin clustering and transcription of distal target genes. Nucleic Acids Res. 2021;49(21):12196\u2013210.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2763_CR118","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41467-018-03017-1","volume":"9","author":"Y Gong","year":"2018","unstructured":"Gong Y, Lazaris C, Sakellaropoulos T, Lozano A, Kambadur P, Ntziachristos P, et al. Stratification of TAD boundaries reveals preferential insulation of super-enhancers by strong boundaries. Nat Commun. 2018;9(1):542.","journal-title":"Nat Commun"},{"issue":"1","key":"2763_CR119","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/ng.3722","volume":"49","author":"J Weischenfeldt","year":"2017","unstructured":"Weischenfeldt J, Dubash T, Drainas AP, Mardin BR, Chen Y, St\u00fctz AM, et al. Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking. Nat Genet. 2017;49(1):65\u201374.","journal-title":"Nat Genet"},{"issue":"1","key":"2763_CR120","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41467-025-67329-9","volume":"17","author":"HY Jeon","year":"2025","unstructured":"Jeon HY, Khadka S, Pornour M, Ryu H, Chen H, Hussain A, et al. BPTF regulates androgen receptor activity by enhancing chromatin accessibility and stabilizing the AR-FOXA1 interaction. Nat Commun. 2025;17(1):670.","journal-title":"Nat Commun"},{"issue":"11","key":"2763_CR121","doi-asserted-by":"publisher","first-page":"gkaf473","DOI":"10.1093\/nar\/gkaf473","volume":"53","author":"KA Orlando","year":"2025","unstructured":"Orlando KA, Grimm SA, Wade PA. Pioneering new enhancers by GATA3: role of facilitating transcription factors and chromatin remodeling. Nucleic Acids Res. 2025;53(11):gkaf473.","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"2763_CR122","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1016\/j.molcel.2025.06.026","volume":"85","author":"YS Chan","year":"2025","unstructured":"Chan YS, Gao Q, Robinson SA, Wang W, Filandrova R, Weinhold LM, et al. \u03b2-catenin functions as a molecular adapter for disordered cBAF interactions. Mol Cell. 2025;85(16):3041-56.e9.","journal-title":"Mol Cell"},{"issue":"2","key":"2763_CR123","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.molcel.2023.10.045","volume":"84","author":"K Ahmad","year":"2024","unstructured":"Ahmad K, Brahma S, Henikoff S. Epigenetic pioneering by SWI\/SNF family remodelers. Mol Cell. 2024;84(2):194\u2013201.","journal-title":"Mol Cell"},{"issue":"10","key":"2763_CR124","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1016\/j.molcel.2024.03.013","volume":"84","author":"D Saha","year":"2024","unstructured":"Saha D, Animireddy S, Lee J, Thommen A, Murvin MM, Lu Y, et al. Enhancer switching in cell lineage priming is linked to eRNA, Brg1\u2019s AT-hook, and SWI\/SNF recruitment. Mol Cell. 2024;84(10):1855-69.e5.","journal-title":"Mol Cell"},{"issue":"1","key":"2763_CR125","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41588-023-01603-8","volume":"56","author":"S Brahma","year":"2024","unstructured":"Brahma S, Henikoff S. The BAF chromatin remodeler synergizes with RNA polymerase II and transcription factors to evict nucleosomes. Nat Genet. 2024;56(1):100\u201311.","journal-title":"Nat Genet"},{"issue":"5","key":"2763_CR126","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ccell.2016.09.010","volume":"30","author":"L Shan","year":"2016","unstructured":"Shan L, Zhou X, Liu X, Wang Y, Su D, Hou Y, et al. FOXK2 Elicits Massive Transcription Repression and Suppresses the Hypoxic Response and Breast Cancer Carcinogenesis. Cancer Cell. 2016;30(5):708\u201322.","journal-title":"Cancer Cell"},{"issue":"7314","key":"2763_CR127","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nature09380","volume":"467","author":"MH Kagey","year":"2010","unstructured":"Kagey MH, Newman JJ, Bilodeau S, Zhan Y, Orlando DA, van Berkum NL, et al. Mediator and cohesin connect gene expression and chromatin architecture. Nature. 2010;467(7314):430\u20135.","journal-title":"Nature"},{"issue":"6","key":"2763_CR128","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.cell.2013.04.053","volume":"153","author":"JE Phillips-Cremins","year":"2013","unstructured":"Phillips-Cremins JE, Sauria ME, Sanyal A, Gerasimova TI, Lajoie BR, Bell JS, et al. Architectural protein subclasses shape 3D organization of genomes during lineage commitment. Cell. 2013;153(6):1281\u201395.","journal-title":"Cell"},{"issue":"4","key":"2763_CR129","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1093\/nar\/gkx1123","volume":"46","author":"D Racko","year":"2018","unstructured":"Racko D, Benedetti F, Dorier J, Stasiak A. Transcription-induced supercoiling as the driving force of chromatin loop extrusion during formation of TADs in interphase chromosomes. Nucleic Acids Res. 2018;46(4):1648\u201360.","journal-title":"Nucleic Acids Res"},{"issue":"22","key":"2763_CR130","doi-asserted-by":"publisher","first-page":"e159628","DOI":"10.1172\/JCI159628","volume":"132","author":"P Deng","year":"2022","unstructured":"Deng P, Wang Z, Chen J, Liu S, Yao X, Liu S, et al. RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer. J Clin Invest. 2022;132(22):e159628.","journal-title":"J Clin Invest"},{"issue":"1","key":"2763_CR131","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1038\/s41467-017-02212-w","volume":"8","author":"K Beishline","year":"2017","unstructured":"Beishline K, Vladimirova O, Tutton S, Wang Z, Deng Z, Lieberman PM. CTCF driven TERRA transcription facilitates completion of telomere DNA replication. Nat Commun. 2017;8(1):2114.","journal-title":"Nat Commun"},{"issue":"3","key":"2763_CR132","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/cr.2011.22","volume":"21","author":"AJ Bannister","year":"2011","unstructured":"Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011;21(3):381\u201395.","journal-title":"Cell Res"},{"issue":"4","key":"2763_CR133","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","volume":"128","author":"T Kouzarides","year":"2007","unstructured":"Kouzarides T. Chromatin modifications and their function. Cell. 2007;128(4):693\u2013705.","journal-title":"Cell"},{"issue":"2","key":"2763_CR134","doi-asserted-by":"publisher","first-page":"gkaf1381","DOI":"10.1093\/nar\/gkaf1381","volume":"54","author":"HA Fuchs","year":"2026","unstructured":"Fuchs HA, Peng Y, Ayyapan S, Rosas R, Zhang H, Panchenko AR, et al. G34R cancer mutation alters the conformational ensemble and dynamics of the histone H3.3 tails. Nucleic Acids Res. 2026;54(2):gkaf1381.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2763_CR135","doi-asserted-by":"publisher","first-page":"7646","DOI":"10.1038\/s41467-024-52040-y","volume":"15","author":"W Engl","year":"2024","unstructured":"Engl W, Kunstar-Thomas A, Chen S, Ng WS, Sielaff H, Zhao ZW. Single-molecule imaging of SWI\/SNF chromatin remodelers reveals bromodomain-mediated and cancer-mutants-specific landscape of multi-modal DNA-binding dynamics. Nat Commun. 2024;15(1):7646.","journal-title":"Nat Commun"},{"issue":"12","key":"2763_CR136","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/nchembio.2218","volume":"12","author":"X Xiong","year":"2016","unstructured":"Xiong X, Panchenko T, Yang S, Zhao S, Yan P, Zhang W, et al. Selective recognition of histone crotonylation by double PHD fingers of MOZ and DPF2. Nat Chem Biol. 2016;12(12):1111\u20138.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"2763_CR137","doi-asserted-by":"publisher","first-page":"9614","DOI":"10.1038\/s41467-024-53981-0","volume":"15","author":"K Hyun","year":"2024","unstructured":"Hyun K, Ahn J, Kim H, Kim J, Kim YI, Park HS, et al. The BAF complex enhances transcription through interaction with H3K56ac in the histone globular domain. Nat Commun. 2024;15(1):9614.","journal-title":"Nat Commun"},{"issue":"11","key":"2763_CR138","doi-asserted-by":"publisher","first-page":"6043","DOI":"10.1093\/nar\/gkab280","volume":"49","author":"HY Ryu","year":"2021","unstructured":"Ryu HY, Hochstrasser M. Histone sumoylation and chromatin dynamics. Nucleic Acids Res. 2021;49(11):6043\u201352.","journal-title":"Nucleic Acids Res"},{"issue":"13","key":"2763_CR139","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1080\/15384101.2018.1493414","volume":"17","author":"SNA Roesley","year":"2018","unstructured":"Roesley SNA, La Marca JE, Deans AJ, McKenzie L, Suryadinata R, Burke P, et al. Phosphorylation of Drosophila Brahma on CDK-phosphorylation sites is important for cell cycle regulation and differentiation. Cell Cycle. 2018;17(13):1559\u201378.","journal-title":"Cell Cycle"},{"issue":"2","key":"2763_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109357","volume":"36","author":"B Kim","year":"2021","unstructured":"Kim B, Luo Y, Zhan X, Zhang Z, Shi X, Yi J, et al. Neuronal activity-induced BRG1 phosphorylation regulates enhancer activation. Cell Rep. 2021;36(2):109357.","journal-title":"Cell Rep"},{"issue":"7","key":"2763_CR141","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41422-022-00673-3","volume":"32","author":"W Li","year":"2022","unstructured":"Li W, Shan B, Zou C, Wang H, Zhang MM, Zhu H, et al. Nuclear RIPK1 promotes chromatin remodeling to mediate inflammatory response. Cell Res. 2022;32(7):621\u201337.","journal-title":"Cell Res"},{"issue":"1","key":"2763_CR142","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccr.2013.12.007","volume":"25","author":"L Wang","year":"2014","unstructured":"Wang L, Zhao Z, Meyer MB, Saha S, Yu M, Guo A, et al. CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis. Cancer Cell. 2014;25(1):21\u201336.","journal-title":"Cancer Cell"},{"issue":"8007","key":"2763_CR143","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41586-024-07250-1","volume":"628","author":"S Radko-Juettner","year":"2024","unstructured":"Radko-Juettner S, Yue H, Myers JA, Carter RD, Robertson AN, Mittal P, et al. Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI\/SNF. Nature. 2024;628(8007):442\u20139.","journal-title":"Nature"},{"issue":"1","key":"2763_CR144","doi-asserted-by":"publisher","first-page":"6696","DOI":"10.1038\/s41467-022-34348-9","volume":"13","author":"P Guo","year":"2022","unstructured":"Guo P, Hoang N, Sanchez J, Zhang EH, Rajawasam K, Trinidad K, et al. The assembly of mammalian SWI\/SNF chromatin remodeling complexes is regulated by lysine-methylation dependent proteolysis. Nat Commun. 2022;13(1):6696.","journal-title":"Nat Commun"},{"issue":"1","key":"2763_CR145","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1038\/s41467-024-47048-3","volume":"15","author":"X Tang","year":"2024","unstructured":"Tang X, Zeng P, Liu K, Qing L, Sun Y, Liu X, et al. The PTM profiling of CTCF reveals the regulation of 3D chromatin structure by O-GlcNAcylation. Nat Commun. 2024;15(1):2813.","journal-title":"Nat Commun"},{"issue":"1","key":"2763_CR146","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/s41467-024-44945-5","volume":"15","author":"RB Davis","year":"2024","unstructured":"Davis RB, Supakar A, Ranganath AK, Moosa MM, Banerjee PR. Heterotypic interactions can drive selective co-condensation of prion-like low-complexity domains of FET proteins and mammalian SWI\/SNF complex. Nat Commun. 2024;15(1):1168.","journal-title":"Nat Commun"},{"issue":"7","key":"2763_CR147","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1158\/0008-5472.CAN-22-2129","volume":"83","author":"C Chambers","year":"2023","unstructured":"Chambers C, Cermakova K, Chan YS, Kurtz K, Wohlan K, Lewis AH, et al. SWI\/SNF blockade disrupts PU.1-directed enhancer programs in normal hematopoietic cells and acute myeloid leukemia. Cancer Res. 2023;83(7):983\u201396.","journal-title":"Cancer Res"},{"issue":"4","key":"2763_CR148","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ccell.2024.02.010","volume":"42","author":"D Barisic","year":"2024","unstructured":"Barisic D, Chin CR, Meydan C, Teater M, Tsialta I, Mlynarczyk C, et al. ARID1A orchestrates SWI\/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis. Cancer Cell. 2024;42(4):583-604.e11.","journal-title":"Cancer Cell"},{"issue":"1","key":"2763_CR149","doi-asserted-by":"publisher","first-page":"6924","DOI":"10.1038\/s41467-021-27176-w","volume":"12","author":"D Laubscher","year":"2021","unstructured":"Laubscher D, Gryder BE, Sunkel BD, Andresson T, Wachtel M, Das S, et al. BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma. Nat Commun. 2021;12(1):6924.","journal-title":"Nat Commun"},{"issue":"10","key":"2763_CR150","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1158\/1535-7163.MCT-19-1013","volume":"19","author":"F Rago","year":"2020","unstructured":"Rago F, Elliott G, Li A, Sprouffske K, Kerr G, Desplat A, et al. The Discovery of SWI\/SNF Chromatin Remodeling Activity as a Novel and Targetable Dependency in Uveal Melanoma. Mol Cancer Ther. 2020;19(10):2186\u201395.","journal-title":"Mol Cancer Ther"},{"issue":"20","key":"2763_CR151","doi-asserted-by":"publisher","first-page":"4522","DOI":"10.1038\/s44318-024-00206-1","volume":"43","author":"M Xu","year":"2024","unstructured":"Xu M, Hong JJ, Zhang X, Sun M, Liu X, Kang J, et al. Targeting SWI\/SNF ATPases reduces neuroblastoma cell plasticity. Embo j. 2024;43(20):4522\u201341.","journal-title":"Embo j"},{"issue":"1","key":"2763_CR152","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/nar\/gkad1081","volume":"52","author":"K Cermakova","year":"2024","unstructured":"Cermakova K, Tao L, Dejmek M, Sala M, Montierth MD, Chan YS, et al. Reactivation of the G1 enhancer landscape underlies core circuitry addiction to SWI\/SNF. Nucleic Acids Res. 2024;52(1):4\u201321.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"2763_CR153","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41580-019-0152-0","volume":"20","author":"R Scully","year":"2019","unstructured":"Scully R, Panday A, Elango R, Willis NA. DNA double-strand break repair-pathway choice in somatic mammalian cells. Nat Rev Mol Cell Biol. 2019;20(11):698\u2013714.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"2763_CR154","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-13-3608","volume":"74","author":"R Watanabe","year":"2014","unstructured":"Watanabe R, Ui A, Kanno S, Ogiwara H, Nagase T, Kohno T, et al. SWI\/SNF factors required for cellular resistance to DNA damage include ARID1A and ARID1B and show interdependent protein stability. Cancer Res. 2014;74(9):2465\u201375.","journal-title":"Cancer Res"},{"issue":"46","key":"2763_CR155","doi-asserted-by":"publisher","first-page":"19873","DOI":"10.1073\/pnas.1003438107","volume":"107","author":"F Erdel","year":"2010","unstructured":"Erdel F, Schubert T, Marth C, L\u00e4ngst G, Rippe K. Human ISWI chromatin-remodeling complexes sample nucleosomes via transient binding reactions and become immobilized at active sites. Proc Natl Acad Sci U S A. 2010;107(46):19873\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"2763_CR156","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/onc.2010.592","volume":"30","author":"H Ogiwara","year":"2011","unstructured":"Ogiwara H, Ui A, Otsuka A, Satoh H, Yokomi I, Nakajima S, et al. Histone acetylation by CBP and p300 at double-strand break sites facilitates SWI\/SNF chromatin remodeling and the recruitment of non-homologous end joining factors. Oncogene. 2011;30(18):2135\u201346.","journal-title":"Oncogene"},{"issue":"7","key":"2763_CR157","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1158\/2159-8290.CD-14-0849","volume":"5","author":"J Shen","year":"2015","unstructured":"Shen J, Peng Y, Wei L, Zhang W, Yang L, Lan L, et al. ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors. Cancer Discov. 2015;5(7):752\u201367.","journal-title":"Cancer Discov"},{"issue":"6","key":"2763_CR158","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1093\/nar\/gkaa006","volume":"48","author":"T Hou","year":"2020","unstructured":"Hou T, Cao Z, Zhang J, Tang M, Tian Y, Li Y, et al. SIRT6 coordinates with CHD4 to promote chromatin relaxation and DNA repair. Nucleic Acids Res. 2020;48(6):2982\u20133000.","journal-title":"Nucleic Acids Res"},{"issue":"8082","key":"2763_CR159","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/s41586-025-09414-z","volume":"645","author":"SC Moser","year":"2025","unstructured":"Moser SC, Khalizieva A, Roehsner J, Pottendorfer E, Kaptein ML, Ricci G, et al. NASP modulates histone turnover to drive PARP inhibitor resistance. Nature. 2025;645(8082):1071\u201380.","journal-title":"Nature"},{"issue":"5945","key":"2763_CR160","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1126\/science.1177321","volume":"325","author":"D Ahel","year":"2009","unstructured":"Ahel D, Horejs\u00ed Z, Wiechens N, Polo SE, Garcia-Wilson E, Ahel I, et al. Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1. Science. 2009;325(5945):1240\u20133.","journal-title":"Science"},{"issue":"2","key":"2763_CR161","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41556-020-00624-3","volume":"23","author":"P Verma","year":"2021","unstructured":"Verma P, Zhou Y, Cao Z, Deraska PV, Deb M, Arai E, et al. ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells. Nat Cell Biol. 2021;23(2):160\u201371.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"2763_CR162","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41467-025-56086-4","volume":"16","author":"M Fedkenheuer","year":"2025","unstructured":"Fedkenheuer M, Shang Y, Jung S, Fedkenheuer K, Park S, Mazza D, et al. A dual role of Cohesin in DNA DSB repair. Nat Commun. 2025;16(1):843.","journal-title":"Nat Commun"},{"issue":"7847","key":"2763_CR163","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41586-021-03193-z","volume":"590","author":"C Arnould","year":"2021","unstructured":"Arnould C, Rocher V, Finoux AL, Clouaire T, Li K, Zhou F, et al. Loop extrusion as a mechanism for formation of DNA damage repair foci. Nature. 2021;590(7847):660\u20135.","journal-title":"Nature"},{"issue":"1","key":"2763_CR164","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.molcel.2012.07.004","volume":"48","author":"M Tittel-Elmer","year":"2012","unstructured":"Tittel-Elmer M, Lengronne A, Davidson MB, Bacal J, Fran\u00e7ois P, Hohl M, et al. Cohesin association to replication sites depends on rad50 and promotes fork restart. Mol Cell. 2012;48(1):98\u2013108.","journal-title":"Mol Cell"},{"issue":"3","key":"2763_CR165","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1093\/nar\/gky519","volume":"47","author":"D Carvajal-Maldonado","year":"2019","unstructured":"Carvajal-Maldonado D, Byrum AK, Jackson J, Wessel S, Lema\u00e7on D, Guitton-Sert L, et al. Perturbing cohesin dynamics drives MRE11 nuclease-dependent replication fork slowing. Nucleic Acids Res. 2019;47(3):1294\u2013310.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"2763_CR166","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.tig.2012.12.004","volume":"29","author":"NJ O'Neil","year":"2013","unstructured":"O\u2019Neil NJ, van Pel DM, Hieter P. Synthetic lethality and cancer: cohesin and PARP at the replication fork. Trends Genet. 2013;29(5):290\u20137.","journal-title":"Trends Genet"},{"issue":"17","key":"2763_CR167","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1038\/sj.emboj.7601291","volume":"25","author":"JH Park","year":"2006","unstructured":"Park JH, Park EJ, Lee HS, Kim SJ, Hur SK, Imbalzano AN, et al. Mammalian SWI\/SNF complexes facilitate DNA double-strand break repair by promoting gamma-H2AX induction. Embo j. 2006;25(17):3986\u201397.","journal-title":"Embo j"},{"issue":"42","key":"2763_CR168","doi-asserted-by":"publisher","first-page":"6403","DOI":"10.1038\/sj.onc.1205841","volume":"21","author":"I Versteege","year":"2002","unstructured":"Versteege I, Medjkane S, Rouillard D, Delattre O. A key role of the hSNF5\/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle. Oncogene. 2002;21(42):6403\u201312.","journal-title":"Oncogene"},{"issue":"10","key":"2763_CR169","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1172\/JCI37210","volume":"121","author":"X Wang","year":"2011","unstructured":"Wang X, Werneck MB, Wilson BG, Kim HJ, Kluk MJ, Thom CS, et al. TCR-dependent transformation of mature memory phenotype T cells in mice. J Clin Invest. 2011;121(10):3834\u201345.","journal-title":"J Clin Invest"},{"issue":"5","key":"2763_CR170","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41580-021-00341-1","volume":"22","author":"A Piunti","year":"2021","unstructured":"Piunti A, Shilatifard A. The roles of Polycomb repressive complexes in mammalian development and cancer. Nat Rev Mol Cell Biol. 2021;22(5):326\u201345.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"2763_CR171","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ccr.2010.09.006","volume":"18","author":"BG Wilson","year":"2010","unstructured":"Wilson BG, Wang X, Shen X, McKenna ES, Lemieux ME, Cho YJ, et al. Epigenetic antagonism between polycomb and SWI\/SNF complexes during oncogenic transformation. Cancer Cell. 2010;18(4):316\u201328.","journal-title":"Cancer Cell"},{"issue":"12","key":"2763_CR172","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1038\/nm.3968","volume":"21","author":"KH Kim","year":"2015","unstructured":"Kim KH, Kim W, Howard TP, Vazquez F, Tsherniak A, Wu JN, et al. SWI\/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2. Nat Med. 2015;21(12):1491\u20136.","journal-title":"Nat Med"},{"issue":"3","key":"2763_CR173","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/leu.2016.240","volume":"31","author":"JB Fisher","year":"2017","unstructured":"Fisher JB, Peterson J, Reimer M, Stelloh C, Pulakanti K, Gerbec ZJ, et al. The cohesin subunit Rad21 is a negative regulator of hematopoietic self-renewal through epigenetic repression of Hoxa7 and Hoxa9. Leukemia. 2017;31(3):712\u20139.","journal-title":"Leukemia"},{"issue":"6","key":"2763_CR174","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.ccell.2021.05.007","volume":"39","author":"B Adane","year":"2021","unstructured":"Adane B, Alexe G, Seong BKA, Lu D, Hwang EE, Hnisz D, et al. STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcoma. Cancer Cell. 2021;39(6):827-44.e10.","journal-title":"Cancer Cell"},{"issue":"3","key":"2763_CR175","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","volume":"34","author":"NN Pavlova","year":"2022","unstructured":"Pavlova NN, Zhu J, Thompson CB. The hallmarks of cancer metabolism: Still emerging. Cell Metab. 2022;34(3):355\u201377.","journal-title":"Cell Metab"},{"issue":"2","key":"2763_CR176","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s43018-020-00160-x","volume":"2","author":"S Wu","year":"2021","unstructured":"Wu S, Fukumoto T, Lin J, Nacarelli T, Wang Y, Ong D, et al. Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma. Nat Cancer. 2021;2(2):189\u2013200.","journal-title":"Nat Cancer"},{"issue":"14","key":"2763_CR177","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1111\/jcmm.17418","volume":"26","author":"Y Tang","year":"2022","unstructured":"Tang Y, Jin YH, Li HL, Xin H, Chen JD, Li XY, et al. PBRM1 deficiency oncogenic addiction is associated with activated AKT-mTOR signalling and aerobic glycolysis in clear cell renal cell carcinoma cells. J Cell Mol Med. 2022;26(14):3837\u201349.","journal-title":"J Cell Mol Med"},{"issue":"9","key":"2763_CR178","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.tips.2025.07.008","volume":"46","author":"H Jing","year":"2025","unstructured":"Jing H, Zhang X, Meng L. Swinging the SWI\/SNF complexes for cancer therapy. Trends Pharmacol Sci. 2025;46(9):907\u201321.","journal-title":"Trends Pharmacol Sci"},{"issue":"7","key":"2763_CR179","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/s41591-018-0019-5","volume":"24","author":"Y Lissanu Deribe","year":"2018","unstructured":"Lissanu Deribe Y, Sun Y, Terranova C, Khan F, Martinez-Ledesma J, Gay J, et al. Mutations in the SWI\/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer. Nat Med. 2018;24(7):1047\u201357.","journal-title":"Nat Med"},{"issue":"1","key":"2763_CR180","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s43556-024-00229-4","volume":"5","author":"Y Hu","year":"2024","unstructured":"Hu Y, Liu W, Fang W, Dong Y, Zhang H, Luo Q. Tumor energy metabolism: implications for therapeutic targets. Mol Biomed. 2024;5(1):63.","journal-title":"Mol Biomed"},{"key":"2763_CR181","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.ebiom.2019.03.021","volume":"42","author":"YL Qu","year":"2019","unstructured":"Qu YL, Deng CH, Luo Q, Shang XY, Wu JX, Shi Y, et al. Arid1a regulates insulin sensitivity and lipid metabolism. EBioMedicine. 2019;42:481\u201393.","journal-title":"EBioMedicine"},{"issue":"11","key":"2763_CR182","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41419-024-07221-4","volume":"15","author":"J Zhang","year":"2024","unstructured":"Zhang J, Gao Z, Yang Y, Li Z, Wu B, Fan C, et al. SNF2L maintains glutathione homeostasis by initiating SLC7A11 transcription through chromatin remodeling. Cell Death Dis. 2024;15(11):820.","journal-title":"Cell Death Dis"},{"issue":"8","key":"2763_CR183","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1016\/j.cell.2025.12.049","volume":"189","author":"D Hanahan","year":"2026","unstructured":"Hanahan D. Hallmarks of cancer-Then and now, and beyond. Cell. 2026;189(8):2254-77.","journal-title":"Cell"},{"issue":"4","key":"2763_CR184","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12(4):252\u201364.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"2763_CR185","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1172\/JCI134402","volume":"130","author":"J Li","year":"2020","unstructured":"Li J, Wang W, Zhang Y, Cie\u015blik M, Guo J, Tan M, et al. Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy. J Clin Invest. 2020;130(5):2712\u201326.","journal-title":"J Clin Invest"},{"issue":"21","key":"2763_CR186","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.1158\/0008-5472.CAN-15-3125","volume":"76","author":"K Mayes","year":"2016","unstructured":"Mayes K, Alkhatib SG, Peterson K, Alhazmi A, Song C, Chan V, et al. BPTF Depletion Enhances T-cell-Mediated Antitumor Immunity. Cancer Res. 2016;76(21):6183\u201392.","journal-title":"Cancer Res"},{"issue":"3","key":"2763_CR187","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1101\/gad.2007311","volume":"25","author":"JW Landry","year":"2011","unstructured":"Landry JW, Banerjee S, Taylor B, Aplan PD, Singer A, Wu C. Chromatin remodeling complex NURF regulates thymocyte maturation. Genes Dev. 2011;25(3):275\u201386.","journal-title":"Genes Dev"},{"issue":"9","key":"2763_CR188","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1158\/2159-8290.CD-19-1352","volume":"10","author":"D Zhao","year":"2020","unstructured":"Zhao D, Cai L, Lu X, Liang X, Li J, Chen P, et al. Chromatin Regulator CHD1 Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Deficient Prostate Cancer. Cancer Discov. 2020;10(9):1374\u201387.","journal-title":"Cancer Discov"},{"issue":"1","key":"2763_CR189","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1038\/s41467-022-29541-9","volume":"13","author":"Z Chu","year":"2022","unstructured":"Chu Z, Gu L, Hu Y, Zhang X, Li M, Chen J, et al. STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming. Nat Commun. 2022;13(1):1859.","journal-title":"Nat Commun"},{"issue":"7","key":"2763_CR190","doi-asserted-by":"publisher","first-page":"e2120540119","DOI":"10.1073\/pnas.2120540119","volume":"119","author":"E Oreskovic","year":"2022","unstructured":"Oreskovic E, Wheeler EC, Mengwasser KE, Fujimura E, Martin TD, Tothova Z, et al. Genetic analysis of cancer drivers reveals cohesin and CTCF as suppressors of PD-L1. Proc Natl Acad Sci U S A. 2022;119(7):e2120540119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"2763_CR191","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1016\/j.cell.2024.04.025","volume":"187","author":"MB Maxwell","year":"2024","unstructured":"Maxwell MB, Hom-Tedla MS, Yi J, Li S, Rivera SA, Yu J, et al. ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunity. Cell. 2024;187(13):3390-408.e19.","journal-title":"Cell"},{"issue":"5","key":"2763_CR192","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.ccell.2017.10.007","volume":"32","author":"X Sun","year":"2017","unstructured":"Sun X, Wang SC, Wei Y, Luo X, Jia Y, Li L, et al. Arid1a has context-dependent oncogenic and tumor suppressor functions in liver cancer. Cancer Cell. 2017;32(5):574-89 e6.","journal-title":"Cancer Cell"},{"issue":"10","key":"2763_CR193","doi-asserted-by":"publisher","first-page":"5698","DOI":"10.1093\/nar\/gkae233","volume":"52","author":"A Bakr","year":"2024","unstructured":"Bakr A, Della Corte G, Veselinov O, Kelek\u00e7i S, Chen MM, Lin YY, et al. ARID1A regulates DNA repair through chromatin organization and its deficiency triggers DNA damage-mediated anti-tumor immune response. Nucleic Acids Res. 2024;52(10):5698\u2013719.","journal-title":"Nucleic Acids Res"},{"key":"2763_CR194","doi-asserted-by":"publisher","first-page":"e45672","DOI":"10.7554\/eLife.45672","volume":"8","author":"LF Langer","year":"2019","unstructured":"Langer LF, Ward JM, Archer TK. Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination. Elife. 2019;8:e45672.","journal-title":"Elife"},{"issue":"1","key":"2763_CR195","doi-asserted-by":"publisher","first-page":"7762","DOI":"10.1038\/s41467-023-43498-3","volume":"14","author":"NQ Liu","year":"2023","unstructured":"Liu NQ, Paassen I, Custers L, Zeller P, Teunissen H, Ayyildiz D, et al. SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors. Nat Commun. 2023;14(1):7762.","journal-title":"Nat Commun"},{"issue":"2","key":"2763_CR196","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1158\/0008-5472.CAN-20-0568","volume":"81","author":"SH Hong","year":"2021","unstructured":"Hong SH, Son KH, Ha SY, Wee TI, Choi SK, Won JE, et al. Nucleoporin 210 serves a key scaffold for SMARCB1 in liver cancer. Cancer Res. 2021;81(2):356\u201370.","journal-title":"Cancer Res"},{"issue":"1","key":"2763_CR197","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13046-022-02321-5","volume":"41","author":"M Di Nardo","year":"2022","unstructured":"Di Nardo M, Pallotta MM, Musio A. The multifaceted roles of cohesin in cancer. J Exp Clin Cancer Res. 2022;41(1):96.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6689","key":"2763_CR198","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/28212","volume":"394","author":"I Versteege","year":"1998","unstructured":"Versteege I, S\u00e9venet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, et al. Truncating mutations of hSNF5\/INI1 in aggressive paediatric cancer. Nature. 1998;394(6689):203\u20136.","journal-title":"Nature"},{"issue":"4","key":"2763_CR199","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/ng0894-502","volume":"7","author":"J Clark","year":"1994","unstructured":"Clark J, Rocques PJ, Crew AJ, Gill S, Shipley J, Chan AM, et al. Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet. 1994;7(4):502\u20138.","journal-title":"Nat Genet"},{"issue":"1","key":"2763_CR200","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cell.2013.02.036","volume":"153","author":"C Kadoch","year":"2013","unstructured":"Kadoch C, Crabtree GR. Reversible disruption of mSWI\/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma. Cell. 2013;153(1):71\u201385.","journal-title":"Cell"},{"key":"2763_CR201","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2021.102175","volume":"95","author":"E Puliga","year":"2021","unstructured":"Puliga E, Corso S, Pietrantonio F, Giordano S. Microsatellite instability in Gastric Cancer: Between lights and shadows. Cancer Treat Rev. 2021;95:102175.","journal-title":"Cancer Treat Rev"},{"issue":"12","key":"2763_CR202","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/ng.982","volume":"43","author":"K Wang","year":"2011","unstructured":"Wang K, Kan J, Yuen ST, Shi ST, Chu KM, Law S, et al. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat Genet. 2011;43(12):1219\u201323.","journal-title":"Nat Genet"},{"key":"2763_CR203","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jare.2025.05.043","volume":"81","author":"S Li","year":"2026","unstructured":"Li S, Zhang W, Yang Q, Li S, Zhou X, Wang H, et al. Genomic landscape of paired primary and peritoneal metastatic lesions in gastric cancer highlights evolutionary dynamics and mutational drivers. J Adv Res. 2026;81:507\u201319.","journal-title":"J Adv Res"},{"issue":"8058","key":"2763_CR204","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41586-025-08708-6","volume":"640","author":"THH Coorens","year":"2025","unstructured":"Coorens THH, Collord G, Jung H, Wang Y, Moore L, Hooks Y, et al. The somatic mutation landscape of normal gastric epithelium. Nature. 2025;640(8058):418\u201326.","journal-title":"Nature"},{"issue":"1","key":"2763_CR205","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/ctm2.32","volume":"10","author":"CY He","year":"2020","unstructured":"He CY, Qiu MZ, Yang XH, Zhou DL, Ma JJ, Long YK, et al. Classification of gastric cancer by EBV status combined with molecular profiling predicts patient prognosis. Clin Transl Med. 2020;10(1):353\u201362.","journal-title":"Clin Transl Med"},{"key":"2763_CR206","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215587","volume":"532","author":"H Yamada","year":"2022","unstructured":"Yamada H, Takeshima H, Fujiki R, Yamashita S, Sekine S, Ando T, et al. ARID1A loss-of-function induces CpG island methylator phenotype. Cancer Lett. 2022;532:215587.","journal-title":"Cancer Lett"},{"issue":"3","key":"2763_CR207","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/gutjnl-2020-322660","volume":"71","author":"X Dong","year":"2022","unstructured":"Dong X, Song S, Li Y, Fan Y, Wang L, Wang R, et al. Loss of ARID1A activates mTOR signaling and SOX9 in gastric adenocarcinoma-rationale for targeting ARID1A deficiency. Gut. 2022;71(3):467\u201378.","journal-title":"Gut"},{"issue":"6","key":"2763_CR208","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1158\/2159-8290.CD-20-1109","volume":"11","author":"YH Lo","year":"2021","unstructured":"Lo YH, Kolahi KS, Du Y, Chang CY, Krokhotin A, Nair A, et al. A CRISPR\/Cas9-Engineered ARID1A-Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic Transformation. Cancer Discov. 2021;11(6):1562\u201381.","journal-title":"Cancer Discov"},{"issue":"6","key":"2763_CR209","doi-asserted-by":"publisher","first-page":"e20200219","DOI":"10.1084\/jem.20200219","volume":"218","author":"AKH Loe","year":"2021","unstructured":"Loe AKH, Francis R, Seo J, Du L, Wang Y, Kim JE, et al. Uncovering the dosage-dependent roles of Arid1a in gastric tumorigenesis for combinatorial drug therapy. J Exp Med. 2021;218(6):e20200219.","journal-title":"J Exp Med"},{"issue":"1","key":"2763_CR210","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.canlet.2014.11.038","volume":"357","author":"H Takeshima","year":"2015","unstructured":"Takeshima H, Niwa T, Takahashi T, Wakabayashi M, Yamashita S, Ando T, et al. Frequent involvement of chromatin remodeler alterations in gastric field cancerization. Cancer Lett. 2015;357(1):328\u201338.","journal-title":"Cancer Lett"},{"issue":"4","key":"2763_CR211","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/annonc\/mdl018","volume":"17","author":"JJ Kim","year":"2006","unstructured":"Kim JJ, Chung SW, Kim JH, Kim JW, Oh JS, Kim S, et al. Promoter methylation of helicase-like transcription factor is associated with the early stages of gastric cancer with family history. Ann Oncol. 2006;17(4):657\u201362.","journal-title":"Ann Oncol"},{"issue":"22","key":"2763_CR212","doi-asserted-by":"publisher","first-page":"10727","DOI":"10.1158\/0008-5472.CAN-07-2601","volume":"67","author":"N Yamamichi","year":"2007","unstructured":"Yamamichi N, Inada K, Ichinose M, Yamamichi-Nishina M, Mizutani T, Watanabe H, et al. Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state. Cancer Res. 2007;67(22):10727\u201335.","journal-title":"Cancer Res"},{"issue":"1","key":"2763_CR213","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.1038\/s41467-023-39901-8","volume":"14","author":"Z Yang","year":"2023","unstructured":"Yang Z, Zou S, Zhang Y, Zhang J, Zhang P, Xiao L, et al. ACTL6A protects gastric cancer cells against ferroptosis through induction of glutathione synthesis. Nat Commun. 2023;14(1):4193.","journal-title":"Nat Commun"},{"issue":"7","key":"2763_CR214","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/ng.2291","volume":"44","author":"A Fujimoto","year":"2012","unstructured":"Fujimoto A, Totoki Y, Abe T, Boroevich KA, Hosoda F, Nguyen HH, et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet. 2012;44(7):760\u20134.","journal-title":"Nat Genet"},{"issue":"6","key":"2763_CR215","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/ng.2256","volume":"44","author":"C Guichard","year":"2012","unstructured":"Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB, et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet. 2012;44(6):694\u20138.","journal-title":"Nat Genet"},{"issue":"1","key":"2763_CR216","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13046-015-0164-3","volume":"34","author":"F He","year":"2015","unstructured":"He F, Li J, Xu J, Zhang S, Xu Y, Zhao W, et al. Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma. J Exp Clin Cancer Res. 2015;34(1):47.","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"2763_CR217","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/ng.2391","volume":"44","author":"J Huang","year":"2012","unstructured":"Huang J, Deng Q, Wang Q, Li KY, Dai JH, Li N, et al. Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. Nat Genet. 2012;44(10):1117\u201321.","journal-title":"Nat Genet"},{"issue":"9","key":"2763_CR218","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/ng.903","volume":"43","author":"M Li","year":"2011","unstructured":"Li M, Zhao H, Zhang X, Wood LD, Anders RA, Choti MA, et al. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet. 2011;43(9):828\u20139.","journal-title":"Nat Genet"},{"issue":"9","key":"2763_CR219","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.1073\/pnas.1914937117","volume":"117","author":"H Jiang","year":"2020","unstructured":"Jiang H, Cao HJ, Ma N, Bao WD, Wang JJ, Chen TW, et al. Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis. Proc Natl Acad Sci U S A. 2020;117(9):4770\u201380.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2763_CR220","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2289-3","volume":"11","author":"P Wang","year":"2020","unstructured":"Wang P, Song X, Cao D, Cui K, Wang J, Utpatel K, et al. Oncogene-dependent function of BRG1 in hepatocarcinogenesis. Cell Death Dis. 2020;11(2):91.","journal-title":"Cell Death Dis"},{"issue":"3","key":"2763_CR221","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jhep.2017.10.028","volume":"68","author":"C Hu","year":"2018","unstructured":"Hu C, Li W, Tian F, Jiang K, Liu X, Cen J, et al. Arid1a regulates response to anti-angiogenic therapy in advanced hepatocellular carcinoma. J Hepatol. 2018;68(3):465\u201375.","journal-title":"J Hepatol"},{"issue":"5","key":"2763_CR222","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.jhep.2016.12.026","volume":"66","author":"A Oba","year":"2017","unstructured":"Oba A, Shimada S, Akiyama Y, Nishikawaji T, Mogushi K, Ito H, et al. ARID2 modulates DNA damage response in human hepatocellular carcinoma cells. J Hepatol. 2017;66(5):942\u201351.","journal-title":"J Hepatol"},{"issue":"2","key":"2763_CR223","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3350\/cmh.2024.0686","volume":"31","author":"RQ Sun","year":"2025","unstructured":"Sun RQ, Ye YH, Xu Y, Wang B, Pan SY, Li N, et al. Integrated molecular characterization of sarcomatoid hepatocellular carcinoma. Clin Mol Hepatol. 2025;31(2):426\u201344.","journal-title":"Clin Mol Hepatol"},{"key":"2763_CR224","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102659","volume":"53","author":"M Fujita","year":"2020","unstructured":"Fujita M, Yamaguchi R, Hasegawa T, Shimada S, Arihiro K, Hayashi S, et al. Classification of primary liver cancer with immunosuppression mechanisms and correlation with genomic alterations. EBioMedicine. 2020;53:102659.","journal-title":"EBioMedicine"},{"issue":"2","key":"2763_CR225","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41419-017-0090-8","volume":"9","author":"Z Chen","year":"2018","unstructured":"Chen Z, Lu X, Jia D, Jing Y, Chen D, Wang Q, et al. Hepatic SMARCA4 predicts HCC recurrence and promotes tumour cell proliferation by regulating SMAD6 expression. Cell Death Dis. 2018;9(2):59.","journal-title":"Cell Death Dis"},{"issue":"10242","key":"2763_CR226","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet. 2020;395(10242):2008\u201320.","journal-title":"Lancet"},{"issue":"11","key":"2763_CR227","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2024.100585","volume":"37","author":"A Yavas","year":"2024","unstructured":"Yavas A, Ozcan K, Adsay NV, Balci S, Tarcan ZC, Hechtman JF, et al. SWI\/SNF Complex-Deficient Undifferentiated Carcinoma of the Pancreas: Clinicopathologic and Genomic Analysis. Mod Pathol. 2024;37(11):100585.","journal-title":"Mod Pathol"},{"key":"2763_CR228","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.canlet.2017.05.006","volume":"402","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Wang F, Du C, Guo H, Ma L, Liu X, et al. BRM\/SMARCA2 promotes the proliferation and chemoresistance of pancreatic cancer cells by targeting JAK2\/STAT3 signaling. Cancer Lett. 2017;402:213\u201324.","journal-title":"Cancer Lett"},{"issue":"2","key":"2763_CR229","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ccell.2017.07.007","volume":"32","author":"Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma","year":"2017","unstructured":"Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell. 2017;32(2):185-203.e13.","journal-title":"Cancer Cell"},{"key":"2763_CR230","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103897","volume":"77","author":"X Zhang","year":"2022","unstructured":"Zhang X, Mao T, Zhang B, Xu H, Cui J, Jiao F, et al. Characterization of the genomic landscape in large-scale Chinese patients with pancreatic cancer. EBioMedicine. 2022;77:103897.","journal-title":"EBioMedicine"},{"issue":"9","key":"2763_CR231","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1093\/jnci\/djae095","volume":"116","author":"F Keane","year":"2024","unstructured":"Keane F, Chou JF, Walch H, Schoenfeld J, Singhal A, Cowzer D, et al. Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease. J Natl Cancer Inst. 2024;116(9):1429\u201338.","journal-title":"J Natl Cancer Inst"},{"issue":"26","key":"2763_CR232","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1038\/s41388-023-02716-4","volume":"42","author":"O Araki","year":"2023","unstructured":"Araki O, Tsuda M, Omatsu M, Namikawa M, Sono M, Fukunaga Y, et al. Brg1 controls stemness and metastasis of pancreatic cancer through regulating hypoxia pathway. Oncogene. 2023;42(26):2139\u201352.","journal-title":"Oncogene"},{"issue":"6","key":"2763_CR233","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1101\/gad.256628.114","volume":"29","author":"N Roy","year":"2015","unstructured":"Roy N, Malik S, Villanueva KE, Urano A, Lu X, Von Figura G, et al. Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation. Genes Dev. 2015;29(6):658\u201371.","journal-title":"Genes Dev"},{"issue":"13","key":"2763_CR234","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1016\/j.ejca.2014.05.017","volume":"50","author":"X Liu","year":"2014","unstructured":"Liu X, Tian X, Wang F, Ma Y, Kornmann M, Yang Y. BRG1 promotes chemoresistance of pancreatic cancer cells through crosstalking with Akt signalling. Eur J Cancer. 2014;50(13):2251\u201362.","journal-title":"Eur J Cancer"},{"issue":"1","key":"2763_CR235","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13059-021-02318-x","volume":"22","author":"CA Lee","year":"2021","unstructured":"Lee CA, Abd-Rabbo D, Reimand J. Functional and genetic determinants of mutation rate variability in regulatory elements of cancer genomes. Genome Biol. 2021;22(1):133.","journal-title":"Genome Biol"},{"issue":"7","key":"2763_CR236","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1136\/gutjnl-2017-315541","volume":"68","author":"W Wang","year":"2019","unstructured":"Wang W, Friedland SC, Guo B, O\u2019Dell MR, Alexander WB, Whitney-Miller CL, et al. ARID1A, a SWI\/SNF subunit, is critical to acinar cell homeostasis and regeneration and is a barrier to transformation and epithelial-mesenchymal transition in the pancreas. Gut. 2019;68(7):1245\u201358.","journal-title":"Gut"},{"issue":"1","key":"2763_CR237","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1053\/j.gastro.2018.03.039","volume":"155","author":"Y Kimura","year":"2018","unstructured":"Kimura Y, Fukuda A, Ogawa S, Maruno T, Takada Y, Tsuda M, et al. ARID1A maintains differentiation of pancreatic ductal cells and inhibits development of pancreatic ductal adenocarcinoma in mice. Gastroenterology. 2018;155(1):194-209.e2.","journal-title":"Gastroenterology"},{"issue":"7","key":"2763_CR238","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1136\/gutjnl-2017-315490","volume":"68","author":"SC Wang","year":"2019","unstructured":"Wang SC, Nassour I, Xiao S, Zhang S, Luo X, Lee J, et al. SWI\/SNF component ARID1A restrains pancreatic neoplasia formation. Gut. 2019;68(7):1259\u201370.","journal-title":"Gut"},{"issue":"11","key":"2763_CR239","doi-asserted-by":"publisher","first-page":"e177533","DOI":"10.1172\/JCI177533","volume":"135","author":"M Kawai","year":"2025","unstructured":"Kawai M, Fukuda A, Ikeda M, Iimori K, Mizukoshi K, Iwane K, et al. Polybromo 1\/vimentin axis dictates tumor grade, epithelial-mesenchymal transition, and metastasis in pancreatic cancer. J Clin Invest. 2025;135(11):e177533.","journal-title":"J Clin Invest"},{"issue":"6","key":"2763_CR240","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1093\/nar\/gkv144","volume":"43","author":"A Cuadrado","year":"2015","unstructured":"Cuadrado A, Remeseiro S, Gra\u00f1a O, Pisano DG, Losada A. The contribution of cohesin-SA1 to gene expression and chromatin architecture in two murine tissues. Nucleic Acids Res. 2015;43(6):3056\u201367.","journal-title":"Nucleic Acids Res"},{"key":"2763_CR241","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.canlet.2019.06.014","volume":"460","author":"J Ma","year":"2019","unstructured":"Ma J, Cui Y, Cao T, Xu H, Shi Y, Xia J, et al. PDS5B regulates cell proliferation and motility via upregulation of Ptch2 in pancreatic cancer cells. Cancer Lett. 2019;460:65\u201374.","journal-title":"Cancer Lett"},{"issue":"3","key":"2763_CR242","first-page":"229","volume":"74","author":"F Bray","year":"2022","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2022;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"7636","key":"2763_CR243","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nature20805","volume":"541","author":"J Kim","year":"2017","unstructured":"Kim J, Bowlby R, Mungall AJ, Robertson AG, Odze RD, Cherniack AD, et al. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017;541(7636):169\u201375.","journal-title":"Nature"},{"issue":"1","key":"2763_CR244","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147372","volume":"11","author":"H Nakazato","year":"2016","unstructured":"Nakazato H, Takeshima H, Kishino T, Kubo E, Hattori N, Nakajima T, et al. Early-Stage Induction of SWI\/SNF Mutations during Esophageal Squamous Cell Carcinogenesis. PLoS ONE. 2016;11(1):e0147372.","journal-title":"PLoS ONE"},{"issue":"17","key":"2763_CR245","doi-asserted-by":"publisher","first-page":"28093","DOI":"10.18632\/oncotarget.15890","volume":"8","author":"GJ Korpanty","year":"2017","unstructured":"Korpanty GJ, Eng L, Qiu X, Olusesan Faluyi O, Renouf DJ, Cheng D, et al. Association of BRM promoter polymorphisms and esophageal adenocarcinoma outcome. Oncotarget. 2017;8(17):28093-100.","journal-title":"Oncotarget"},{"issue":"1","key":"2763_CR246","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12885-019-6425-3","volume":"20","author":"S Schallenberg","year":"2020","unstructured":"Schallenberg S, Bork J, Essakly A, Alakus H, Buettner R, Hillmer AM, et al. Loss of the SWI\/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma. BMC Cancer. 2020;20(1):12.","journal-title":"BMC Cancer"},{"issue":"6","key":"2763_CR247","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1038\/s41418-019-0475-6","volume":"27","author":"Q Luo","year":"2020","unstructured":"Luo Q, Wu X, Chang W, Zhao P, Nan Y, Zhu X, et al. ARID1A prevents squamous cell carcinoma initiation and chemoresistance by antagonizing pRb\/E2F1\/c-Myc-mediated cancer stemness. Cell Death Differ. 2020;27(6):1981\u201397.","journal-title":"Cell Death Differ"},{"issue":"22","key":"2763_CR248","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.3390\/cancers15225377","volume":"15","author":"L Zhang","year":"2023","unstructured":"Zhang L, Zheng Y, Chien W, Ziman B, Billet S, Koeffler HP, et al. ARID1A Deficiency Regulates Anti-Tumor Immune Response in Esophageal Adenocarcinoma. Cancers (Basel). 2023;15(22):5377.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2763_CR249","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12935-022-02757-x","volume":"22","author":"Y Li","year":"2022","unstructured":"Li Y, Yang X, Zhu W, Xu Y, Ma J, He C, et al. SWI\/SNF complex gene variations are associated with a higher tumor mutational burden and a better response to immune checkpoint inhibitor treatment: a pan-cancer analysis of next-generation sequencing data corresponding to 4591 cases. Cancer Cell Int. 2022;22(1):347.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"2763_CR250","doi-asserted-by":"publisher","first-page":"11661","DOI":"10.1038\/s41598-019-48152-x","volume":"9","author":"K Ehrenh\u00f6fer-W\u00f6lfer","year":"2019","unstructured":"Ehrenh\u00f6fer-W\u00f6lfer K, Puchner T, Schwarz C, Rippka J, Blaha-Ostermann S, Strobl U, et al. SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines. Sci Rep. 2019;9(1):11661.","journal-title":"Sci Rep"},{"issue":"20","key":"2763_CR251","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202501681R","volume":"39","author":"S Zhou","year":"2025","unstructured":"Zhou S, Sun T, Liu L, Guo D, Zhang X, Shen W, et al. The Knockdown of ACTL6A Enhances the Radiosensitivity of Esophageal Squamous Cell Carcinoma by Modulating the Wnt\/\u03b2-Catenin Signaling Pathway. FASEB J. 2025;39(20):e71047.","journal-title":"FASEB J"},{"issue":"2","key":"2763_CR252","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/gcc.1172","volume":"32","author":"K Yasui","year":"2001","unstructured":"Yasui K, Imoto I, Fukuda Y, Pimkhaokham A, Yang Z-Q, Naruto T, et al. Identification of target genes within an amplicon at 14q12-q13 in esophageal squamous cell carcinoma. Genes Chromosom Cancer. 2001;32(2):112\u20138.","journal-title":"Genes Chromosom Cancer"},{"issue":"12","key":"2763_CR253","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3390\/cells14120928","volume":"14","author":"Y Lin","year":"2025","unstructured":"Lin Y, Zhao X, Du Z, Jia Z, Zhou S, Cao G, et al. MicroRNA miR-193b-3p Regulates Esophageal Cancer Progression Through Targeting RSF1. Cells. 2025;14(12):928.","journal-title":"Cells"},{"issue":"4","key":"2763_CR254","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1158\/1078-0432.CCR-24-2505","volume":"31","author":"C Liu","year":"2025","unstructured":"Liu C, Zou H, Ruan Y, Fang L, Wang B, Cui L, et al. Multiomics Reveals the Immunologic Features and the Immune Checkpoint Blockade Potential of Colorectal Medullary Carcinoma. Clin Cancer Res. 2025;31(4):773\u201386.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2763_CR255","doi-asserted-by":"publisher","first-page":"5478","DOI":"10.1038\/s41467-022-33172-5","volume":"13","author":"RM Johnson","year":"2022","unstructured":"Johnson RM, Qu X, Lin CF, Huw LY, Venkatanarayan A, Sokol E, et al. ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer. Nat Commun. 2022;13(1):5478.","journal-title":"Nat Commun"},{"issue":"6","key":"2763_CR256","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1158\/1078-0432.CCR-20-2404","volume":"27","author":"A Mehrvarz Sarshekeh","year":"2021","unstructured":"Mehrvarz Sarshekeh A, Alshenaifi J, Roszik J, Manyam GC, Advani SM, Katkhuda R, et al. ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer. Clin Cancer Res. 2021;27(6):1663\u201370.","journal-title":"Clin Cancer Res"},{"issue":"24","key":"2763_CR257","doi-asserted-by":"publisher","first-page":"7347","DOI":"10.1158\/1078-0432.CCR-06-1264","volume":"12","author":"M Wallner","year":"2006","unstructured":"Wallner M, Herbst A, Behrens A, Crispin A, Stieber P, G\u00f6ke B, et al. Methylation of serum DNA is an independent prognostic marker in colorectal cancer. Clin Cancer Res. 2006;12(24):7347\u201352.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"2763_CR258","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1111\/j.1572-0241.2005.50412.x","volume":"100","author":"WK Leung","year":"2005","unstructured":"Leung WK, To KF, Man EP, Chan MW, Bai AH, Hui AJ, et al. Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer. Am J Gastroenterol. 2005;100(10):2274\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"2763_CR259","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13046-019-1116-0","volume":"38","author":"P Sarogni","year":"2019","unstructured":"Sarogni P, Palumbo O, Servadio A, Astigiano S, D\u2019Alessio B, Gatti V, et al. Overexpression of the cohesin-core subunit SMC1A contributes to colorectal cancer development. J Exp Clin Cancer Res. 2019;38(1):108.","journal-title":"J Exp Clin Cancer Res"},{"key":"2763_CR260","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.canlet.2020.10.006","volume":"497","author":"M Sasaki","year":"2021","unstructured":"Sasaki M, Miyoshi N, Fujino S, Saso K, Ogino T, Takahashi H, et al. The meiosis-specific cohesin component stromal antigen 3 promotes cell migration and chemotherapeutic resistance in colorectal cancer. Cancer Lett. 2021;497:112\u201322.","journal-title":"Cancer Lett"},{"issue":"1","key":"2763_CR261","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41419-025-07912-6","volume":"16","author":"JY Chen","year":"2025","unstructured":"Chen JY, Ke TW, Chiang SF, Hong WZ, Chang HY, Liang JA, et al. CHK1 inhibition increases the therapeutic response to radiotherapy via antitumor immunity in ARID1A-deficient colorectal cancer. Cell Death Dis. 2025;16(1):584.","journal-title":"Cell Death Dis"},{"issue":"5","key":"2763_CR262","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1073\/pnas.1804858116","volume":"116","author":"Y Hiramatsu","year":"2019","unstructured":"Hiramatsu Y, Fukuda A, Ogawa S, Goto N, Ikuta K, Tsuda M, et al. Arid1a is essential for intestinal stem cells through Sox9 regulation. Proc Natl Acad Sci U S A. 2019;116(5):1704\u201313.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2763_CR263","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41698-023-00367-y","volume":"7","author":"X Zeng","year":"2023","unstructured":"Zeng X, Yao B, Liu J, Gong GW, Liu M, Li J, et al. The SMARCA4(R1157W) mutation facilitates chromatin remodeling and confers PRMT1\/SMARCA4 inhibitors sensitivity in colorectal cancer. NPJ Precis Oncol. 2023;7(1):28.","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"2763_CR264","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13073-021-00871-5","volume":"13","author":"B Yao","year":"2021","unstructured":"Yao B, Gui T, Zeng X, Deng Y, Wang Z, Wang Y, et al. PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling. Genome Med. 2021;13(1):58.","journal-title":"Genome Med"},{"issue":"1","key":"2763_CR265","doi-asserted-by":"publisher","first-page":"4614","DOI":"10.1038\/s41467-019-12573-z","volume":"10","author":"M Liu","year":"2019","unstructured":"Liu M, Sun T, Li N, Peng J, Fu D, Li W, et al. BRG1 attenuates colonic inflammation and tumorigenesis through autophagy-dependent oxidative stress sequestration. Nat Commun. 2019;10(1):4614.","journal-title":"Nat Commun"},{"issue":"5","key":"2763_CR266","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/onc.2015.124","volume":"35","author":"G Wang","year":"2016","unstructured":"Wang G, Fu Y, Yang X, Luo X, Wang J, Gong J, et al. Brg-1 targeting of novel miR550a-5p\/RNF43\/Wnt signaling axis regulates colorectal cancer metastasis. Oncogene. 2016;35(5):651\u201361.","journal-title":"Oncogene"},{"issue":"2","key":"2763_CR267","doi-asserted-by":"publisher","first-page":"e2607","DOI":"10.1038\/cddis.2017.1","volume":"8","author":"G Wang","year":"2017","unstructured":"Wang G, Fu Y, Hu F, Lan J, Xu F, Yang X, et al. Loss of BRG1 induces CRC cell senescence by regulating p53\/p21 pathway. Cell Death Dis. 2017;8(2):e2607.","journal-title":"Cell Death Dis"},{"issue":"15","key":"2763_CR268","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1016\/j.molcel.2025.06.020","volume":"85","author":"I Akano","year":"2025","unstructured":"Akano I, Hebert JM, Tiedemann RL, Gao Q, Xiao Y, Prescott NA, et al. The SWI\/SNF-related protein SMARCA3 is a histone H3K23 ubiquitin ligase that regulates H3K9me3 in cancer. Mol Cell. 2025;85(15):2885-99 e8.","journal-title":"Mol Cell"},{"issue":"12","key":"2763_CR269","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/s41419-022-05499-w","volume":"13","author":"Z Yang","year":"2022","unstructured":"Yang Z, Huang D, Meng M, Wang W, Feng J, Fang L, et al. BAF53A drives colorectal cancer development by regulating DUSP5-mediated ERK phosphorylation. Cell Death Dis. 2022;13(12):1049.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2763_CR270","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/s41419-025-07946-w","volume":"16","author":"HJ Yang","year":"2025","unstructured":"Yang HJ, Kim EJ, Kim Y, Cho Y, Choi Y, Song SH, et al. ACTL6A depletion induces KLF4-mediated anti-tumorigenic effects in colorectal cancer. Cell Death Dis. 2025;16(1):653.","journal-title":"Cell Death Dis"},{"key":"2763_CR271","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217933","volume":"631","author":"H Wang","year":"2025","unstructured":"Wang H, Du S, Ji S, Miao G, Yu J, Zhou M, et al. SMARCA1-NPFF axis inhibits colorectal cancer metastasis by blocking epithelial-mesenchymal transition and macrophage-dependent immune reprogramming. Cancer Lett. 2025;631:217933.","journal-title":"Cancer Lett"},{"key":"2763_CR272","doi-asserted-by":"crossref","unstructured":"Li D, Wang X, Miao H, Liu H, Pang M, Guo H, et al. The lncRNA MIR99AHG directs alternative splicing of SMARCA1 by PTBP1 to enable invadopodia formation in colorectal cancer cells. Sci Signal. 2023;16(803):eadh4210.","DOI":"10.1126\/scisignal.adh4210"},{"key":"2763_CR273","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.canlet.2016.10.041","volume":"385","author":"P Zhou","year":"2017","unstructured":"Zhou P, Xiao N, Wang J, Wang Z, Zheng S, Shan S, et al. SMC1A recruits tumor-associated-fibroblasts (TAFs) and promotes colorectal cancer metastasis. Cancer Lett. 2017;385:39\u201345.","journal-title":"Cancer Lett"},{"issue":"1","key":"2763_CR274","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin"},{"issue":"14","key":"2763_CR275","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1001\/jama.2025.9495","volume":"334","author":"G Caruso","year":"2025","unstructured":"Caruso G, Weroha SJ, Cliby W. Ovarian Cancer: A Review. JAMA. 2025;334(14):1278\u201391.","journal-title":"JAMA"},{"key":"2763_CR276","doi-asserted-by":"crossref","unstructured":"Li J, Han T, Guo D, Kong R, Chen S, Wang M, et al. Molecular profile of SWI\/SNF complex in Chinese patients with ovarian cancer. Journal of Clinical Oncology. 2023;41(16_suppl):e17538-e.","DOI":"10.1200\/JCO.2023.41.16_suppl.e17538"},{"issue":"11","key":"2763_CR277","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1136\/ijgc-2021-002973","volume":"31","author":"S Banerjee","year":"2021","unstructured":"Banerjee S, Stewart J, Porta N, Toms C, Leary A, Lheureux S, et al. ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT\/GYN1\/NCRI). Int J Gynecol Cancer. 2021;31(11):1471\u20135.","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"2763_CR278","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.ccell.2023.03.002","volume":"41","author":"W Zhou","year":"2023","unstructured":"Zhou W, Liu H, Yuan Z, Zundell J, Towers M, Lin J, et al. Targeting the mevalonate pathway suppresses ARID1A-inactivated cancers by promoting pyroptosis. Cancer Cell. 2023;41(4):740-56.e10.","journal-title":"Cancer Cell"},{"issue":"1","key":"2763_CR279","doi-asserted-by":"publisher","first-page":"20412","DOI":"10.1038\/s41598-020-77532-x","volume":"10","author":"K Leitner","year":"2020","unstructured":"Leitner K, Tsibulak I, Wieser V, Knoll K, Reimer D, Marth C, et al. Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer. Sci Rep. 2020;10(1):20412.","journal-title":"Sci Rep"},{"issue":"5","key":"2763_CR280","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/ng.2931","volume":"46","author":"L Witkowski","year":"2014","unstructured":"Witkowski L, Carrot-Zhang J, Albrecht S, Fahiminiya S, Hamel N, Tomiak E, et al. Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type. Nat Genet. 2014;46(5):438\u201343.","journal-title":"Nat Genet"},{"issue":"5","key":"2763_CR281","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/ng.2922","volume":"46","author":"P Jelinic","year":"2014","unstructured":"Jelinic P, Mueller JJ, Olvera N, Dao F, Scott SN, Shah R, et al. Recurrent SMARCA4 mutations in small cell carcinoma of the ovary. Nat Genet. 2014;46(5):424\u20136.","journal-title":"Nat Genet"},{"key":"2763_CR282","volume-title":"WHO classification of tumours of female reproductive organs","author":"RJ Kurman","year":"2014","unstructured":"Kurman RJ, International Agency for Research on C, World Health O. WHO classification of tumours of female reproductive organs. Fourth edition. Lyon, [France: International Agency for Research on Cancer; 2014.","edition":"Fourth edition"},{"issue":"1","key":"2763_CR283","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41598-020-57530-9","volume":"10","author":"TR Leylek","year":"2020","unstructured":"Leylek TR, Jeusset LM, Lichtensztejn Z, McManus KJ. Reduced Expression of Genes Regulating Cohesion Induces Chromosome Instability that May Promote Cancer and Impact Patient Outcomes. Sci Rep. 2020;10(1):592.","journal-title":"Sci Rep"},{"key":"2763_CR284","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.936550","volume":"12","author":"R Gou","year":"2022","unstructured":"Gou R, Li X, Dong H, Hu Y, Liu O, Liu J, et al. RAD21 Confers Poor Prognosis and Affects Ovarian Cancer Sensitivity to Poly(ADP-Ribose)Polymerase Inhibitors Through DNA Damage Repair. Front Oncol. 2022;12:936550.","journal-title":"Front Oncol"},{"issue":"39","key":"2763_CR285","doi-asserted-by":"publisher","first-page":"14004","DOI":"10.1073\/pnas.0504195102","volume":"102","author":"I-M Shih","year":"2005","unstructured":"Shih I-M, Sheu JJ-C, Santillan A, Nakayama K, Yen MJ, Bristow RE, et al. Amplification of a chromatin remodeling gene, Rsf-1\/HBXAP, in ovarian carcinoma. Proc Natl Acad Sci U S A. 2005;102(39):14004\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2763_CR286","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1158\/0008-5472.CAN-13-2459","volume":"74","author":"Y-I Yang","year":"2014","unstructured":"Yang Y-I, Ahn J-H, Lee K-T, Shih I-M, Choi J-H. RSF1 Is a Positive Regulator of NF-\u03baB\u2013Induced Gene Expression Required for Ovarian Cancer Chemoresistance. Can Res. 2014;74(8):2258\u201369.","journal-title":"Can Res"},{"issue":"4","key":"2763_CR287","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1158\/0008-5472.CAN-08-3602","volume":"69","author":"JH Choi","year":"2009","unstructured":"Choi JH, Sheu JJ-C, Guan B, Jinawath N, Markowski P, Wang T-L, et al. Functional analysis of 11q13.5 amplicon identifies Rsf-1 (HBXAP) as a gene involved in paclitaxel resistance in ovarian cancer. Cancer Res. 2009;69(4):1407\u201315.","journal-title":"Cancer Res"},{"issue":"11","key":"2763_CR288","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1593\/neo.08718","volume":"10","author":"KL Gorringe","year":"2008","unstructured":"Gorringe KL, Choong DY, Williams LH, Ramakrishna M, Sridhar A, Qiu W, et al. Mutation and methylation analysis of the chromodomain-helicase-DNA binding 5 gene in ovarian cancer. Neoplasia. 2008;10(11):1253\u20138.","journal-title":"Neoplasia"},{"issue":"3","key":"2763_CR289","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000323883","volume":"72","author":"RR Wong","year":"2011","unstructured":"Wong RR, Chan LK, Tsang TP, Lee CW, Cheung TH, Yim SF, et al. CHD5 Downregulation Associated with Poor Prognosis in Epithelial Ovarian Cancer. Gynecol Obstet Invest. 2011;72(3):203\u20137.","journal-title":"Gynecol Obstet Invest"},{"issue":"5","key":"2763_CR290","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1101\/gad.256214.114","volume":"29","author":"S Guillemette","year":"2015","unstructured":"Guillemette S, Serra RW, Peng M, Hayes JA, Konstantinopoulos PA, Green MR, et al. Resistance to therapy in BRCA2 mutant cells due to loss of the nucleosome remodeling factor CHD4. Genes Dev. 2015;29(5):489\u201394.","journal-title":"Genes Dev"},{"issue":"3","key":"2763_CR291","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70634","volume":"14","author":"G Chen","year":"2025","unstructured":"Chen G, Li W, Guo J, Liu L, Wang Y. Development and Validation of Prognostic Characteristics Associated With Chromatin Remodeling-Related Genes in Ovarian Cancer. Cancer Med. 2025;14(3):e70634.","journal-title":"Cancer Med"},{"issue":"10528","key":"2763_CR292","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S0140-6736(25)02221-4","volume":"407","author":"V Fonteyne","year":"2026","unstructured":"Fonteyne V, Tree A, Castro E, Touijer K, Walz J. Prostate cancer. Lancet. 2026;407(10528):622\u201336.","journal-title":"Lancet"},{"issue":"1","key":"2763_CR293","doi-asserted-by":"publisher","first-page":"5549","DOI":"10.1038\/s41467-020-19328-1","volume":"11","author":"J Cyrta","year":"2020","unstructured":"Cyrta J, Augspach A, De Filippo MR, Prandi D, Thienger P, Benelli M, et al. Role of specialized composition of SWI\/SNF complexes in prostate cancer lineage plasticity. Nat Commun. 2020;11(1):5549.","journal-title":"Nat Commun"},{"key":"2763_CR294","doi-asserted-by":"crossref","unstructured":"Gokbayrak B, Altintas UB, Lingadahalli S, Morova T, Huang C-CF, Ersoy Fazlioglu B, et al. Identification of selective SWI\/SNF dependencies in enzalutamide-resistant prostate cancer. Communications Biology. 2025;8(1):169.","DOI":"10.1038\/s42003-024-07413-w"},{"issue":"7893","key":"2763_CR295","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-021-04246-z","volume":"601","author":"L Xiao","year":"2022","unstructured":"Xiao L, Parolia A, Qiao Y, Bawa P, Eyunni S, Mannan R, et al. Targeting SWI\/SNF ATPases in enhancer-addicted prostate cancer. Nature. 2022;601(7893):434\u20139.","journal-title":"Nature"},{"issue":"1","key":"2763_CR296","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/pros.20670","volume":"68","author":"B Saha","year":"2008","unstructured":"Saha B, Arase A, Imam SS, Tsao-Wei D, Naritoku WY, Groshen S, et al. Overexpression of E-cadherin and \u03b2-Catenin proteins in metastatic prostate cancer cells in bone. Prostate. 2008;68(1):78\u201384.","journal-title":"Prostate"},{"issue":"4","key":"2763_CR297","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.ccell.2020.03.001","volume":"37","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Zhou C, Li X, Barnes SD, Deng S, Hoover E, et al. Loss of <em>CHD1<\/em> Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation. Cancer Cell. 2020;37(4):584-98.e11.","journal-title":"Cancer Cell"},{"issue":"17","key":"2763_CR298","doi-asserted-by":"publisher","first-page":"4836","DOI":"10.1158\/1078-0432.CCR-21-0121","volume":"27","author":"C Calagua","year":"2021","unstructured":"Calagua C, Ficial M, Jansen CS, Hirz T, Del Balzo L, Wilkinson S, et al. A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes. Clin Cancer Res. 2021;27(17):4836\u201347.","journal-title":"Clin Cancer Res"},{"issue":"21","key":"2763_CR299","doi-asserted-by":"publisher","first-page":"12186","DOI":"10.1093\/nar\/gkac1090","volume":"50","author":"D Zhao","year":"2022","unstructured":"Zhao D, Zhang M, Huang S, Liu Q, Zhu S, Li Y, et al. CHD6 promotes broad nucleosome eviction for transcriptional activation in prostate cancer cells. Nucleic Acids Res. 2022;50(21):12186\u2013201.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2763_CR300","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2024.102397","volume":"35","author":"L Bu","year":"2024","unstructured":"Bu L, Huang S, Rao Z, Wu C, Sun B-Y, Liu Y, et al. CHD6 eviction of promoter nucleosomes maintains housekeeping transcriptional program in prostate cancer. Molecular Therapy Nucleic Acids. 2024;35(4):102397.","journal-title":"Molecular Therapy Nucleic Acids"},{"issue":"12","key":"2763_CR301","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.neo.2014.10.003","volume":"16","author":"NA Damaschke","year":"2014","unstructured":"Damaschke NA, Yang B, Blute ML Jr, Lin CP, Huang W, Jarrard DF. Frequent disruption of chromodomain helicase DNA-binding protein 8 (CHD8) and functionally associated chromatin regulators in prostate cancer. Neoplasia. 2014;16(12):1018\u201327.","journal-title":"Neoplasia"},{"issue":"6","key":"2763_CR302","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1210\/me.2009-0421","volume":"24","author":"T Menon","year":"2010","unstructured":"Menon T, Yates JA, Bochar DA. Regulation of androgen-responsive transcription by the chromatin remodeling factor CHD8. Mol Endocrinol. 2010;24(6):1165\u201374.","journal-title":"Mol Endocrinol"},{"issue":"5","key":"2763_CR303","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.molcel.2006.08.008","volume":"23","author":"K Ishihara","year":"2006","unstructured":"Ishihara K, Oshimura M, Nakao M. CTCF-Dependent Chromatin Insulator Is Linked to Epigenetic Remodeling. Mol Cell. 2006;23(5):733\u201342.","journal-title":"Mol Cell"},{"issue":"6","key":"2763_CR304","doi-asserted-by":"publisher","first-page":"oyaf133","DOI":"10.1093\/oncolo\/oyaf133","volume":"30","author":"C Zhu","year":"2025","unstructured":"Zhu C, Gong Z, Yin P, Huang J, He D, Zhu B, et al. Predictive role of ARID1A and B2M mutations and the antigen presentation pathway in the efficacy of definitive chemoradiotherapy for cervical cancer. The Oncologist. 2025;30(6):oyaf133.","journal-title":"Oncologist"},{"issue":"2","key":"2763_CR305","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/IGC.0b013e3182313d78","volume":"22","author":"A Katagiri","year":"2012","unstructured":"Katagiri A, Nakayama K, Rahman MT, Rahman M, Katagiri H, Ishikawa M, et al. Frequent Loss of Tumor Suppressor ARID1A Protein Expression in Adenocarcinomas\/Adenosquamous Carcinomas of the Uterine Cervix. Int J Gynecol Cancer. 2012;22(2):208\u201312.","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"2763_CR306","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.humpath.2012.11.007","volume":"44","author":"H Cho","year":"2013","unstructured":"Cho H, Kim JS-Y, Chung H, Perry C, Lee H, Kim J-H. Loss of ARID1A\/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer. Hum Pathol. 2013;44(7):1365\u201374.","journal-title":"Hum Pathol"},{"issue":"7730","key":"2763_CR307","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-018-0658-1","volume":"563","author":"L Chang","year":"2018","unstructured":"Chang L, Azzolin L, Di Biagio D, Zanconato F, Battilana G, Lucon Xiccato R, et al. The SWI\/SNF complex is a mechanoregulated inhibitor of YAP and TAZ. Nature. 2018;563(7730):265\u20139.","journal-title":"Nature"},{"key":"2763_CR308","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.724832","volume":"11","author":"Q Wang","year":"2021","unstructured":"Wang Q, Cao Z, Wei Y, Zhang J, Cheng Z. Potential Role of SWI\/SNF Complex Subunit Actin-Like Protein 6A in Cervical Cancer. Front Oncol. 2021;11:724832.","journal-title":"Front Oncol"},{"issue":"12","key":"2763_CR309","doi-asserted-by":"publisher","first-page":"9718","DOI":"10.1002\/jcp.29783","volume":"235","author":"J Zhao","year":"2020","unstructured":"Zhao J, Li L, Yang T. MiR-216a-3p suppresses the proliferation and invasion of cervical cancer through downregulation of ACTL6A-mediated YAP signaling. J Cell Physiol. 2020;235(12):9718\u201328.","journal-title":"J Cell Physiol"},{"issue":"2","key":"2763_CR310","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.bbrc.2011.07.098","volume":"412","author":"K Lee","year":"2011","unstructured":"Lee K, Lee A-Y, Kwon YK, Kwon H. Suppression of HPV E6 and E7 expression by BAF53 depletion in cervical cancer cells. Biochem Biophys Res Commun. 2011;412(2):328\u201333.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"2763_CR311","doi-asserted-by":"publisher","DOI":"10.3390\/genes15050560","volume":"15","author":"A Fudulu","year":"2024","unstructured":"Fudulu A, Diaconu CC, Iancu IV, Plesa A, Albulescu A, Bostan M, et al. Exploring the role of E6 and E7 oncoproteins in cervical oncogenesis through MBD2\/3-NuRD complex chromatin remodeling. Genes (Basel). 2024;15(5):560.","journal-title":"Genes (Basel)"},{"issue":"9","key":"2763_CR312","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1093\/emboj\/18.9.2449","volume":"18","author":"A Brehm","year":"1999","unstructured":"Brehm A, Nielsen SJ, Miska EA, McCance DJ, Reid JL, Bannister AJ, et al. The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. EMBO J. 1999;18(9):2449\u201358.","journal-title":"EMBO J"},{"issue":"4","key":"2763_CR313","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004763","volume":"11","author":"K Mehta","year":"2015","unstructured":"Mehta K, Gunasekharan V, Satsuka A, Laimins LA. Human papillomaviruses activate and recruit SMC1 cohesin proteins for the differentiation-dependent life cycle through association with CTCF insulators. PLoS Pathog. 2015;11(4):e1004763.","journal-title":"PLoS Pathog"},{"issue":"10","key":"2763_CR314","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2005752","volume":"16","author":"I Pentland","year":"2018","unstructured":"Pentland I, Campos-Le\u00f3n K, Cotic M, Davies K-J, Wood CD, Groves IJ, et al. Disruption of CTCF-YY1\u2013dependent looping of the human papillomavirus genome activates differentiation-induced viral oncogene transcription. PLoS Biol. 2018;16(10):e2005752.","journal-title":"PLoS Biol"},{"issue":"44","key":"2763_CR315","doi-asserted-by":"publisher","first-page":"72250","DOI":"10.18632\/oncotarget.12667","volume":"7","author":"J Hu","year":"2016","unstructured":"Hu J, Liu J, Chen A, Lyu J, Ai G, Zeng Q, et al. Ino80 promotes cervical cancer tumorigenesis by activating Nanog expression. Oncotarget. 2016;7(44):72250\u201362.","journal-title":"Oncotarget"},{"issue":"7408","key":"2763_CR316","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nature11288","volume":"487","author":"O Rozenblatt-Rosen","year":"2012","unstructured":"Rozenblatt-Rosen O, Deo RC, Padi M, Adelmant G, Calderwood MA, Rolland T, et al. Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. Nature. 2012;487(7408):491\u20135.","journal-title":"Nature"},{"issue":"7","key":"2763_CR317","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1002\/cam4.1592","volume":"7","author":"L Xia","year":"2018","unstructured":"Xia L, Wang M, Li H, Tang X, Chen F, Cui J. The effect of aberrant expression and genetic polymorphisms of Rad21 on cervical cancer biology. Cancer Med. 2018;7(7):3393\u2013405.","journal-title":"Cancer Med"},{"key":"2763_CR318","doi-asserted-by":"crossref","unstructured":"Wagle NS, Nogueira L, Devasia TP, Mariotto AB, Yabroff KR, Islami F, et al. Cancer treatment and survivorship statistics. 2025. CA: A Cancer Journal for Clinicians. 2025;75(4):308\u201340.","DOI":"10.3322\/caac.70011"},{"issue":"15","key":"2763_CR319","doi-asserted-by":"publisher","first-page":"7306","DOI":"10.3390\/ijms26157306","volume":"26","author":"R Piergentili","year":"2025","unstructured":"Piergentili R, Marinelli E, De Paola L, Cucinella G, Billone V, Zaami S, et al. Epigenetics of Endometrial Cancer: The Role of Chromatin Modifications and Medicolegal Implications. Int J Mol Sci. 2025;26(15):7306.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2763_CR320","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/PAS.0000000000000941","volume":"42","author":"M K\u00f6bel","year":"2018","unstructured":"K\u00f6bel M, Hoang LN, Tessier-Cloutier B, Meng B, Soslow RA, Stewart CJR, et al. Undifferentiated Endometrial Carcinomas Show Frequent Loss of Core Switch\/Sucrose Nonfermentable Complex Proteins. Am J Surg Pathol. 2018;42(1):76\u201383.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2763_CR321","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/PAT.0000000000000270","volume":"47","author":"CJ Stewart","year":"2015","unstructured":"Stewart CJ, Crook ML. SWI\/SNF complex deficiency and mismatch repair protein expression in undifferentiated and dedifferentiated endometrial carcinoma. Pathology. 2015;47(5):439\u201345.","journal-title":"Pathology"},{"issue":"5","key":"2763_CR322","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/PAS.0b013e318212782a","volume":"35","author":"B Guan","year":"2011","unstructured":"Guan B, Mao T-L, Panuganti PK, Kuhn E, Kurman RJ, Maeda D, et al. Mutation and Loss of Expression of ARID1A in Uterine Low-grade Endometrioid Carcinoma. Am J Surg Pathol. 2011;35(5):625\u201332.","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"2763_CR323","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1038\/s41588-025-02333-9","volume":"57","author":"JD St. Laurent","year":"2025","unstructured":"St. Laurent JD, Xu GD, Ying AW, Gokbayrak B, Patil A, Paulo JA, et al. Shifted assembly and function of mSWI\/SNF family subcomplexes underlie targetable dependencies in dedifferentiated endometrial carcinomas. Nat Genet. 2025;57(11):2743\u201355.","journal-title":"Nat Genet"},{"issue":"9","key":"2763_CR324","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/apm.12977","volume":"127","author":"A Raffone","year":"2019","unstructured":"Raffone A, Travaglino A, Saccone G, Cieri M, Mascolo M, Mollo A, et al. Diagnostic and prognostic value of ARID1A in endometrial hyperplasia: a novel marker of occult cancer. APMIS. 2019;127(9):597\u2013606.","journal-title":"APMIS"},{"issue":"1","key":"2763_CR325","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1038\/s41467-020-16416-0","volume":"11","author":"Y Suryo Rahmanto","year":"2020","unstructured":"Suryo Rahmanto Y, Shen W, Shi X, Chen X, Yu Y, Yu Z-C, et al. Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming. Nat Commun. 2020;11(1):2717.","journal-title":"Nat Commun"},{"key":"2763_CR326","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.humpath.2021.07.001","volume":"116","author":"A Kihara","year":"2021","unstructured":"Kihara A, Amano Y, Matsubara D, Fukushima N, Fujiwara H, Niki T. Infrequent loss of SMARCA4, SMARCA2, and SMARCB1 expression in uterine mesenchymal tumors. Hum Pathol. 2021;116:12\u201321.","journal-title":"Hum Pathol"},{"issue":"3","key":"2763_CR327","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/path.4633","volume":"238","author":"AN Karnezis","year":"2016","unstructured":"Karnezis AN, Wang Y, Ramos P, Hendricks WP, Oliva E, D\u2019Angelo E, et al. Dual loss of the SWI\/SNF complex ATPases SMARCA4\/BRG1 and SMARCA2\/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type. J Pathol. 2016;238(3):389\u2013400.","journal-title":"J Pathol"},{"issue":"3","key":"2763_CR328","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/modpathol.2015.155","volume":"29","author":"AN Karnezis","year":"2016","unstructured":"Karnezis AN, Hoang LN, Coatham M, Ravn S, Almadani N, Tessier-Cloutier B, et al. Loss of switch\/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas. Mod Pathol. 2016;29(3):302\u201314.","journal-title":"Mod Pathol"},{"issue":"7447","key":"2763_CR329","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"C Kandoth","year":"2013","unstructured":"Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67\u201373.","journal-title":"Nature"},{"issue":"1","key":"2763_CR330","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41419-025-07776-w","volume":"16","author":"L Ye","year":"2025","unstructured":"Ye L, Jiang G, Sun Y, Li B. ARNTL-mediated INO80-DHX15 axis reprograms the glycolytic metabolism and augments the progression of endometrial carcinoma. Cell Death Dis. 2025;16(1):463.","journal-title":"Cell Death Dis"},{"issue":"12","key":"2763_CR331","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/ng.2455","volume":"44","author":"M Le Gallo","year":"2012","unstructured":"Le Gallo M, O\u2019Hara AJ, Rudd ML, Urick ME, Hansen NF, O\u2019Neil NJ, et al. Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes. Nat Genet. 2012;44(12):1310\u20135.","journal-title":"Nat Genet"},{"issue":"5","key":"2763_CR332","first-page":"903","volume":"8","author":"Y Li","year":"2018","unstructured":"Li Y, Liu Q, McGrail DJ, Dai H, Li K, Lin SY. CHD4 mutations promote endometrial cancer stemness by activating TGF-beta signaling. Am J Cancer Res. 2018;8(5):903\u201314.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"2763_CR333","doi-asserted-by":"publisher","first-page":"18617","DOI":"10.1038\/s41598-024-69233-6","volume":"14","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Zhu F, Tong Y, Shi D, Zhang J. CHD4 R975H mutant activates tumorigenic pathways and promotes stemness and M2-like macrophage polarization in endometrial cancer. Sci Rep. 2024;14(1):18617.","journal-title":"Sci Rep"},{"issue":"2","key":"2763_CR334","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1200\/JCO.2005.01.5180","volume":"24","author":"IM Bachmann","year":"2006","unstructured":"Bachmann IM, Halvorsen OJ, Collett K, Stefansson IM, Straume O, Haukaas SA, et al. EZH2 Expression Is Associated With High Proliferation Rate and Aggressive Tumor Subgroups in Cutaneous Melanoma and Cancers of the Endometrium, Prostate, and Breast. J Clin Oncol. 2006;24(2):268\u201373.","journal-title":"J Clin Oncol"},{"issue":"2","key":"2763_CR335","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ygyno.2019.12.003","volume":"156","author":"L Krill","year":"2020","unstructured":"Krill L, Deng W, Eskander R, Mutch D, Zweizig S, Hoang B, et al. Overexpression of enhance of Zeste homolog 2 (EZH2) in endometrial carcinoma: An NRG Oncology\/Gynecologic Oncology Group Study. Gynecol Oncol. 2020;156(2):423\u20139.","journal-title":"Gynecol Oncol"},{"issue":"8","key":"2763_CR336","doi-asserted-by":"publisher","first-page":"13509","DOI":"10.18632\/oncotarget.14586","volume":"8","author":"K Ihira","year":"2017","unstructured":"Ihira K, Dong P, Xiong Y, Watari H, Konno Y, Hanley SJ, et al. EZH2 inhibition suppresses endometrial cancer progression via miR-361\/Twist axis. Oncotarget. 2017;8(8):13509.","journal-title":"Oncotarget"},{"issue":"16","key":"2763_CR337","doi-asserted-by":"publisher","first-page":"e190989","DOI":"10.1172\/JCI190989","volume":"135","author":"SS Sahoo","year":"2025","unstructured":"Sahoo SS, Ramanand SG, Cuevas IC, Gao Y, Lee S, Abbas A, et al. A distinct mechanism of epigenetic reprogramming silences PAX2 and initiates endometrial carcinogenesis. The Journal of clinical investigation. 2025;135(16):e190989.","journal-title":"J Clin Invest"},{"issue":"2","key":"2763_CR338","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41588-019-0541-5","volume":"52","author":"S Nagarajan","year":"2020","unstructured":"Nagarajan S, Rao SV, Sutton J, Cheeseman D, Dunn S, Papachristou EK, et al. ARID1A influences HDAC1\/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response. Nat Genet. 2020;52(2):187\u201397.","journal-title":"Nat Genet"},{"issue":"2","key":"2763_CR339","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41588-019-0554-0","volume":"52","author":"G Xu","year":"2020","unstructured":"Xu G, Chhangawala S, Cocco E, Razavi P, Cai Y, Otto JE, et al. ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer. Nat Genet. 2020;52(2):198\u2013207.","journal-title":"Nat Genet"},{"issue":"1","key":"2763_CR340","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s11658-025-00788-6","volume":"30","author":"WY Sheng","year":"2025","unstructured":"Sheng WY, Zhu Y, Liu SQ, Huang QY, Qian WF, Cheng JL, et al. A novel SWI\/SNF complex promotes triple-negative breast cancer progression. Cell Mol Biol Lett. 2025;30(1):105.","journal-title":"Cell Mol Biol Lett"},{"issue":"10","key":"2763_CR341","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1158\/0008-5472.CAN-24-2801","volume":"85","author":"Z Sun","year":"2025","unstructured":"Sun Z, Li Z, Wei Y, Xu L, Hang X, Kang Y. SMARCA4 Inhibits Breast Cancer Progression and Metastasis through RHOA Suppression. Cancer Res. 2025;85(10):1803\u201318.","journal-title":"Cancer Res"},{"issue":"2","key":"2763_CR342","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0092-8674(00)00030-1","volume":"102","author":"DA Bochar","year":"2000","unstructured":"Bochar DA, Wang L, Beniya H, Kinev A, Xue Y, Lane WS, et al. BRCA1 is associated with a human SWI\/SNF-related complex: linking chromatin remodeling to breast cancer. Cell. 2000;102(2):257\u201365.","journal-title":"Cell"},{"issue":"6","key":"2763_CR343","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1158\/0008-5472.CAN-09-2089","volume":"70","author":"MT Harte","year":"2010","unstructured":"Harte MT, O\u2019Brien GJ, Ryan NM, Gorski JJ, Savage KI, Crawford NT, et al. BRD7, a subunit of SWI\/SNF complexes, binds directly to BRCA1 and regulates BRCA1-dependent transcription. Cancer Res. 2010;70(6):2538\u201347.","journal-title":"Cancer Res"},{"issue":"1","key":"2763_CR344","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1038\/s41467-025-56347-2","volume":"16","author":"J Mondal","year":"2025","unstructured":"Mondal J, Zhang J, Qing F, Li S, Kumar D, Huse JT, et al. Brd7 loss reawakens dormant metastasis initiating cells in lung by forging an immunosuppressive niche. Nat Commun. 2025;16(1):1378.","journal-title":"Nat Commun"},{"issue":"1","key":"2763_CR345","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-023-02982-1","volume":"24","author":"Y Sun","year":"2023","unstructured":"Sun Y, Xu X, Zhao W, Zhang Y, Chen K, Li Y, et al. RAD21 is the core subunit of the cohesin complex involved in directing genome organization. Genome Biol. 2023;24(1):155.","journal-title":"Genome Biol"},{"issue":"2","key":"2763_CR346","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3176","volume":"14","author":"M Yan","year":"2012","unstructured":"Yan M, Xu H, Waddell N, Shield-Artin K, Haviv I, McKay MJ, et al. Enhanced RAD21 cohesin expression confers poor prognosis in BRCA2 and BRCAX, but not BRCA1 familial breast cancers. Breast Cancer Res. 2012;14(2):R69.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"2763_CR347","doi-asserted-by":"publisher","first-page":"R9","DOI":"10.1186\/bcr2814","volume":"13","author":"H Xu","year":"2011","unstructured":"Xu H, Yan M, Patra J, Natrajan R, Yan Y, Swagemakers S, et al. Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers. Breast Cancer Res. 2011;13(1):R9.","journal-title":"Breast Cancer Res"},{"issue":"9","key":"2763_CR348","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.15252\/embr.201541852","volume":"17","author":"J Yun","year":"2016","unstructured":"Yun J, Song SH, Kim HP, Han SW, Yi EC, Kim TY. Dynamic cohesin-mediated chromatin architecture controls epithelial-mesenchymal plasticity in cancer. EMBO Rep. 2016;17(9):1343\u201359.","journal-title":"EMBO Rep"},{"issue":"4","key":"2763_CR349","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.eururo.2025.06.005","volume":"88","author":"A Larcher","year":"2025","unstructured":"Larcher A, Campi R, Bex A, Bray F, Bukavina L, Jonasch E, et al. Epidemiology of Renal Cancer: Incidence, Mortality, Survival, Genetic Predisposition, and Risk Factors. Eur Urol. 2025;88(4):341\u201358.","journal-title":"Eur Urol"},{"issue":"1","key":"2763_CR350","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.eururo.2017.05.033","volume":"73","author":"SK Pal","year":"2018","unstructured":"Pal SK, Ali SM, Yakirevich E, Geynisman DM, Karam JA, Elvin JA, et al. Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling. Eur Urol. 2018;73(1):71\u20138.","journal-title":"Eur Urol"},{"issue":"7331","key":"2763_CR351","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nature09639","volume":"469","author":"I Varela","year":"2011","unstructured":"Varela I, Tarpey P, Raine K, Huang D, Ong CK, Stephens P, et al. Exome sequencing identifies frequent mutation of the SWI\/SNF complex gene PBRM1 in renal carcinoma. Nature. 2011;469(7331):539\u201342.","journal-title":"Nature"},{"issue":"6377","key":"2763_CR352","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1126\/science.aan5951","volume":"359","author":"D Miao","year":"2018","unstructured":"Miao D, Margolis CA, Gao W, Voss MH, Li W, Martini DJ, et al. Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma. Science. 2018;359(6377):801\u20136.","journal-title":"Science"},{"issue":"1","key":"2763_CR353","doi-asserted-by":"publisher","first-page":"4168","DOI":"10.1038\/s41467-020-17965-0","volume":"11","author":"AA Hakimi","year":"2020","unstructured":"Hakimi AA, Attalla K, DiNatale RG, Ostrovnaya I, Flynn J, Blum KA, et al. A pan-cancer analysis of PBAF complex mutations and their association with immunotherapy response. Nat Commun. 2020;11(1):4168.","journal-title":"Nat Commun"},{"issue":"5","key":"2763_CR354","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s41556-023-01122-y","volume":"25","author":"X Yao","year":"2023","unstructured":"Yao X, Hong JH, Nargund AM, Ng MSW, Heng HL, Li Z, et al. PBRM1-deficient PBAF complexes target aberrant genomic loci to activate the NF-\u03baB pathway in clear cell renal cell carcinoma. Nat Cell Biol. 2023;25(5):765\u201377.","journal-title":"Nat Cell Biol"},{"issue":"6","key":"2763_CR355","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.eururo.2015.09.027","volume":"69","author":"J Calderaro","year":"2016","unstructured":"Calderaro J, Masliah-Planchon J, Richer W, Maillot L, Maille P, Mansuy L, et al. Balanced Translocations Disrupting SMARCB1 Are Hallmark Recurrent Genetic Alterations in Renal Medullary Carcinomas. Eur Urol. 2016;69(6):1055\u201361.","journal-title":"Eur Urol"},{"key":"2763_CR356","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2023.102558","volume":"116","author":"M Rizzo","year":"2022","unstructured":"Rizzo M, Cali\u00f2 A, Brunelli M, Pezzicoli G, Ganini C, Martignoni G, et al. Clinico-pathological implications of the 2022 WHO renal cell carcinoma classification. Cancer Treat Rev. 2022;116:102558.","journal-title":"Cancer Treat Rev"},{"issue":"9","key":"2763_CR357","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1038\/s41379-019-0273-1","volume":"32","author":"L Jia","year":"2019","unstructured":"Jia L, Carlo MI, Khan H, Nanjangud GJ, Rana S, Cimera R, et al. Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases. Mod Pathol. 2019;32(9):1329\u201343.","journal-title":"Mod Pathol"},{"key":"2763_CR358","doi-asserted-by":"crossref","unstructured":"Vokshi BH, Davidson G, Tawanaie Pour Sedehi N, Helleux A, Rippinger M, Haller AR, et al. SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance. Nat Commun. 2023;14(1):3034.","DOI":"10.1038\/s41467-023-38472-y"},{"issue":"5","key":"2763_CR359","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.ccell.2020.04.002","volume":"37","author":"P Msaouel","year":"2020","unstructured":"Msaouel P, Malouf GG, Su X, Yao H, Tripathi DN, Soeung M, et al. Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma. Cancer Cell. 2020;37(5):720-34.e13.","journal-title":"Cancer Cell"},{"issue":"9","key":"2763_CR360","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/j.ajhg.2021.07.009","volume":"108","author":"LM Colli","year":"2021","unstructured":"Colli LM, Jessop L, Myers TA, Camp SY, Machiela MJ, Choi J, et al. Altered regulation of DPF3, a member of the SWI\/SNF complexes, underlies the 14q24 renal cancer susceptibility locus. Am J Hum Genet. 2021;108(9):1590\u2013610.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"2763_CR361","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1038\/s41467-022-32472-0","volume":"13","author":"H Cui","year":"2022","unstructured":"Cui H, Yi H, Bao H, Tan Y, Tian C, Shi X, et al. The SWI\/SNF chromatin remodeling factor DPF3 regulates metastasis of ccRCC by modulating TGF-\u03b2 signaling. Nat Commun. 2022;13(1):4680.","journal-title":"Nat Commun"},{"issue":"7","key":"2763_CR362","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.jtho.2021.03.024","volume":"16","author":"JV Alessi","year":"2021","unstructured":"Alessi JV, Ricciuti B, Spurr LF, Gupta H, Li YY, Glass C, et al. SMARCA4 and Other SWItch\/Sucrose NonFermentable Family Genomic Alterations in NSCLC: Clinicopathologic Characteristics and Outcomes to Immune Checkpoint Inhibition. J Thorac Oncol. 2021;16(7):1176\u201387.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"2763_CR363","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13045-024-01572-3","volume":"17","author":"E Redin","year":"2024","unstructured":"Redin E, Sridhar H, Zhan YA, Pereira Mello B, Zhong H, Durani V, et al. SMARCA4 controls state plasticity in small cell lung cancer through regulation of neuroendocrine transcription factors and REST splicing. J Hematol Oncol. 2024;17(1):58.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"2763_CR364","first-page":"560","volume":"63","author":"DN Reisman","year":"2003","unstructured":"Reisman DN, Sciarrotta J, Wang W, Funkhouser WK, Weissman BE. Loss of BRG1\/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis. Cancer Res. 2003;63(3):560\u20136.","journal-title":"Cancer Res"},{"issue":"29","key":"2763_CR365","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1038\/onc.2011.81","volume":"30","author":"G Liu","year":"2011","unstructured":"Liu G, Gramling S, Munoz D, Cheng D, Azad AK, Mirshams M, et al. Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk. Oncogene. 2011;30(29):3295\u2013304.","journal-title":"Oncogene"},{"issue":"10","key":"2763_CR366","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1158\/1078-0432.CCR-16-1640","volume":"23","author":"G Liu","year":"2017","unstructured":"Liu G, Cuffe S, Liang S, Azad AK, Cheng L, Brhane Y, et al. BRM promoter polymorphisms and survival of advanced non-small cell lung cancer patients in the Princess Margaret cohort and CCTG BR.24 trial. Clin Cancer Res. 2017;23(10):2460\u201370.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2763_CR367","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1158\/2159-8290.CD-21-0248","volume":"12","author":"CP Concepcion","year":"2022","unstructured":"Concepcion CP, Ma S, LaFave LM, Bhutkar A, Liu M, DeAngelo LP, et al. Smarca4 Inactivation Promotes Lineage-Specific Transformation and Early Metastatic Features in the Lung. Cancer Discov. 2022;12(2):562\u201385.","journal-title":"Cancer Discov"},{"issue":"7","key":"2763_CR368","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/emmm.201200236","volume":"4","author":"OA Romero","year":"2012","unstructured":"Romero OA, Setien F, John S, Gimenez-Xavier P, G\u00f3mez-L\u00f3pez G, Pisano D, et al. The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer. EMBO Mol Med. 2012;4(7):603\u201316.","journal-title":"EMBO Mol Med"},{"issue":"3","key":"2763_CR369","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1158\/2159-8290.CD-13-0799","volume":"4","author":"OA Romero","year":"2014","unstructured":"Romero OA, Torres-Diz M, Pros E, Savola S, Gomez A, Moran S, et al. MAX inactivation in small cell lung cancer disrupts MYC-SWI\/SNF programs and is synthetic lethal with BRG1. Cancer Discov. 2014;4(3):292\u2013303.","journal-title":"Cancer Discov"},{"issue":"1","key":"2763_CR370","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41467-019-08380-1","volume":"10","author":"Y Xue","year":"2019","unstructured":"Xue Y, Meehan B, Fu Z, Wang XQD, Fiset PO, Rieker R, et al. SMARCA4 loss is synthetic lethal with CDK4\/6 inhibition in non-small cell lung cancer. Nat Commun. 2019;10(1):557.","journal-title":"Nat Commun"},{"issue":"18","key":"2763_CR371","doi-asserted-by":"publisher","first-page":"3841","DOI":"10.1158\/0008-5472.CAN-20-1744","volume":"80","author":"M Gupta","year":"2020","unstructured":"Gupta M, Concepcion CP, Fahey CG, Keshishian H, Bhutkar A, Brainson CF, et al. BRG1 Loss Predisposes Lung Cancers to Replicative Stress and ATR Dependency. Cancer Res. 2020;80(18):3841\u201354.","journal-title":"Cancer Res"},{"issue":"3","key":"2763_CR372","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/sj.onc.1209068","volume":"25","author":"H Watanabe","year":"2006","unstructured":"Watanabe H, Mizutani T, Haraguchi T, Yamamichi N, Minoguchi S, Yamamichi-Nishina M, et al. SWI\/SNF complex is essential for NRSF-mediated suppression of neuronal genes in human nonsmall cell lung carcinoma cell lines. Oncogene. 2006;25(3):470\u20139.","journal-title":"Oncogene"},{"issue":"49","key":"2763_CR373","doi-asserted-by":"publisher","first-page":"7058","DOI":"10.1038\/sj.onc.1210514","volume":"26","author":"S Glaros","year":"2007","unstructured":"Glaros S, Cirrincione GM, Muchardt C, Kleer CG, Michael CW, Reisman D. The reversible epigenetic silencing of BRM: implications for clinical targeted therapy. Oncogene. 2007;26(49):7058\u201366.","journal-title":"Oncogene"},{"issue":"18","key":"2763_CR374","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1158\/0008-5472.CAN-14-3798","volume":"75","author":"B Vangamudi","year":"2015","unstructured":"Vangamudi B, Paul TA, Shah PK, Kost-Alimova M, Nottebaum L, Shi X, et al. The SMARCA2\/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI\/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies. Cancer Res. 2015;75(18):3865\u201378.","journal-title":"Cancer Res"},{"issue":"8","key":"2763_CR375","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1073\/pnas.1316793111","volume":"111","author":"GR Hoffman","year":"2014","unstructured":"Hoffman GR, Rahal R, Buxton F, Xiang K, McAllister G, Frias E, et al. Functional epigenetics approach identifies BRM\/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers. Proc Natl Acad Sci U S A. 2014;111(8):3128\u201333.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2763_CR376","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217282","volume":"605","author":"NR Field","year":"2024","unstructured":"Field NR, Dickson KA, Nassif NT, Marsh DJ. SMARCA4 and SMARCA2 co-deficiency: An uncommon molecular signature defining a subset of rare, aggressive and undifferentiated malignancies associated with defective chromatin remodeling. Cancer Lett. 2024;605:217282.","journal-title":"Cancer Lett"},{"issue":"1","key":"2763_CR377","doi-asserted-by":"publisher","first-page":"5404","DOI":"10.1038\/s41467-021-25260-9","volume":"12","author":"Y Xue","year":"2021","unstructured":"Xue Y, Morris JL, Yang K, Fu Z, Zhu X, Johnson F, et al. SMARCA4\/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca(2+) flux to mitochondria. Nat Commun. 2021;12(1):5404.","journal-title":"Nat Commun"},{"issue":"11","key":"2763_CR378","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1158\/0008-5472.CAN-24-2054","volume":"85","author":"Y Wang","year":"2025","unstructured":"Wang Y, Meraz IM, Qudratullah M, Kotagiri S, Han Y, Xi Y, et al. Mutation of SMARCA4 Induces Cancer Cell-Intrinsic Defects in the Enhancer Landscape and Resistance to Immunotherapy. Cancer Res. 2025;85(11):1997\u20132013.","journal-title":"Cancer Res"},{"issue":"8","key":"2763_CR379","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.ccell.2023.07.005","volume":"41","author":"FJ de Miguel","year":"2023","unstructured":"de Miguel FJ, Gentile C, Feng WW, Silva SJ, Sankar A, Exposito F, et al. Mammalian SWI\/SNF chromatin remodeling complexes promote tyrosine kinase inhibitor resistance in EGFR-mutant lung cancer. Cancer Cell. 2023;41(8):1516-34.e9.","journal-title":"Cancer Cell"},{"issue":"4","key":"2763_CR380","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/cr.2015.16","volume":"25","author":"AI Papadakis","year":"2015","unstructured":"Papadakis AI, Sun C, Knijnenburg TA, Xue Y, Grernrum W, H\u00f6lzel M, et al. SMARCE1 suppresses EGFR expression and controls responses to MET and ALK inhibitors in lung cancer. Cell Res. 2015;25(4):445\u201358.","journal-title":"Cell Res"},{"issue":"5","key":"2763_CR381","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1158\/0008-5472.CAN-21-0763","volume":"82","author":"X Liu","year":"2022","unstructured":"Liu X, Li Z, Wang Z, Liu F, Zhang L, Ke J, et al. Chromatin Remodeling Induced by ARID1A Loss in Lung Cancer Promotes Glycolysis and Confers JQ1 Vulnerability. Cancer Res. 2022;82(5):791\u2013804.","journal-title":"Cancer Res"},{"key":"2763_CR382","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.218062","volume":"634","author":"C Xiao","year":"2025","unstructured":"Xiao C, Fan T, Wang D, Yin H, Deng Z, Cai W, et al. RAD21-mediated epigenetic regulation promotes lung adenocarcinoma progression and sensitizes cancer cells to ERK-targeted therapy. Cancer Lett. 2025;634:218062.","journal-title":"Cancer Lett"},{"key":"2763_CR383","doi-asserted-by":"crossref","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBdO, Berti E, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022;36(7):1720\u201348.","DOI":"10.1038\/s41375-022-01620-2"},{"key":"2763_CR384","doi-asserted-by":"crossref","unstructured":"Lunning MA, Green MR. Mutation of chromatin modifiers; an emerging hallmark of germinal center B-cell lymphomas. Blood Cancer Journal. 2015;5(10):e361-e.","DOI":"10.1038\/bcj.2015.89"},{"issue":"23","key":"2763_CR385","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1182\/bloodadvances.2019001012","volume":"3","author":"K Wienand","year":"2019","unstructured":"Wienand K, Chapuy B, Stewart C, Dunford AJ, Wu D, Kim J, et al. Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion. Blood Adv. 2019;3(23):4065\u201380.","journal-title":"Blood Adv"},{"issue":"5","key":"2763_CR386","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41418-025-01445-3","volume":"32","author":"M Antoniolli","year":"2025","unstructured":"Antoniolli M, Solovey M, Hildebrand JA, Freyholdt T, Strobl CD, Bararia D, et al. ARID1A mutations protect follicular lymphoma from FAS-dependent immune surveillance by reducing RUNX3\/ETS1-driven FAS-expression. Cell Death Differ. 2025;32(5):899\u2013910.","journal-title":"Cell Death Differ"},{"issue":"3","key":"2763_CR387","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3324\/haematol.2020.274258","volume":"107","author":"MCJ Ma","year":"2022","unstructured":"Ma MCJ, Tadros S, Bouska A, Heavican T, Yang H, Deng Q, et al. Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma. Haematologica. 2022;107(3):690\u2013701.","journal-title":"Haematologica"},{"issue":"7841","key":"2763_CR388","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-020-3017-y","volume":"589","author":"N Yusufova","year":"2021","unstructured":"Yusufova N, Kloetgen A, Teater M, Osunsade A, Camarillo JM, Chin CR, et al. Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture. Nature. 2021;589(7841):299\u2013305.","journal-title":"Nature"},{"issue":"4","key":"2763_CR389","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ccell.2024.02.011","volume":"42","author":"Q Deng","year":"2024","unstructured":"Deng Q, Lakra P, Gou P, Yang H, Meydan C, Teater M, et al. SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions. Cancer Cell. 2024;42(4):605-22.e11.","journal-title":"Cancer Cell"},{"issue":"3","key":"2763_CR390","doi-asserted-by":"publisher","first-page":"e153283","DOI":"10.1172\/JCI153283","volume":"132","author":"S Yi","year":"2022","unstructured":"Yi S, Yan Y, Jin M, Bhattacharya S, Wang Y, Wu Y, et al. Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma. The Journal of Clinical Investigation. 2021;132(3):e153283.","journal-title":"J Clin Invest"},{"issue":"1","key":"2763_CR391","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12943-023-01736-8","volume":"22","author":"A Andrades","year":"2023","unstructured":"Andrades A, Peinado P, Alvarez-Perez JC, Sanjuan-Hidalgo J, Garc\u00eda DJ, Arenas AM, et al. SWI\/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities. Mol Cancer. 2023;22(1):39.","journal-title":"Mol Cancer"},{"issue":"Supplement 1","key":"2763_CR392","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1182\/blood-2024-201941","volume":"144","author":"Y Yan","year":"2024","unstructured":"Yan Y, Shan D, Yu Y, Chen W, Zhang X, Wenjie X, et al. TENT5C as a target of chromatin remodeler SMARCA2 participates BTK inhibitor resistance in mantle cell lymphoma by regulating ATP metabolism. Blood. 2024;144(Supplement 1):832.","journal-title":"Blood"},{"issue":"1","key":"2763_CR393","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41467-017-00578-5","volume":"8","author":"S Mroczek","year":"2017","unstructured":"Mroczek S, Chlebowska J, Kuli\u0144ski TM, Gewartowska O, Gruchota J, Cysewski D, et al. The non-canonical poly(A) polymerase FAM46C acts as an onco-suppressor in multiple myeloma. Nat Commun. 2017;8(1):619.","journal-title":"Nat Commun"},{"issue":"2","key":"2763_CR394","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41590-020-00827-8","volume":"22","author":"MA Rivas","year":"2021","unstructured":"Rivas MA, Meydan C, Chin CR, Challman MF, Kim D, Bhinder B, et al. Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation. Nat Immunol. 2021;22(2):240\u201353.","journal-title":"Nat Immunol"},{"key":"2763_CR395","doi-asserted-by":"publisher","first-page":"688493","DOI":"10.3389\/fimmu.2021.688493","volume":"12","author":"MA Rivas","year":"2021","unstructured":"Rivas MA, Durmaz C, Kloetgen A, Chin CR, Chen Z, Bhinder B, et al. Cohesin Core Complex Gene Dosage Contributes to Germinal Center Derived Lymphoma Phenotypes and Outcomes. Frontiers in Immunology. 2021; 12:688493.","journal-title":"Front Immunol"},{"issue":"1","key":"2763_CR396","doi-asserted-by":"publisher","first-page":"18923","DOI":"10.1038\/s41598-024-68644-9","volume":"14","author":"Y Lu","year":"2024","unstructured":"Lu Y, Jiang J, He Z, Bao Z, Chen X, Cheng J. Molecular characteristics and oncogenic role of CHD family genes: a pan-cancer analysis based on bioinformatic and biological analysis. Sci Rep. 2024;14(1):18923.","journal-title":"Sci Rep"},{"issue":"13\u201314","key":"2763_CR397","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1101\/gad.321901.118","volume":"33","author":"T Yoshida","year":"2019","unstructured":"Yoshida T, Hu Y, Zhang Z, Emmanuel AO, Galani K, Muhire B, et al. Chromatin restriction by the nucleosome remodeler Mi-2\u03b2 and functional interplay with lineage-specific transcription regulators control B-cell differentiation. Genes Dev. 2019;33(13\u201314):763\u201381.","journal-title":"Genes Dev"},{"issue":"10","key":"2763_CR398","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1084\/jem.20161827","volume":"214","author":"SJ Loughran","year":"2017","unstructured":"Loughran SJ, Comoglio F, Hamey FK, Giustacchini A, Errami Y, Earp E, et al. Mbd3\/NuRD controls lymphoid cell fate and inhibits tumorigenesis by repressing a B cell transcriptional program. J Exp Med. 2017;214(10):3085\u2013104.","journal-title":"J Exp Med"},{"issue":"1","key":"2763_CR399","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.molcel.2024.11.040","volume":"85","author":"G Gambi","year":"2025","unstructured":"Gambi G, Boccalatte F, Rodriguez Hernaez J, Lin Z, Nadorp B, Polyzos A, et al. 3D chromatin hubs as regulatory units of identity and survival in human acute leukemia. Mol Cell. 2025;85(1):42-60.e7.","journal-title":"Mol Cell"},{"issue":"4","key":"2763_CR400","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41588-020-0602-9","volume":"52","author":"A Kloetgen","year":"2020","unstructured":"Kloetgen A, Thandapani P, Ntziachristos P, Ghebrechristos Y, Nomikou S, Lazaris C, et al. Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia. Nat Genet. 2020;52(4):388\u2013400.","journal-title":"Nat Genet"},{"key":"2763_CR401","doi-asserted-by":"publisher","first-page":"762598","DOI":"10.3389\/fimmu.2021.762598","volume":"12","author":"L Peng","year":"2021","unstructured":"Peng L, Li J, Wu J, Xu B, Wang Z, Giamas G, et al. A Pan-Cancer Analysis of SMARCA4 Alterations in Human Cancers. Frontiers in Immunology. 2021;12:762598.","journal-title":"Front Immunol"},{"issue":"8","key":"2763_CR402","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41419-024-06996-w","volume":"15","author":"Q Kang","year":"2024","unstructured":"Kang Q, Ma D, Zhao P, Chai X, Huang Y, Gao R, et al. BRG1 promotes progression of B-cell acute lymphoblastic leukemia by disrupting PPP2R1A transcription. Cell Death Dis. 2024;15(8):621.","journal-title":"Cell Death Dis"},{"issue":"11","key":"2763_CR403","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1182\/blood-2013-02-483495","volume":"123","author":"M Buscarlet","year":"2014","unstructured":"Buscarlet M, Krasteva V, Ho L, Simon C, H\u00e9bert J, Wilhelm B, et al. Essential role of BRG, the ATPase subunit of BAF chromatin remodeling complexes, in leukemia maintenance. Blood. 2014;123(11):1720\u20138.","journal-title":"Blood"},{"issue":"1","key":"2763_CR404","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41467-017-02465-5","volume":"9","author":"SI Lee","year":"2018","unstructured":"Lee SI, Celik S, Logsdon BA, Lundberg SM, Martins TJ, Oehler VG, et al. A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia. Nat Commun. 2018;9(1):42.","journal-title":"Nat Commun"},{"issue":"1","key":"2763_CR405","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41408-025-01251-7","volume":"15","author":"W Fiskus","year":"2025","unstructured":"Fiskus W, Mill CP, Piel J, Collins M, Hentemann M, Cuglievan B, et al. Superior preclinical efficacy of co-treatment with BRG1\/BRM and FLT3 inhibitor against AML cells with FLT3 mutations. Blood Cancer J. 2025;15(1):40.","journal-title":"Blood Cancer J"},{"key":"2763_CR406","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1182\/blood-2020-139427","volume":"136","author":"S Stratmann","year":"2020","unstructured":"Stratmann S, Yones SA, Sun J, Skaftason A, Mayrhofer M, Norgren N, et al. Genomic and Transcriptomic Characterization of Adult and Pediatric Relapsed Acute Myeloid Leukemia Reveals Novel Therapeutic Targets. Blood. 2020;136:37\u20138.","journal-title":"Blood"},{"issue":"4","key":"2763_CR407","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41587-019-0055-9","volume":"37","author":"J Zhang","year":"2019","unstructured":"Zhang J, Bajari R, Andric D, Gerthoffert F, Lepsa A, Nahal-Bose H, et al. The International Cancer Genome Consortium Data Portal. Nat Biotechnol. 2019;37(4):367\u20139.","journal-title":"Nat Biotechnol"},{"issue":"3","key":"2763_CR408","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1182\/bloodadvances.2020003709","volume":"5","author":"S Stratmann","year":"2021","unstructured":"Stratmann S, Yones SA, Mayrhofer M, Norgren N, Skaftason A, Sun J, et al. Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets. Blood Adv. 2021;5(3):900\u201312.","journal-title":"Blood Adv"},{"issue":"3","key":"2763_CR409","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s10238-022-00863-8","volume":"23","author":"T Ren","year":"2023","unstructured":"Ren T, Wang J, Tang W, Chen D, Wang S, Zhang X, et al. ARID1A has prognostic value in acute myeloid leukemia and promotes cell proliferation via TGF-\u03b21\/SMAD3 signaling. Clin Exp Med. 2023;23(3):777\u201385.","journal-title":"Clin Exp Med"},{"issue":"9","key":"2763_CR410","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1038\/s41375-019-0438-4","volume":"33","author":"L Han","year":"2019","unstructured":"Han L, Madan V, Mayakonda A, Dakle P, Woon TW, Shyamsunder P, et al. Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice. Leukemia. 2019;33(9):2291\u2013305.","journal-title":"Leukemia"},{"issue":"7","key":"2763_CR411","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3324\/haematol.2017.183970","volume":"103","author":"H Yaser","year":"2018","unstructured":"Yaser H, G\u00f6zde T, Aditya H, Shabnam K, Johan B, Esmat Kamali D, et al. The chromatin-remodeling factor CHD4 is required for maintenance of childhood acute myeloid leukemia. Haematologica. 2018;103(7):1169\u201381.","journal-title":"Haematologica"},{"issue":"12","key":"2763_CR412","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1182\/blood-2015-03-631606","volume":"126","author":"J Sperlazza","year":"2015","unstructured":"Sperlazza J, Rahmani M, Beckta J, Aust M, Hawkins E, Wang SZ, et al. Depletion of the chromatin remodeler CHD4 sensitizes AML blasts to genotoxic agents and reduces tumor formation. Blood. 2015;126(12):1462\u201372.","journal-title":"Blood"},{"issue":"38","key":"2763_CR413","doi-asserted-by":"publisher","first-page":"23626","DOI":"10.1073\/pnas.2003228117","volume":"117","author":"J Hsu","year":"2020","unstructured":"Hsu J, Huang HT, Lee CT, Choudhuri A, Wilson NK, Abraham BJ, et al. CHD7 and Runx1 interaction provides a braking mechanism for hematopoietic differentiation. Proc Natl Acad Sci U S A. 2020;117(38):23626\u201335.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"2763_CR414","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1182\/blood-2017-04-780106","volume":"130","author":"T Zhen","year":"2017","unstructured":"Zhen T, Kwon EM, Zhao L, Hsu J, Hyde RK, Lu Y, et al. Chd7 deficiency delays leukemogenesis in mice induced by Cbfb-MYH11. Blood. 2017;130(22):2431\u201342.","journal-title":"Blood"},{"issue":"5","key":"2763_CR415","doi-asserted-by":"publisher","DOI":"10.1002\/inmd.70053","volume":"3","author":"D Yang","year":"2025","unstructured":"Yang D, Zhang T, Yang Y, Zhang D, Zhou Z, Wang N, et al. Integration of CRISPR-Cas9 screens and multi-omics profiling reveals chromodomain helicase DNA binding protein 7-angiopoietin-1 as a novel multidrug resistance axis in acute myeloid leukemia. Interdisciplinary Medicine. 2025;3(5):e70053.","journal-title":"Interdisciplinary Medicine"},{"issue":"29","key":"2763_CR416","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1200\/JCO.23.02238","volume":"42","author":"TC Chang","year":"2024","unstructured":"Chang TC, Chen W, Qu C, Cheng Z, Hedges D, Elsayed A, et al. Genomic Determinants of Outcome in Acute Lymphoblastic Leukemia. J Clin Oncol. 2024;42(29):3491\u2013503.","journal-title":"J Clin Oncol"},{"issue":"51","key":"2763_CR417","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adc8911","volume":"8","author":"X Xu","year":"2022","unstructured":"Xu X, Chan AKN, Li M, Liu Q, Mattson N, Pangeni Pokharel S, et al. ACTR5 controls CDKN2A and tumor progression in an INO80-independent manner. Sci Adv. 2022;8(51):eadc8911.","journal-title":"Sci Adv"},{"issue":"1","key":"2763_CR418","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41408-023-00790-1","volume":"13","author":"J-N Eckardt","year":"2023","unstructured":"Eckardt J-N, Stasik S, R\u00f6llig C, Sauer T, Scholl S, Hochhaus A, et al. Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome. Blood Cancer J. 2023;13(1):18.","journal-title":"Blood Cancer J"},{"issue":"10","key":"2763_CR419","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/ng.2731","volume":"45","author":"A Kon","year":"2013","unstructured":"Kon A, Shih L-Y, Minamino M, Sanada M, Shiraishi Y, Nagata Y, et al. Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms. Nat Genet. 2013;45(10):1232\u20137.","journal-title":"Nat Genet"},{"issue":"11","key":"2763_CR420","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1182\/blood-2014-04-567057","volume":"124","author":"S Thota","year":"2014","unstructured":"Thota S, Viny AD, Makishima H, Spitzer B, Radivoyevitch T, Przychodzen B, et al. Genetic alterations of the cohesin complex genes in myeloid malignancies. Blood. 2014;124(11):1790\u20138.","journal-title":"Blood"},{"issue":"8","key":"2763_CR421","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114498","volume":"43","author":"A Fischer","year":"2024","unstructured":"Fischer A, Hern\u00e1ndez-Rodr\u00edguez B, Mulet-Lazaro R, Nuetzel M, H\u00f6lzl F, van Herk S, et al. STAG2 mutations reshape the cohesin-structured spatial chromatin architecture to drive gene regulation in acute myeloid leukemia. Cell Rep. 2024;43(8):114498.","journal-title":"Cell Rep"},{"key":"2763_CR422","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.semcancer.2020.12.015","volume":"83","author":"MS Uddin","year":"2022","unstructured":"Uddin MS, Mamun AA, Alghamdi BS, Tewari D, Jeandet P, Sarwar MS, et al. Epigenetics of glioblastoma multiforme: From molecular mechanisms to therapeutic approaches. Semin Cancer Biol. 2022;83:100\u201320.","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"2763_CR423","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.stem.2016.11.003","volume":"20","author":"BB Liau","year":"2017","unstructured":"Liau BB, Sievers C, Donohue LK, Gillespie SM, Flavahan WA, Miller TE, et al. Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance. Cell Stem Cell. 2017;20(2):233-46.e7.","journal-title":"Cell Stem Cell"},{"issue":"18","key":"2763_CR424","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2221175120","volume":"120","author":"M Mota","year":"2023","unstructured":"Mota M, Sweha SR, Pun M, Natarajan SK, Ding Y, Chung C, et al. Targeting SWI\/SNF ATPases in H3.3K27M diffuse intrinsic pontine gliomas. Proc Natl Acad Sci U S A. 2023;120(18):e2221175120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2763_CR425","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1158\/2159-8290.CD-21-1491","volume":"12","author":"E Panditharatna","year":"2022","unstructured":"Panditharatna E, Marques JG, Wang T, Trissal MC, Liu I, Jiang L, et al. BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M Glioma. Cancer Discov. 2022;12(12):2880\u2013905.","journal-title":"Cancer Discov"},{"key":"2763_CR426","doi-asserted-by":"crossref","unstructured":"Mo Y, Duan S, Zhang X, Hua X, Zhou H, Wei HJ, et al. Epigenome Programming by H3.3K27M Mutation Creates a Dependence of Pediatric Glioma on SMARCA4. Cancer Discov. 2022;12(12):2906\u201329.","DOI":"10.1158\/2159-8290.CD-21-1492"},{"issue":"1","key":"2763_CR427","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ccell.2018.11.014","volume":"35","author":"S Erkek","year":"2019","unstructured":"Erkek S, Johann PD, Finetti MA, Drosos Y, Chou HC, Zapatka M, et al. Comprehensive Analysis of Chromatin States in Atypical Teratoid\/Rhabdoid Tumor Identifies Diverging Roles for SWI\/SNF and Polycomb in Gene Regulation. Cancer Cell. 2019;35(1):95-110.e8.","journal-title":"Cancer Cell"},{"issue":"11","key":"2763_CR428","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/s41419-022-05439-8","volume":"13","author":"C Li","year":"2022","unstructured":"Li C, Wang T, Gu J, Qi S, Li J, Chen L, et al. SMARCC2 mediates the regulation of DKK1 by the transcription factor EGR1 through chromatin remodeling to reduce the proliferative capacity of glioblastoma. Cell Death Dis. 2022;13(11):990.","journal-title":"Cell Death Dis"},{"issue":"4","key":"2763_CR429","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.7150\/thno.36218","volume":"10","author":"T Strub","year":"2020","unstructured":"Strub T, Ballotti R, Bertolotto C. The, \u201cART\u201d of Epigenetics in Melanoma: From histone \u201cAlterations, to Resistance and Therapies.\u201d Theranostics. 2020;10(4):1777\u201397.","journal-title":"Theranostics"},{"issue":"12","key":"2763_CR430","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1002\/ijc.32064","volume":"144","author":"D Guo","year":"2019","unstructured":"Guo D, Lui GYL, Lai SL, Wilmott JS, Tikoo S, Jackett LA, et al. RAB27A promotes melanoma cell invasion and metastasis via regulation of pro-invasive exosomes. Int J Cancer. 2019;144(12):3070\u201385.","journal-title":"Int J Cancer"},{"issue":"7","key":"2763_CR431","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.jid.2019.12.023","volume":"140","author":"D Guo","year":"2020","unstructured":"Guo D, Jain R, Hwang JS, Weninger W, Beaumont KA, Tikoo S. RAB27A\/Melanophilin Blocker Inhibits Melanoma Cell Motility and Invasion. J Investig Dermatol. 2020;140(7):1470-3.e3.","journal-title":"J Investig Dermatol"},{"issue":"47","key":"2763_CR432","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2303978120","volume":"120","author":"D Guo","year":"2023","unstructured":"Guo D, Jurek R, Beaumont KA, Sharp DS, Tan SY, Mariana A, et al. Invasion-Block and S-MARVEL: A high-content screening and image analysis platform identifies ATM kinase as a modulator of melanoma invasion and metastasis. Proc Natl Acad Sci U S A. 2023;120(47):e2303978120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2763_CR433","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.semcancer.2017.10.006","volume":"51","author":"B Moran","year":"2018","unstructured":"Moran B, Silva R, Perry AS, Gallagher WM. Epigenetics of malignant melanoma. Semin Cancer Biol. 2018;51:80\u20138.","journal-title":"Semin Cancer Biol"},{"key":"2763_CR434","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1476-4598-8-4","volume":"8","author":"TM Becker","year":"2009","unstructured":"Becker TM, Haferkamp S, Dijkstra MK, Scurr LL, Frausto M, Diefenbach E, et al. The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4a. Mol Cancer. 2009;8:4.","journal-title":"Mol Cancer"},{"issue":"6","key":"2763_CR435","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1111\/j.1365-2133.2011.10267.x","volume":"164","author":"VL Bock","year":"2011","unstructured":"Bock VL, Lyons JG, Huang XX, Jones AM, McDonald LA, Scolyer RA, et al. BRM and BRG1 subunits of the SWI\/SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours. Br J Dermatol. 2011;164(6):1221\u20137.","journal-title":"Br J Dermatol"},{"issue":"3","key":"2763_CR436","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/j.1365-2133.2010.09851.x","volume":"163","author":"H Lin","year":"2010","unstructured":"Lin H, Wong RP, Martinka M, Li G. BRG1 expression is increased in human cutaneous melanoma. Br J Dermatol. 2010;163(3):502\u201310.","journal-title":"Br J Dermatol"},{"key":"2763_CR437","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/1476-4598-9-280","volume":"9","author":"SV Saladi","year":"2010","unstructured":"Saladi SV, Keenen B, Marathe HG, Qi H, Chin KV, de la Serna IL. Modulation of extracellular matrix\/adhesion molecule expression by BRG1 is associated with increased melanoma invasiveness. Mol Cancer. 2010;9:280.","journal-title":"Mol Cancer"},{"issue":"20","key":"2763_CR438","doi-asserted-by":"publisher","first-page":"6404","DOI":"10.1158\/1078-0432.CCR-09-1135","volume":"15","author":"H Lin","year":"2009","unstructured":"Lin H, Wong RP, Martinka M, Li G. Loss of SNF5 expression correlates with poor patient survival in melanoma. Clin Cancer Res. 2009;15(20):6404\u201311.","journal-title":"Clin Cancer Res"},{"issue":"42","key":"2763_CR439","doi-asserted-by":"publisher","first-page":"6071","DOI":"10.1038\/s41388-021-01994-0","volume":"40","author":"NV Soshnikova","year":"2021","unstructured":"Soshnikova NV, Tatarskiy EV, Tatarskiy VV, Klimenko NS, Shtil AA, Nikiforov MA, et al. PHF10 subunit of PBAF complex mediates transcriptional activation by MYC. Oncogene. 2021;40(42):6071\u201380.","journal-title":"Oncogene"},{"issue":"9","key":"2763_CR440","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.molcel.2025.03.026","volume":"85","author":"E Grossi","year":"2025","unstructured":"Grossi E, Nguyen CB, Carcamo S, Kirigin Calla\u00fa V, Moran S, Filipescu D, et al. The SWI\/SNF PBAF complex facilitates REST occupancy at repressive chromatin. Mol Cell. 2025;85(9):1714-29.e7.","journal-title":"Mol Cell"},{"issue":"9","key":"2763_CR441","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/nm.4155","volume":"22","author":"CH Shen","year":"2016","unstructured":"Shen CH, Kim SH, Trousil S, Frederick DT, Piris A, Yuan P, et al. Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma. Nat Med. 2016;22(9):1056\u201361.","journal-title":"Nat Med"},{"issue":"6377","key":"2763_CR442","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1126\/science.aao1710","volume":"359","author":"D Pan","year":"2018","unstructured":"Pan D, Kobayashi A, Jiang P, Ferrari de Andrade L, Tay RE, Luoma AM, et al. A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing. Science. 2018;359(6377):770\u20135.","journal-title":"Science"},{"issue":"17","key":"2763_CR443","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1158\/0008-5472.CAN-23-2846","volume":"84","author":"M Okada","year":"2024","unstructured":"Okada M, Yamasaki S, Nakazato H, Hirahara Y, Ishibashi T, Kawamura M, et al. ARID1A-Deficient Tumors Acquire Immunogenic Neoantigens during the Development of Resistance to Targeted Therapy. Cancer Res. 2024;84(17):2792\u2013805.","journal-title":"Cancer Res"},{"issue":"32","key":"2763_CR444","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401712","volume":"11","author":"W Zhang","year":"2024","unstructured":"Zhang W, Ruan X, Huang Y, Zhang W, Xu G, Zhao J, et al. SETMAR Facilitates the Differentiation of Thyroid Cancer by Regulating SMARCA2-Mediated Chromatin Remodeling. Adv Sci (Weinh). 2024;11(32):e2401712.","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"2763_CR445","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1172\/JCI85271","volume":"126","author":"I Landa","year":"2016","unstructured":"Landa I, Ibrahimpasic T, Boucai L, Sinha R, Knauf JA, Shah RH, et al. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J Clin Invest. 2016;126(3):1052\u201366.","journal-title":"J Clin Invest"},{"issue":"19","key":"2763_CR446","doi-asserted-by":"publisher","first-page":"5970","DOI":"10.1158\/1078-0432.CCR-17-1183","volume":"23","author":"T Ibrahimpasic","year":"2017","unstructured":"Ibrahimpasic T, Xu B, Landa I, Dogan S, Middha S, Seshan V, et al. Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor Virulence. Clin Cancer Res. 2017;23(19):5970\u201380.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"2763_CR447","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1158\/1078-0432.CCR-18-2953","volume":"25","author":"I Landa","year":"2019","unstructured":"Landa I, Pozdeyev N, Korch C, Marlow LA, Smallridge RC, Copland JA, et al. Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies. Clin Cancer Res. 2019;25(10):3141\u201351.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2763_CR448","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1158\/2159-8290.CD-20-0735","volume":"11","author":"M Saqcena","year":"2021","unstructured":"Saqcena M, Leandro-Garcia LJ, Maag JLV, Tchekmedyian V, Krishnamoorthy GP, Tamarapu PP, et al. SWI\/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies. Cancer Discov. 2021;11(5):1158\u201375.","journal-title":"Cancer Discov"},{"issue":"10","key":"2763_CR449","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1158\/0008-5472.CAN-04-3050","volume":"65","author":"P Modena","year":"2005","unstructured":"Modena P, Lualdi E, Facchinetti F, Galli L, Teixeira MR, Pilotti S, et al. SMARCB1\/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas. Cancer Res. 2005;65(10):4012\u20139.","journal-title":"Cancer Res"},{"issue":"4","key":"2763_CR450","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/onc.2010.424","volume":"30","author":"J Ahn","year":"2011","unstructured":"Ahn J, Ko M, Lee C, Kim J, Yoon H, Seong RH. Srg3, a mouse homolog of BAF155, is a novel p53 target and acts as a tumor suppressor by modulating p21(WAF1\/CIP1) expression. Oncogene. 2011;30(4):445\u201356.","journal-title":"Oncogene"},{"issue":"7","key":"2763_CR451","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.1074\/jbc.M108702200","volume":"277","author":"H Kato","year":"2002","unstructured":"Kato H, Tjernberg A, Zhang W, Krutchinsky AN, An W, Takeuchi T, et al. SYT associates with human SNF\/SWI complexes and the C-terminal region of its fusion partner SSX1 targets histones. J Biol Chem. 2002;277(7):5498\u2013505.","journal-title":"J Biol Chem"},{"issue":"19","key":"2763_CR452","doi-asserted-by":"publisher","first-page":"9474","DOI":"10.1158\/0008-5472.CAN-05-3726","volume":"66","author":"DR de Bruijn","year":"2006","unstructured":"de Bruijn DR, Allander SV, van Dijk AH, Willemse MP, Thijssen J, van Groningen JJ, et al. The synovial-sarcoma-associated SS18-SSX2 fusion protein induces epigenetic gene (de)regulation. Cancer Res. 2006;66(19):9474\u201382.","journal-title":"Cancer Res"},{"issue":"1","key":"2763_CR453","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cell.2013.03.015","volume":"153","author":"JQ Svejstrup","year":"2013","unstructured":"Svejstrup JQ. Synovial sarcoma mechanisms: a series of unfortunate events. Cell. 2013;153(1):11\u20132.","journal-title":"Cell"},{"issue":"6","key":"2763_CR454","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.ccell.2018.05.002","volume":"33","author":"MJ McBride","year":"2018","unstructured":"McBride MJ, Pulice JL, Beird HC, Ingram DR, D\u2019Avino AR, Shern JF, et al. The SS18-SSX Fusion Oncoprotein Hijacks BAF Complex Targeting and Function to Drive Synovial Sarcoma. Cancer Cell. 2018;33(6):1128-41.e7.","journal-title":"Cancer Cell"},{"issue":"18","key":"2763_CR455","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1038\/onc.2013.188","volume":"33","author":"R Taulli","year":"2014","unstructured":"Taulli R, Foglizzo V, Morena D, Coda DM, Ala U, Bersani F, et al. Failure to downregulate the BAF53a subunit of the SWI\/SNF chromatin remodeling complex contributes to the differentiation block in rhabdomyosarcoma. Oncogene. 2014;33(18):2354\u201362.","journal-title":"Oncogene"},{"issue":"7\u20138","key":"2763_CR456","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1101\/gad.345454.120","volume":"35","author":"XA Su","year":"2021","unstructured":"Su XA, Ma D, Parsons JV, Replogle JM, Amatruda JF, Whittaker CA, et al. RAD21 is a driver of chromosome 8 gain in Ewing sarcoma to mitigate replication stress. Genes Dev. 2021;35(7\u20138):556\u201372.","journal-title":"Genes Dev"},{"issue":"6","key":"2763_CR457","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.ccell.2021.04.001","volume":"39","author":"D Surdez","year":"2021","unstructured":"Surdez D, Zaidi S, Grosset\u00eate S, Laud-Duval K, Ferre AS, Mous L, et al. STAG2 mutations alter CTCF-anchored loop extrusion, reduce cis-regulatory interactions and EWSR1-FLI1 activity in Ewing sarcoma. Cancer Cell. 2021;39(6):810-26.e9.","journal-title":"Cancer Cell"},{"issue":"7","key":"2763_CR458","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1172\/JCI98727","volume":"128","author":"Y Liu","year":"2018","unstructured":"Liu Y, Xu H, Van der Jeught K, Li Y, Liu S, Zhang L, et al. Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancer. J Clin Invest. 2018;128(7):2951\u201365.","journal-title":"J Clin Invest"},{"key":"2763_CR459","doi-asserted-by":"publisher","first-page":"1123362","DOI":"10.3389\/fonc.2023.1123362","volume":"13","author":"H Li","year":"2023","unstructured":"Li H, Gigi L, Zhao D. CHD1, a multifaceted epigenetic remodeler in prostate cancer. Front Oncol. 2023;13:1123362.","journal-title":"Front Oncol"},{"issue":"1","key":"2763_CR460","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12929-022-00856-5","volume":"29","author":"J Mandal","year":"2022","unstructured":"Mandal J, Mandal P, Wang TL, Shih IM. Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response. J Biomed Sci. 2022;29(1):71.","journal-title":"J Biomed Sci"},{"issue":"10","key":"2763_CR461","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.jtho.2025.06.007","volume":"20","author":"K Fukuda","year":"2025","unstructured":"Fukuda K, Nanjo S, Takeuchi S, Chakrabarti T, Brown T, Dev Sahadevan SW, et al. Targeting WEE1 to Overcome ARID1A Mutation-Driven Osimertinib Resistance in EGFR-Mutant Lung Cancer. J Thorac Oncol. 2025;20(10):1459\u201374.","journal-title":"J Thorac Oncol"},{"issue":"9","key":"2763_CR462","doi-asserted-by":"publisher","first-page":"e12074","DOI":"10.1002\/advs.202512074","volume":"13","author":"C Zhang","year":"2026","unstructured":"Zhang C, Zhu Y, Ai L, Wang J, Yu S, Wang Y, et al. Targeting WEE1 in ARID1A\/TP53 Concurrent Mutant Colorectal Cancer by Exploiting RLoop Accumulation and DNA Repair Deficiencies. Adv Sci (Weinh). 2026;13(9):e12074.","journal-title":"Adv Sci (Weinh)"},{"issue":"36","key":"2763_CR463","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202415585","volume":"12","author":"O Odnokoz","year":"2025","unstructured":"Odnokoz O, Banerjee A, Cui X, Zeng L, Uddin A, Li C, et al. Disruption of ARID1B Recruitment to the Nuclear Pore Complex as a New Anticancer Therapeutic Strategy. Adv Sci (Weinh). 2025;12(36):e15585.","journal-title":"Adv Sci (Weinh)"},{"issue":"6","key":"2763_CR464","doi-asserted-by":"publisher","first-page":"952","DOI":"10.3390\/cells12060952","volume":"12","author":"T Lebedev","year":"2023","unstructured":"Lebedev T, Kousar R, Patrick B, Usama M, Lee MK, Tan M, et al. Targeting ARID1A-Deficient Cancers: An Immune-Metabolic Perspective. Cells. 2023;12(6):952.","journal-title":"Cells"},{"issue":"1, Supplement 1","key":"2763_CR465","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.100814","volume":"8","author":"S Banerjee","year":"2023","unstructured":"Banerjee S, Leary A, Stewart JR, Dewan M, Lheureux S, Clamp AR, et al. 34O ATR inhibitor alone (ceralasertib) or in combination with olaparib in gynaecological cancers with ARID1A loss or no loss: results from the ENGOT\/GYN1\/NCRI ATARI trial. ESMO Open. 2023;8(1, Supplement 1):100814.","journal-title":"ESMO Open"},{"issue":"11","key":"2763_CR466","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1038\/s41418-025-01510-x","volume":"32","author":"X Zhang","year":"2025","unstructured":"Zhang X, Wang Z, He Y, Wang K, Xiang C, Liu Y, et al. ARID1A loss enhances sensitivity to c-MET inhibition by dual targeting of GPX4 and iron homeostasis, inducing ferroptosis. Cell Death Differ. 2025;32(11):2009\u201321.","journal-title":"Cell Death Differ"},{"issue":"11","key":"2763_CR467","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101264","volume":"4","author":"T Xing","year":"2023","unstructured":"Xing T, Li L, Chen Y, Ju G, Li G, Zhu X, et al. Targeting the TCA cycle through cuproptosis confers synthetic lethality on ARID1A-deficient hepatocellular carcinoma. Cell Rep Med. 2023;4(11):101264.","journal-title":"Cell Rep Med"},{"issue":"5","key":"2763_CR468","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41419-024-06751-1","volume":"15","author":"Z Wang","year":"2024","unstructured":"Wang Z, Zhang X, Luo Y, Song Y, Xiang C, He Y, et al. Therapeutic targeting of ARID1A-deficient cancer cells with RITA (reactivating p53 and inducing tumor apoptosis). Cell Death Dis. 2024;15(5):375.","journal-title":"Cell Death Dis"},{"key":"2763_CR469","doi-asserted-by":"publisher","unstructured":"Qiu Q, Ding Y, Han J, Guo X, Zhang J, Chen Y, et al. EZH2 deficiency suppresses colorectal cancer progression by inhibiting the mismatch repair pathway and consequently reducing extrachromosomal circular DNA formation. Cell Death Dis. 2026. https:\/\/doi.org\/10.1038\/s41419-026-08919-3.","DOI":"10.1038\/s41419-026-08919-3"},{"issue":"3","key":"2763_CR470","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nm.3799","volume":"21","author":"BG Bitler","year":"2015","unstructured":"Bitler BG, Aird KM, Garipov A, Li H, Amatangelo M, Kossenkov AV, et al. Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers. Nat Med. 2015;21(3):231\u20138.","journal-title":"Nat Med"},{"issue":"7","key":"2763_CR471","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1158\/1535-7163.MCT-15-0554","volume":"15","author":"RE Miller","year":"2016","unstructured":"Miller RE, Brough R, Bajrami I, Williamson CT, McDade S, Campbell J, et al. Synthetic Lethal Targeting of ARID1A-Mutant Ovarian Clear Cell Tumors with Dasatinib. Mol Cancer Ther. 2016;15(7):1472\u201384.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"2763_CR472","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1038\/s41467-018-05694-4","volume":"9","author":"C Wu","year":"2018","unstructured":"Wu C, Lyu J, Yang EJ, Liu Y, Zhang B, Shim JS. Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells. Nat Commun. 2018;9(1):3212.","journal-title":"Nat Commun"},{"key":"2763_CR473","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115727","volume":"215","author":"C Lanzi","year":"2023","unstructured":"Lanzi C, Arrighetti N, Pasquali S, Cassinelli G. Targeting EZH2 in SMARCB1-deficient sarcomas: Advances and opportunities to potentiate the efficacy of EZH2 inhibitors. Biochem Pharmacol. 2023;215:115727.","journal-title":"Biochem Pharmacol"},{"key":"2763_CR474","doi-asserted-by":"publisher","first-page":"1529239","DOI":"10.3389\/fimmu.2025.1529239","volume":"16","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wang H, Zhan Z, Gan L, Bai O. Mechanisms of HDACs in cancer development. Front Immunol. 2025;16:1529239.","journal-title":"Front Immunol"},{"issue":"9","key":"2763_CR475","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1158\/0008-5472.CAN-18-3066","volume":"79","author":"TP Howard","year":"2019","unstructured":"Howard TP, Arnoff TE, Song MR, Giacomelli AO, Wang X, Hong AL, et al. MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors. Cancer Res. 2019;79(9):2404\u201314.","journal-title":"Cancer Res"},{"issue":"15","key":"2763_CR476","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.3390\/cancers14153645","volume":"14","author":"GW Cooper","year":"2022","unstructured":"Cooper GW, Hong AL. SMARCB1-Deficient Cancers: Novel Molecular Insights and Therapeutic Vulnerabilities. Cancers (Basel). 2022;14(15):3645.","journal-title":"Cancers (Basel)"},{"key":"2763_CR477","doi-asserted-by":"publisher","first-page":"e44161","DOI":"10.7554\/eLife.44161","volume":"8","author":"AL Hong","year":"2019","unstructured":"Hong AL, Tseng YY, Wala JA, Kim WJ, Kynnap BD, Doshi MB, et al. Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition. Elife. 2019;8:e44161.","journal-title":"Elife"},{"key":"2763_CR478","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.canlet.2019.02.031","volume":"449","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Li J, Guo H, Wang F, Ma L, Du C, et al. BRM transcriptionally regulates miR-302a-3p to target SOCS5\/STAT3 signaling axis to potentiate pancreatic cancer metastasis. Cancer Lett. 2019;449:215\u201325.","journal-title":"Cancer Lett"},{"issue":"21","key":"2763_CR479","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1038\/s41388-021-01781-x","volume":"40","author":"M Wanior","year":"2021","unstructured":"Wanior M, Kramer A, Knapp S, Joerger AC. Exploiting vulnerabilities of SWI\/SNF chromatin remodelling complexes for cancer therapy. Oncogene. 2021;40(21):3637\u201354.","journal-title":"Oncogene"},{"issue":"22","key":"2763_CR480","doi-asserted-by":"publisher","first-page":"6330","DOI":"10.1158\/0008-5472.CAN-17-2043","volume":"77","author":"EH Yau","year":"2017","unstructured":"Yau EH, Kummetha IR, Lichinchi G, Tang R, Zhang Y, Rana TM. Genome-Wide CRISPR Screen for Essential Cell Growth Mediators in Mutant KRAS Colorectal Cancers. Cancer Res. 2017;77(22):6330\u20139.","journal-title":"Cancer Res"},{"issue":"22","key":"2763_CR481","doi-asserted-by":"publisher","first-page":"10155","DOI":"10.1021\/acs.jmedchem.8b01318","volume":"61","author":"JPN Papillon","year":"2018","unstructured":"Papillon JPN, Nakajima K, Adair CD, Hempel J, Jouk AO, Karki RG, et al. Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)\/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)\/SMARCA4-Mutant Cancers. J Med Chem. 2018;61(22):10155\u201372.","journal-title":"J Med Chem"},{"issue":"2","key":"2763_CR482","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1021\/acs.jmedchem.4c02535","volume":"68","author":"RG Vaswani","year":"2025","unstructured":"Vaswani RG, Huang DS, Anthony N, Xu L, Centore R, Schiller S, et al. Discovery of FHD-286, a First-in-Class, Orally Bioavailable, Allosteric Dual Inhibitor of the Brahma Homologue (BRM) and Brahma-Related Gene 1 (BRG1) ATPase Activity for the Treatment of SWItch\/Sucrose Non-Fermentable (SWI\/SNF) Dependent Cancers. J Med Chem. 2025;68(2):1772\u201392.","journal-title":"J Med Chem"},{"issue":"12","key":"2763_CR483","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1158\/1078-0432.CCR-24-3790","volume":"31","author":"CD DiNardo","year":"2025","unstructured":"DiNardo CD, Fathi AT, Kishtagari A, Bhalla KN, Quint\u00e1s-Cardama A, Reilly SA, et al. A Phase I Study of FHD-286, a Dual BRG1\/BRM (SMARCA4\/SMARCA2) Inhibitor, in Patients with Advanced Myeloid Malignancies. Clin Cancer Res. 2025;31(12):2327\u201338.","journal-title":"Clin Cancer Res"},{"issue":"24","key":"2763_CR484","doi-asserted-by":"publisher","first-page":"5290","DOI":"10.1016\/j.cell.2023.10.006","volume":"186","author":"BJE Martin","year":"2023","unstructured":"Martin BJE, Ablondi EF, Goglia C, Mimoso CA, Espinel-Cabrera PR, Adelman K. Global identification of SWI\/SNF targets reveals compensation by EP400. Cell. 2023;186(24):5290-307.e26.","journal-title":"Cell"},{"key":"2763_CR485","doi-asserted-by":"crossref","unstructured":"Lee JY, Brooks N, Antonakos B, Perria B, Langan C, Jones BD, et al. Abstract PR015: Discovery of LY4050784 (FHD-909), a selective BRM (SMARCA2) ATPase inhibitor for the treatment of BRG1(SMARCA4) mutant cancers. Molecular Cancer Therapeutics. 2024;23(6_Supplement):PR015-PR.","DOI":"10.1158\/1538-8514.SYNTHLETH24-PR015"},{"issue":"10","key":"2763_CR486","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1021\/acsmedchemlett.5c00459","volume":"16","author":"J Zhu","year":"2025","unstructured":"Zhu J, Bai X, Xiong Y, Xie C, Chen Y, Sun H. Discovery of Novel Selective Inhibitors of SMARCA2 ATPase Domain by Virtual Screening and Biological Evaluation. ACS Med Chem Lett. 2025;16(10):2032\u201340.","journal-title":"ACS Med Chem Lett"},{"issue":"1","key":"2763_CR487","doi-asserted-by":"publisher","first-page":"6814","DOI":"10.1038\/s41467-022-34562-5","volume":"13","author":"J Cantley","year":"2022","unstructured":"Cantley J, Ye X, Rousseau E, Januario T, Hamman BD, Rose CM, et al. Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers. Nat Commun. 2022;13(1):6814.","journal-title":"Nat Commun"},{"issue":"1","key":"2763_CR488","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1158\/0008-5472.CAN-25-1141","volume":"86","author":"M Hulse","year":"2026","unstructured":"Hulse M, Wang M, Xu C, Carter J, Agarwal A, Lu L, et al. PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers. Cancer Res. 2026;86(1):213\u201335.","journal-title":"Cancer Res"},{"issue":"18","key":"2763_CR489","doi-asserted-by":"publisher","first-page":"e150453","DOI":"10.1172\/jci.insight.150453","volume":"6","author":"GP Botta","year":"2021","unstructured":"Botta GP, Kato S, Patel H, Fanta P, Lee S, Okamura R, et al. SWI\/SNF complex alterations as a biomarker of immunotherapy efficacy in pancreatic cancer. JCI Insight. 2021;6(18):e150453.","journal-title":"JCI Insight"},{"issue":"1","key":"2763_CR490","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/s41467-020-15959-6","volume":"11","author":"XD Liu","year":"2020","unstructured":"Liu XD, Kong W, Peterson CB, McGrail DJ, Hoang A, Zhang X, et al. PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma. Nat Commun. 2020;11(1):2135.","journal-title":"Nat Commun"},{"issue":"5","key":"2763_CR491","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1158\/0008-5472.CAN-24-1611","volume":"85","author":"L Cui","year":"2025","unstructured":"Cui L, Liu R, Han S, Zhang C, Wang B, Ruan Y, et al. Targeting Arachidonic Acid Metabolism Enhances Immunotherapy Efficacy in ARID1A-Deficient Colorectal Cancer. Cancer Res. 2025;85(5):925\u201341.","journal-title":"Cancer Res"},{"issue":"4","key":"2763_CR492","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101504","volume":"5","author":"M Bagheri","year":"2024","unstructured":"Bagheri M, Mohamed GA, Mohamed Saleem MA, Ognjenovic NB, Lu H, Kolling FW, et al. Pharmacological induction of chromatin remodeling drives chemosensitization in triple-negative breast cancer. Cell Rep Med. 2024;5(4):101504.","journal-title":"Cell Rep Med"},{"issue":"12","key":"2763_CR493","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.52586\/5035","volume":"26","author":"F Gao","year":"2021","unstructured":"Gao F, Li P, Kong X, Song T, Han Q, Zhou S. ARID1A-mutated cervical cancer depends on the activation of YAP signaling. Front Biosci (Landmark Ed). 2021;26(12):1411\u201321.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2763_CR494","doi-asserted-by":"crossref","unstructured":"Tolcher AW, Lakhani NJ, McKean M, Lingaraj T, Victor L, Sanchez-Martin M, et al. A phase 1, first-in-human study of IK-930, an oral TEAD inhibitor targeting the Hippo pathway in subjects with advanced solid tumors. Journal of Clinical Oncology. 2022;40(16_suppl):TPS3168-TPS.","DOI":"10.1200\/JCO.2022.40.16_suppl.TPS3168"},{"issue":"12","key":"2763_CR495","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1038\/s41591-025-04029-3","volume":"31","author":"TA Yap","year":"2025","unstructured":"Yap TA, Kwiatkowski DJ, Dagogo-Jack I, Offin M, Zauderer MG, Kratzke R, et al. YAP\/TEAD inhibitor VT3989 in solid tumors: a phase 1\/2 trial. Nat Med. 2025;31(12):4281\u201390.","journal-title":"Nat Med"},{"key":"2763_CR496","doi-asserted-by":"publisher","first-page":"S562","DOI":"10.1016\/j.annonc.2025.08.1488","volume":"36","author":"E Garralda","year":"2025","unstructured":"Garralda E, Florescu M, Aerts JG, Yoshida T, Postel-Vinay S, Dagogo-Jack I, et al. 919O A first-in-human study of oral IAG933 in adult patients with advanced mesothelioma and other solid tumours. Ann Oncol. 2025;36:S562.","journal-title":"Ann Oncol"},{"key":"2763_CR497","doi-asserted-by":"publisher","first-page":"e41305","DOI":"10.7554\/eLife.41305","volume":"7","author":"GL Brien","year":"2018","unstructured":"Brien GL, Remillard D, Shi J, Hemming ML, Chabon J, Wynne K, et al. Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma. Elife. 2018;7:e41305.","journal-title":"Elife"},{"issue":"Supplement_1","key":"2763_CR498","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1182\/blood-2019-130308","volume":"134","author":"M Vallurupalli","year":"2019","unstructured":"Vallurupalli M, Gorelov R, Garcia JS, Morgan EA, Ebert B, Tothova Z. Talazoparib treatment preferentially depletes cohesin-mutant clones in new in vivo models of cohesin-mutant myeloid diseases. Blood. 2019;134(Supplement_1):560.","journal-title":"Blood"},{"key":"2763_CR499","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116751","volume":"277","author":"M Ji","year":"2024","unstructured":"Ji M, Yu D, Liu X, Wang L, Zhang D, Yang Z, et al. Glutathione-dependent degradation of SMARCA2\/4 for targeted lung cancer therapy with improved selectivity. Eur J Med Chem. 2024;277:116751.","journal-title":"Eur J Med Chem"},{"issue":"39","key":"2763_CR500","doi-asserted-by":"publisher","first-page":"35481","DOI":"10.1021\/jacs.5c09857","volume":"147","author":"WS Byun","year":"2025","unstructured":"Byun WS, Zhuang Z, Hnatiuk AP, Jin C, Jiang Z, Baek K, et al. Discovery of BRD9 Molecular Glue Degraders That Spare Cardiomyocytes. J Am Chem Soc. 2025;147(39):35481\u201392.","journal-title":"J Am Chem Soc"},{"issue":"10","key":"2763_CR501","doi-asserted-by":"publisher","first-page":"12583","DOI":"10.1021\/acs.jmedchem.6c00592","volume":"69","author":"SA Baker Dockrey","year":"2026","unstructured":"Baker Dockrey SA, Chandra P, Chen H, Chen S, Cheung TK, Cosino E, et al. Antibody-Mediated Delivery of BRM\/BRG1 Protein Degraders Affords Strong Antitumor Efficacy in Multiple BRM-Dependent Non-Small Cell Lung Cancer Xenograft Models. J Med Chem. 2026;69(10):12583\u2013618.","journal-title":"J Med Chem"},{"issue":"3","key":"2763_CR502","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nm.3480","volume":"20","author":"KC Helming","year":"2014","unstructured":"Helming KC, Wang X, Wilson BG, Vazquez F, Haswell JR, Manchester HE, et al. ARID1B is a specific vulnerability in ARID1A-mutant cancers. Nat Med. 2014;20(3):251\u20134.","journal-title":"Nat Med"},{"issue":"11","key":"2763_CR503","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1002\/1878-0261.13193","volume":"16","author":"C Megino-Luque","year":"2022","unstructured":"Megino-Luque C, Sis\u00f3 P, Mota-Martorell N, Navaridas R, de la Rosa I, Urdanibia I, et al. ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma. Mol Oncol. 2022;16(11):2235\u201359.","journal-title":"Mol Oncol"},{"issue":"2","key":"2763_CR504","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/cas.14768","volume":"112","author":"M Tsuda","year":"2021","unstructured":"Tsuda M, Fukuda A, Kawai M, Araki O, Seno H. The role of the SWI\/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma. Cancer Sci. 2021;112(2):490\u20137.","journal-title":"Cancer Sci"},{"issue":"1","key":"2763_CR505","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/cancers18010142","volume":"18","author":"G Shankari","year":"2025","unstructured":"Shankari G, Prabhu D, Sureshan M, Jeyakanthan J, Rajamanikandan S. A Review of ARID1A's Role in Breast Cancer Progression: Context-Dependent Mechanisms and Therapeutic Implications. Cancers (Basel). 2025;18(1):142.","journal-title":"Cancers (Basel)"},{"issue":"21","key":"2763_CR506","doi-asserted-by":"publisher","first-page":"12815","DOI":"10.3390\/ijms232112815","volume":"23","author":"FL Zhang","year":"2022","unstructured":"Zhang FL, Li DQ. Targeting Chromatin-Remodeling Factors in Cancer Cells: Promising Molecules in Cancer Therapy. Int J Mol Sci. 2022;23(21):12815.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"2763_CR507","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41573-024-00978-5","volume":"23","author":"HA Malone","year":"2024","unstructured":"Malone HA, Roberts CWM. Chromatin remodellers as therapeutic targets. Nat Rev Drug Discov. 2024;23(9):661\u201381.","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"2763_CR508","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41576-023-00666-x","volume":"25","author":"S Gourisankar","year":"2024","unstructured":"Gourisankar S, Krokhotin A, Wenderski W, Crabtree GR. Context-specific functions of chromatin remodellers in development and disease. Nat Rev Genet. 2024;25(5):340\u201361.","journal-title":"Nat Rev Genet"},{"issue":"11","key":"2763_CR509","doi-asserted-by":"publisher","first-page":"5868","DOI":"10.3390\/ijms22115868","volume":"22","author":"N Zhang","year":"2021","unstructured":"Zhang N, Coutinho LE, Pati D. PDS5A and PDS5B in Cohesin Function and Human Disease. Int J Mol Sci. 2021;22(11):5868.","journal-title":"Int J Mol Sci"},{"issue":"19","key":"2763_CR510","doi-asserted-by":"publisher","first-page":"14964","DOI":"10.3390\/ijms241914964","volume":"24","author":"E Patnaik","year":"2023","unstructured":"Patnaik E, Madu C, Lu Y. Epigenetic Modulators as Therapeutic Agents in Cancer. Int J Mol Sci. 2023;24(19):14964.","journal-title":"Int J Mol Sci"},{"key":"2763_CR511","doi-asserted-by":"publisher","first-page":"1085391","DOI":"10.3389\/fgene.2022.1085391","volume":"13","author":"L Ren","year":"2022","unstructured":"Ren L, Yang Y, Li W, Yang H, Zhang Y, Ge B, et al. Recent advances in epigenetic anticancer therapeutics and future perspectives. Front Genet. 2022;13:1085391.","journal-title":"Front Genet"},{"issue":"8","key":"2763_CR512","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.trecan.2024.05.005","volume":"10","author":"J Neefjes","year":"2024","unstructured":"Neefjes J, Gurova K, Sarthy J, Szabo G, Henikoff S. Chromatin as an old and new anticancer target. Trends Cancer. 2024;10(8):696\u2013707.","journal-title":"Trends Cancer"},{"issue":"7","key":"2763_CR513","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1158\/0008-5472.CAN-23-2244","volume":"84","author":"A Chaudhri","year":"2024","unstructured":"Chaudhri A, Lizee G, Hwu P, Rai K. Chromatin Remodelers Are Regulators of the Tumor Immune Microenvironment. Cancer Res. 2024;84(7):965\u201376.","journal-title":"Cancer Res"},{"issue":"1","key":"2763_CR514","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s41065-025-00564-8","volume":"162","author":"S Ghorbian","year":"2025","unstructured":"Ghorbian S. Cancer cell plasticity and therapeutic resistance: mechanisms, crosstalk, and translational perspectives. Hereditas. 2025;162(1):188.","journal-title":"Hereditas"},{"issue":"1","key":"2763_CR515","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41392-021-00572-w","volume":"6","author":"L Zhong","year":"2021","unstructured":"Zhong L, Li Y, Xiong L, Wang W, Wu M, Yuan T, et al. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. Signal Transduct Target Ther. 2021;6(1):201.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2763_CR516","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41392-024-01856-7","volume":"9","author":"B Liu","year":"2024","unstructured":"Liu B, Zhou H, Tan L, Siu KTH, Guan XY. Exploring treatment options in cancer: Tumor treatment strategies. Signal Transduct Target Ther. 2024;9(1):175.","journal-title":"Signal Transduct Target Ther"},{"key":"2763_CR517","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2025.115755","volume":"229","author":"X Gou","year":"2026","unstructured":"Gou X, He S, Wang B, Zhang L, Cheng Y, Gao X. Integrating PROTAC-based targeted protein degradation with nanodelivery systems to overcome cancer therapeutic resistance. Adv Drug Deliv Rev. 2026;229:115755.","journal-title":"Adv Drug Deliv Rev"},{"key":"2763_CR518","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.605380","volume":"10","author":"M Montano-Samaniego","year":"2020","unstructured":"Montano-Samaniego M, Bravo-Estupinan DM, Mendez-Guerrero O, Alarcon-Hernandez E, Ibanez-Hernandez M. Strategies for Targeting Gene Therapy in Cancer Cells With Tumor-Specific Promoters. Front Oncol. 2020;10:605380.","journal-title":"Front Oncol"},{"issue":"10","key":"2763_CR519","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1039\/D2CS00141A","volume":"51","author":"PS Dragovich","year":"2022","unstructured":"Dragovich PS. Degrader-antibody conjugates. Chem Soc Rev. 2022;51(10):3886\u201397.","journal-title":"Chem Soc Rev"},{"key":"2763_CR520","doi-asserted-by":"crossref","unstructured":"Tsai PF, Dell'Orso S, Rodriguez J, Vivanco KO, Ko KD, Jiang K, et al. A Muscle-Specific Enhancer RNA Mediates Cohesin Recruitment and Regulates Transcription In trans. Mol Cell. 2018;71(1):129\u201341 e8.","DOI":"10.1016\/j.molcel.2018.06.008"},{"issue":"7","key":"2763_CR521","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1111\/febs.16362","volume":"290","author":"JA Horsfield","year":"2023","unstructured":"Horsfield JA. Full circle: a brief history of cohesin and the regulation of gene expression. FEBS J. 2023;290(7):1670\u201387.","journal-title":"FEBS J"},{"issue":"7818","key":"2763_CR522","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41586-020-2151-x","volume":"583","author":"F Grubert","year":"2020","unstructured":"Grubert F, Srivas R, Spacek DV, Kasowski M, Ruiz-Velasco M, Sinnott-Armstrong N, et al. Landscape of cohesin-mediated chromatin loops in the human genome. Nature. 2020;583(7818):737\u201343.","journal-title":"Nature"},{"issue":"2","key":"2763_CR523","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/ijc.35378","volume":"158","author":"AD Swett","year":"2026","unstructured":"Swett AD, Tothova Z. Cohesin mutations and chromatin changes in cancer. Int J Cancer. 2026;158(2):368\u201381.","journal-title":"Int J Cancer"},{"key":"2763_CR524","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.872729","volume":"10","author":"MR Burke","year":"2022","unstructured":"Burke MR, Smith AR, Zheng G. Overcoming cancer drug resistance utilizing PROTAC technology. Front Cell Dev Biol. 2022;10:872729.","journal-title":"Front Cell Dev Biol"},{"issue":"10","key":"2763_CR525","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1021\/acsmedchemlett.0c00347","volume":"11","author":"RB Kargbo","year":"2020","unstructured":"Kargbo RB. SMARCA2\/4 PROTAC for targeted protein degradation and cancer therapy. ACS Med Chem Lett. 2020;11(10):1797\u20138.","journal-title":"ACS Med Chem Lett"},{"issue":"2","key":"2763_CR526","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1021\/acs.jmedchem.8b01413","volume":"62","author":"V Zoppi","year":"2019","unstructured":"Zoppi V, Hughes SJ, Maniaci C, Testa A, Gmaschitz T, Wieshofer C, et al. Iterative design and optimization of initially inactive proteolysis targeting chimeras (PROTACs) identify VZ185 as a potent, fast, and selective von Hippel-Lindau (VHL) based dual degrader probe of BRD9 and BRD7. J Med Chem. 2019;62(2):699\u2013726.","journal-title":"J Med Chem"},{"issue":"2","key":"2763_CR527","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.apsb.2023.09.003","volume":"14","author":"X Peng","year":"2024","unstructured":"Peng X, Hu Z, Zeng L, Zhang M, Xu C, Lu B, et al. Overview of epigenetic degraders based on PROTAC, molecular glue, and hydrophobic tagging technologies. Acta Pharm Sin B. 2024;14(2):533\u201378.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"2763_CR528","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cell.2020.12.020","volume":"184","author":"SL Schreiber","year":"2021","unstructured":"Schreiber SL. The Rise of Molecular Glues. Cell. 2021;184(1):3\u20139.","journal-title":"Cell"},{"key":"2763_CR529","doi-asserted-by":"crossref","unstructured":"Zhang Y, Li L, Xu J, Che C, Jia J, Lu H, et al. A Novel Paradigm for Targeting Challenging Targets: Advancing Technologies and Future Directions of Molecular Glue Degraders. Molecules. 2026;31(3);459.","DOI":"10.3390\/molecules31030459"},{"key":"2763_CR530","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2026.115776","volume":"230","author":"Y Liu","year":"2026","unstructured":"Liu Y, Ullah I, Yuan Y, Wang J. Harnessing targeted protein degradation to potentiate cancer immunotherapy: from molecular mechanisms to delivery strategies. Adv Drug Deliv Rev. 2026;230:115776.","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"2763_CR531","doi-asserted-by":"publisher","first-page":"7897","DOI":"10.1021\/jacs.4c18398","volume":"147","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Gu W, Chen W, Zhu J, Fan L, Zhang L, et al. A Dual-Targeted Molecule for Disease-Activatable Proteolysis Targeting Chimeras and Targeted Radionuclide Therapy of Cancer. J Am Chem Soc. 2025;147(9):7897\u2013907.","journal-title":"J Am Chem Soc"},{"issue":"6717","key":"2763_CR532","doi-asserted-by":"publisher","DOI":"10.1126\/science.adl5361","volume":"386","author":"RC Sarott","year":"2024","unstructured":"Sarott RC, Gourisankar S, Karim B, Nettles S, Yang H, Dwyer BG, et al. Relocalizing transcriptional kinases to activate apoptosis. Science. 2024;386(6717):eadl5361.","journal-title":"Science"},{"issue":"7973","key":"2763_CR533","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41586-023-06348-2","volume":"620","author":"S Gourisankar","year":"2023","unstructured":"Gourisankar S, Krokhotin A, Ji W, Liu X, Chang CY, Kim SH, et al. Rewiring cancer drivers to activate apoptosis. Nature. 2023;620(7973):417\u201325.","journal-title":"Nature"},{"issue":"1","key":"2763_CR534","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s41392-024-02089-4","volume":"9","author":"K Huang","year":"2024","unstructured":"Huang K. Chemical inducers of proximity: precision tools for apoptosis in transcriptional regulation. Signal Transduct Target Ther. 2024;9(1):364.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2763_CR535","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41392-023-01548-8","volume":"8","author":"Q Li","year":"2023","unstructured":"Li Q, Qian W, Zhang Y, Hu L, Chen S, Xia Y. A new wave of innovations within the DNA damage response. Signal Transduct Target Ther. 2023;8(1):338.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2763_CR536","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1042\/BST20241633","volume":"53","author":"L Buckley-Benbow","year":"2025","unstructured":"Buckley-Benbow L, Agnarelli A, Bellelli R. \u201cWhere is my gap\u201d: mechanisms underpinning PARP inhibitor sensitivity in cancer. Biochem Soc Trans. 2025;53(1):225\u201334.","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"2763_CR537","doi-asserted-by":"publisher","first-page":"41","DOI":"10.36401\/JIPO-22-37","volume":"7","author":"KZ Hein","year":"2024","unstructured":"Hein KZ, Stephen B, Fu S. Therapeutic Role of Synthetic Lethality in ARID1A-Deficient Malignancies. J Immunother Precis Oncol. 2024;7(1):41\u201352.","journal-title":"J Immunother Precis Oncol"},{"issue":"6","key":"2763_CR538","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41416-023-02326-7","volume":"129","author":"D Bhamidipati","year":"2023","unstructured":"Bhamidipati D, Haro-Silerio JI, Yap TA, Ngoi N. PARP inhibitors: enhancing efficacy through rational combinations. Br J Cancer. 2023;129(6):904\u201316.","journal-title":"Br J Cancer"},{"key":"2763_CR539","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2025.103887","volume":"153","author":"SG Lee","year":"2025","unstructured":"Lee SG, Kim J, Jeong E, Myung K. DNA damage response inhibitors in cancer therapy: Mechanisms, clinical development, and combination strategies. DNA Repair (Amst). 2025;153:103887.","journal-title":"DNA Repair (Amst)"},{"issue":"11","key":"2763_CR540","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/nmeth.3999","volume":"13","author":"MR Mumbach","year":"2016","unstructured":"Mumbach MR, Rubin AJ, Flynn RA, Dai C, Khavari PA, Greenleaf WJ, et al. HiChIP: efficient and sensitive analysis of protein-directed genome architecture. Nat Methods. 2016;13(11):919\u201322.","journal-title":"Nat Methods"},{"issue":"6785","key":"2763_CR541","doi-asserted-by":"publisher","DOI":"10.1126\/science.adt4221","volume":"391","author":"KL Hansen","year":"2026","unstructured":"Hansen KL, Adachi AS, Braccioli L, Kadvani S, Boileau RM, Martinovic M, et al. Synergy between regulatory elements can render cohesin dispensable for distal enhancer function. Science. 2026;391(6785):eadt4221.","journal-title":"Science"},{"issue":"1","key":"2763_CR542","doi-asserted-by":"publisher","first-page":"5612","DOI":"10.1038\/s41467-020-19283-x","volume":"11","author":"EP Nora","year":"2020","unstructured":"Nora EP, Caccianini L, Fudenberg G, So K, Kameswaran V, Nagle A, et al. Molecular basis of CTCF binding polarity in genome folding. Nat Commun. 2020;11(1):5612.","journal-title":"Nat Commun"},{"issue":"1","key":"2763_CR543","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","volume":"10","author":"M Tufail","year":"2025","unstructured":"Tufail M, Jiang CH, Li N. Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. Signal Transduct Target Ther. 2025;10(1):227.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2763_CR544","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.immuni.2013.07.005","volume":"39","author":"GT Motz","year":"2013","unstructured":"Motz GT, Coukos G. Deciphering and reversing tumor immune suppression. Immunity. 2013;39(1):61\u201373.","journal-title":"Immunity"},{"issue":"1","key":"2763_CR545","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1165\/rcmb.2017-0110ED","volume":"57","author":"RW Vandivier","year":"2017","unstructured":"Vandivier RW, Ghosh M. Understanding the Relevance of the Mouse Cigarette Smoke Model of COPD: Peering through the Smoke. Am J Respir Cell Mol Biol. 2017;57(1):3\u20134.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2763_CR546","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.omto.2021.04.001","volume":"21","author":"G Sun","year":"2021","unstructured":"Sun G, Li Z, Rong D, Zhang H, Shi X, Yang W, et al. Single-cell RNA sequencing in cancer: applications, advances, and emerging challenges. Mol Ther Oncolytics. 2021;21:183\u2013206.","journal-title":"Mol Ther Oncolytics"},{"issue":"1","key":"2763_CR547","doi-asserted-by":"publisher","first-page":"8579","DOI":"10.1038\/s41467-024-52980-5","volume":"15","author":"A Ianevski","year":"2024","unstructured":"Ianevski A, Nader K, Driva K, Senkowski W, Bulanova D, Moyano-Galceran L, et al. Single-cell transcriptomes identify patient-tailored therapies for selective co-inhibition of cancer clones. Nat Commun. 2024;15(1):8579.","journal-title":"Nat Commun"},{"issue":"1","key":"2763_CR548","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1038\/s41467-019-12037-4","volume":"10","author":"B Zhao","year":"2019","unstructured":"Zhao B, Lin J, Rong L, Wu S, Deng Z, Fatkhutdinov N, et al. ARID1A promotes genomic stability through protecting telomere cohesion. Nat Commun. 2019;10(1):4067.","journal-title":"Nat Commun"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02763-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02763-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02763-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:02:44Z","timestamp":1789617764000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-026-02763-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":548,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2763"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02763-x","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"11 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"218"}}